N-PX 1 ghwt-html5397_npx.htm THE GABELLI HEALTHCARE WELLNESSRX TRUST_N-PX

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM N-PX

 

ANNUAL REPORT OF PROXY VOTING RECORD OF REGISTERED

MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number 811-22021

 

The Gabelli Healthcare & WellnessRx Trust

 

(Exact name of registrant as specified in charter)

 

One Corporate Center

Rye, New York 10580-1422

 

(Address of principal executive offices) (Zip code)

 

John C. Ball

Gabelli Funds, LLC

One Corporate Center

Rye, New York 10580-1422

 

(Name and address of agent for service)

 

Registrant’s telephone number, including area code: 1-800-422-3554

 

Date of fiscal year end: December 31

 

Date of reporting period: July 1, 2021 – June 30, 2022

 

Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (17 CFR 239.24 and 274.5), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.

 

 

PROXY VOTING RECORD

FOR PERIOD JULY 1, 2021 TO JUNE 30, 2022

ProxyEdge

Meeting Date Range: 07/01/2021 - 06/30/2022

The Gabelli Healthcare & Wellness Trust

Report Date: 07/05/2022

1

 

Investment Company Report
  MCKESSON CORPORATION    
  Security 58155Q103       Meeting Type Annual  
  Ticker Symbol MCK                   Meeting Date 23-Jul-2021  
  ISIN US58155Q1031       Agenda 935457425 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director for a one-year term: Dominic J. Caruso Management   For   For    
  1B.   Election of Director for a one-year term: Donald R. Knauss Management   For   For    
  1C.   Election of Director for a one-year term: Bradley E. Lerman Management   For   For    
  1D.   Election of Director for a one-year term: Linda P. Mantia Management   For   For    
  1E.   Election of Director for a one-year term: Maria Martinez Management   For   For    
  1F.   Election of Director for a one-year term: Edward A. Mueller Management   For   For    
  1G.   Election of Director for a one-year term: Susan R. Salka Management   For   For    
  1H.   Election of Director for a one-year term: Brian S. Tyler Management   For   For    
  1I.   Election of Director for a one-year term: Kenneth E. Washington Management   For   For    
  2.    Ratification of the appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending March 31, 2022. Management   For   For    
  3.    Advisory vote on executive compensation. Management   For   For    
  4.    Shareholder proposal on action by written consent of shareholders. Shareholder   Against   For    
  ITO EN,LTD.    
  Security J25027103       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 27-Jul-2021  
  ISIN JP3143000002       Agenda 714422285 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
    Please reference meeting materials. Non-Voting            
  1     Approve Appropriation of Surplus Management   For   For    
  2     Appoint a Corporate Auditor Yokokura, Hitoshi Management   For   For    
  HAEMONETICS CORPORATION    
  Security 405024100       Meeting Type Annual  
  Ticker Symbol HAE                   Meeting Date 06-Aug-2021  
  ISIN US4050241003       Agenda 935461715 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Christopher A. Simon       For   For    
      2 Robert E. Abernathy       For   For    
      3 Catherine M. Burzik       For   For    
      4 Michael J. Coyle       For   For    
      5 Charles J. Dockendorff       For   For    
      6 Lloyd E. Johnson       For   For    
  2.    To approve, on an advisory basis, the compensation of our named executive officers. Management   For   For    
  3.    To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending April 2, 2022. Management   For   For    
  THE J. M. SMUCKER COMPANY    
  Security 832696405       Meeting Type Annual  
  Ticker Symbol SJM                   Meeting Date 18-Aug-2021  
  ISIN US8326964058       Agenda 935468264 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director whose term of office will expire in 2022: Susan E. Chapman-Hughes Management   For   For    
  1B.   Election of Director whose term of office will expire in 2022: Paul J. Dolan Management   For   For    
  1C.   Election of Director whose term of office will expire in 2022: Jay L. Henderson Management   For   For    
  1D.   Election of Director whose term of office will expire in 2022: Kirk L. Perry Management   For   For    
  1E.   Election of Director whose term of office will expire in 2022: Sandra Pianalto Management   For   For    
  1F.   Election of Director whose term of office will expire in 2022: Alex Shumate Management   For   For    
  1G.   Election of Director whose term of office will expire in 2022: Mark T. Smucker Management   For   For    
  1H.   Election of Director whose term of office will expire in 2022: Richard K. Smucker Management   For   For    
  1I.   Election of Director whose term of office will expire in 2022: Timothy P. Smucker Management   For   For    
  1J.   Election of Director whose term of office will expire in 2022: Jodi L. Taylor Management   For   For    
  1K.   Election of Director whose term of office will expire in 2022: Dawn C. Willoughby Management   For   For    
  2.    Ratification of appointment of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for the 2022 fiscal year. Management   For   For    
  3.    Advisory approval of the Company’s executive compensation. Management   For   For    
  VITASOY INTERNATIONAL HOLDINGS LTD    
  Security Y93794108       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 23-Aug-2021  
  ISIN HK0345001611       Agenda 714476670 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  CMMT  PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2021/ 0714/2021071400452.pdf-AND- https://www1.hkexnews.hk/listedco/listconews/sehk/2021/ 0714/2021071400422.pdf Non-Voting            
  CMMT  PLEASE NOTE IN THE HONG KONG MARKET THAT A VOTE OF ‘ABSTAIN’ WILL BE TREATED-THE SAME AS A ‘TAKE NO ACTION’ VOTE Non-Voting            
  1     TO RECEIVE AND ADOPT THE AUDITED FINANCIAL STATEMENTS AND THE REPORTS OF THE DIRECTORS AND AUDITORS FOR THE YEAR ENDED 31ST MARCH, 2021 Management   For   For    
  2     TO DECLARE A FINAL DIVIDEND Management   For   For    
  3.AI  TO TO RE-ELECT DR. THE HON. SIR DAVID KWOK- PO LI AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR Management   Against   Against    
  3.AII TO RE-ELECT MR. JAN P.S. ERLUND AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR Management   For   For    
  3AIII TO RE-ELECT MR. ANTHONY JOHN LIDDELL NIGHTINGALE AS AN INDEPENDENT NON- EXECUTIVE DIRECTOR Management   Against   Against    
  3.B   TO DETERMINE THE REMUNERATION OF THE DIRECTORS Management   For   For    
  4     TO APPOINT AUDITORS AND AUTHORISE THE DIRECTORS TO FIX THEIR REMUNERATION: KPMG Management   For   For    
  5.A   TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO ISSUE, ALLOT AND DEAL WITH ADDITIONAL SHARES OF THE COMPANY, NOT EXCEEDING 10% OF THE NUMBER OF ISSUED SHARES OF THE COMPANY AS AT THE DATE OF THIS RESOLUTION Management   Against   Against    
  5.B   TO GRANT A GENERAL MANDATE TO THE DIRECTORS TO BUY-BACK SHARES OF THE COMPANY, NOT EXCEEDING 10% OF THE NUMBER OF ISSUED SHARES OF THE COMPANY AS AT THE DATE OF THIS RESOLUTION Management   For   For    
  5.C   TO ADD THE NUMBER OF SHARES BOUGHT-BACK PURSUANT TO RESOLUTION 5B TO THE NUMBER OF SHARES AVAILABLE PURSUANT TO RESOLUTION 5A Management   Against   Against    
  CMMT  23 JUL 2021: PLEASE NOTE THAT THIS IS A REVISION DUE TO MODIFICATION OF THE-TEXT OF RESOLUTION 3.AI AND RECEIPT OF NAME FOR RESOLUTION 4. IF YOU HAVE-ALREADY SENT IN YOUR VOTES, PLEASE DO NOT VOTE AGAIN UNLESS YOU DECIDE TO-AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU Non-Voting            
  PATTERSON COMPANIES, INC.    
  Security 703395103       Meeting Type Annual  
  Ticker Symbol PDCO                  Meeting Date 13-Sep-2021  
  ISIN US7033951036       Agenda 935478506 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director to have terms expiring in 2022: John D. Buck Management   For   For    
  1B.   Election of Director to have terms expiring in 2022: Alex N. Blanco Management   For   For    
  1C.   Election of Director to have terms expiring in 2022: Jody H. Feragen Management   For   For    
  1D.   Election of Director to have terms expiring in 2022: Robert C. Frenzel Management   For   For    
  1E.   Election of Director to have terms expiring in 2022: Francis J. Malecha Management   For   For    
  1F.   Election of Director to have terms expiring in 2022: Ellen A. Rudnick Management   For   For    
  1G.   Election of Director to have terms expiring in 2022: Neil A. Schrimsher Management   For   For    
  1H.   Election of Director to have terms expiring in 2022: Mark S. Walchirk Management   For   For    
  2.    Approval of amendment to Amended and Restated 2015 Omnibus Incentive Plan. Management   Against   Against    
  3.    Advisory approval of executive compensation. Management   For   For    
  4.    To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending April 30, 2022. Management   For   For    
  CONAGRA BRANDS, INC.    
  Security 205887102       Meeting Type Annual  
  Ticker Symbol CAG                   Meeting Date 15-Sep-2021  
  ISIN US2058871029       Agenda 935479558 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Anil Arora Management   For   For    
  1B.   Election of Director: Thomas K. Brown Management   For   For    
  1C.   Election of Director: Emanuel Chirico Management   For   For    
  1D.   Election of Director: Sean M. Connolly Management   For   For    
  1E.   Election of Director: Joie A. Gregor Management   For   For    
  1F.   Election of Director: Fran Horowitz Management   For   For    
  1G.   Election of Director: Rajive Johri Management   For   For    
  1H.   Election of Director: Richard H. Lenny Management   For   For    
  1I.   Election of Director: Melissa Lora Management   For   For    
  1J.   Election of Director: Ruth Ann Marshall Management   For   For    
  1K.   Election of Director: Craig P. Omtvedt Management   For   For    
  1L.   Election of Director: Scott Ostfeld Management   For   For    
  2.    Ratification of the appointment of KPMG LLP as our independent auditor for fiscal 2022. Management   For   For    
  3.    Advisory approval of our named executive officer compensation. Management   For   For    
  4.    A shareholder proposal regarding written consent. Shareholder   Against   For    
  GENERAL MILLS, INC.    
  Security 370334104       Meeting Type Annual  
  Ticker Symbol GIS                   Meeting Date 28-Sep-2021  
  ISIN US3703341046       Agenda 935483987 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: R. Kerry Clark Management   For   For    
  1B.   Election of Director: David M. Cordani Management   For   For    
  1C.   Election of Director: Jeffrey L. Harmening Management   For   For    
  1D.   Election of Director: Maria G. Henry Management   For   For    
  1E.   Election of Director: Jo Ann Jenkins Management   For   For    
  1F.   Election of Director: Elizabeth C. Lempres Management   For   For    
  1G.   Election of Director: Diane L. Neal Management   For   For    
  1H.   Election of Director: Steve Odland Management   For   For    
  1I.   Election of Director: Maria A. Sastre Management   For   For    
  1J.   Election of Director: Eric D. Sprunk Management   For   For    
  1K.   Election of Director: Jorge A. Uribe Management   For   For    
  2.    Advisory Vote on Executive Compensation. Management   For   For    
  3.    Ratify Appointment of the Independent Registered Public Accounting Firm. Management   For   For    
  4.    Amendment and Restatement of Our Certificate of Incorporation to Eliminate Supermajority Voting Provisions. Management   For   For    
  INTERSECT ENT, INC.    
  Security 46071F103       Meeting Type Special 
  Ticker Symbol XENT                  Meeting Date 08-Oct-2021  
  ISIN US46071F1030       Agenda 935495641 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    To adopt the Agreement and Plan of Merger, dated August 6, 2021 (the “Merger Agreement”), by and among Intersect ENT, Inc. (“Intersect ENT”), Medtronic, Inc., and Project Kraken Merger Sub, Inc. Management   For   For    
  2.    To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Intersect ENT’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. Management   For   For    
  3.    To adjourn the Special Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. Management   For   For    
  CHINA MENGNIU DAIRY CO LTD    
  Security G21096105       Meeting Type ExtraOrdinary General Meeting
  Ticker Symbol         Meeting Date 12-Oct-2021  
  ISIN KYG210961051       Agenda 714681764 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  CMMT  PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2021/ 0923/2021092301214.pdf-AND- https://www1.hkexnews.hk/listedco/listconews/sehk/2021/ 0923/2021092301197.pdf Non-Voting            
  CMMT  PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE ‘IN FAVOR’ OR ‘AGAINST’ FOR- RESOLUTION 1, ABSTAIN IS NOT A VOTING OPTION ON THIS MEETING Non-Voting            
  1     THAT: (A) THE PROPOSED RELEVANT SCHEME (INCLUDING BUT NOT LIMITED TO THE ISSUANCE AND SUBSCRIPTION OF THE CONVERTIBLE BONDS, THE LOAN GUARANTEE AND THE SECURITY DEED) BE AND IS HEREBY APPROVED, CONFIRMED AND RATIFIED; (B) THE PLACING AGREEMENT DATED JANUARY 24, 2021 ENTERED INTO BETWEEN THE COMPANY AND THE PLACING AGENT IN RELATION TO THE PLACING OF THE CONVERTIBLE BONDS IN THE AGGREGATE PRINCIPAL AMOUNT OF UP TO HKD EQUIVALENT OF RMB4,000,000,000, A COPY OF THE PLACING AGREEMENT HAVING BEEN PRODUCED TO THE EGM MARKED ’‘B’’ AND SIGNED BY THE CHAIRMAN OF THE EGM FOR IDENTIFICATION PURPOSE, AND THE TRANSACTIONS CONTEMPLATED THEREUNDER BE AND ARE HEREBY APPROVED, CONFIRMED AND RATIFIED; (C) THE TERMS AND CONDITIONS OF THE CONVERTIBLE BONDS TO BE EXECUTED BY THE COMPANY IN RELATION TO THE ISSUE BY THE COMPANY OF THE CONVERTIBLE BONDS UNDER THE SPECIFIC MANDATE (A COPY OF WHICH HAS BEEN PRODUCED TO THE EGM MARKED ’‘C’’ AND SIGNED BY THE CHAIRMAN OF THE EGM FOR IDENTIFICATION PURPOSE), SUBJECT TO COMPLETION, WHICH ARE CONVERTIBLE AT AN INITIAL CONVERSION PRICE OF HKD 34.73 PER SHARE (SUBJECT TO ADJUSTMENTS) BE AND IS HEREBY APPROVED; (D) THE GRANT OF THE SPECIFIC MANDATE TO THE DIRECTORS TO ISSUE THE CONVERTIBLE BOND SUBJECT TO COMPLETION OF THE PLACING AND TO ISSUE AND ALLOT THE CONVERSION SHARES TO THE NOTES ISSUER BE AND IS HEREBY APPROVED, CONFIRMED AND RATIFIED. THE SPECIFIC MANDATE IS IN ADDITION TO, AND SHALL NOT Management   For   For    
    PREJUDICE NOR REVOKE ANY GENERAL OR SPECIFIC MANDATE(S) WHICH HAS/HAVE BEEN GRANTED OR MAY FROM TIME TO TIME BE GRANTED TO THE DIRECTORS BY THE SHAREHOLDERS PRIOR TO THE PASSING OF THIS RESOLUTION; (E) ANY OTHER DOCUMENTS ENTERED INTO AND/OR TO BE ENTERED INTO IN CONNECTION WITH THE RELEVANT SCHEME AND THE CONVERTIBLE BONDS, INCLUDING BUT NOT LIMITED TO (I) THE FACILITY AGREEMENT, (II) THE SECURITY DEED, (III) THE LOAN GUARANTEE, (IV) THE TRUST DEED AND (V) THE AGENCY AGREEMENT, A COPY OF WHICH HAVING BEEN PRODUCED TO THE EGM MARKED ’‘D’’, ’‘E’’, ’‘F’’, ’‘G’’ AND ’‘H’’, RESPECTIVELY, AND SIGNED BY THE CHAIRMAN OF THE EGM FOR IDENTIFICATION PURPOSE, AND THE TRANSACTIONS CONTEMPLATED THEREUNDER BE AND ARE HEREBY APPROVED, CONFIRMED AND RATIFIED; (F) EACH OF THE DIRECTORS AND THE COMPANY SECRETARY BE AND IS HEREBY AUTHORISED TO DO ALL SUCH ACTS AND THINGS AND SIGN, RATIFY OR EXECUTE (WITH OR WITHOUT AFFIXATION OF SEAL) ALL SUCH DOCUMENTS AND TAKE ALL SUCH STEPS AS SUCH DIRECTOR AND/OR THE COMPANY SECRETARY IN HIS/HER DISCRETION MAY CONSIDER NECESSARY, APPROPRIATE, DESIRABLE AND EXPEDIENT TO IMPLEMENT, GIVE EFFECT TO OR IN CONNECTION WITH THE TRANSACTIONS; AND (G) ANY AND ALL ACTIONS HERETOFORE TAKEN BY ANY DIRECTOR, OFFICER, THE COMPANY SECRETARY AND/OR SHARE REGISTRARS OF THE COMPANY, IN CONNECTION WITH THE FOREGOING RESOLUTIONS, BE AND ARE HEREBY RATIFIED, CONFIRMED AND APPROVED IN ALL RESPECTS                  
  THE PROCTER & GAMBLE COMPANY    
  Security 742718109       Meeting Type Annual  
  Ticker Symbol PG                    Meeting Date 12-Oct-2021  
  ISIN US7427181091       Agenda 935488002 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   ELECTION OF DIRECTOR: B. Marc Allen Management   For   For    
  1B.   ELECTION OF DIRECTOR: Angela F. Braly Management   For   For    
  1C.   ELECTION OF DIRECTOR: Amy L. Chang Management   For   For    
  1D.   ELECTION OF DIRECTOR: Joseph Jimenez Management   For   For    
  1E.   ELECTION OF DIRECTOR: Christopher Kempczinski Management   For   For    
  1F.   ELECTION OF DIRECTOR: Debra L. Lee Management   For   For    
  1G.   ELECTION OF DIRECTOR: Terry J. Lundgren Management   For   For    
  1H.   ELECTION OF DIRECTOR: Christine M. McCarthy Management   For   For    
  1I.   ELECTION OF DIRECTOR: Jon R. Moeller Management   For   For    
  1J.   ELECTION OF DIRECTOR: David S. Taylor Management   For   For    
  1K.   ELECTION OF DIRECTOR: Margaret C. Whitman Management   For   For    
  1L.   ELECTION OF DIRECTOR: Patricia A. Woertz Management   For   For    
  2.    Ratify Appointment of the Independent Registered Public Accounting Firm. Management   For   For    
  3.    Advisory Vote to Approve the Company’s Executive Compensation (the “Say on Pay” vote). Management   For   For    
  4.    Shareholder Proposal - Inclusion of Non-Management Employees on Director Nominee Candidate Lists. Shareholder   Against   For    
  TRILLIUM THERAPEUTICS INC.    
  Security 89620X506       Meeting Type Special 
  Ticker Symbol TRIL                  Meeting Date 26-Oct-2021  
  ISIN CA89620X5064       Agenda 935501723 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1     To consider and, if deemed advisable, pass, with or without variation, a special resolution, the full text of which is set forth in Appendix B to the accompanying Management Information Circular and Proxy Statement of Trillium dated September 27, 2021 (the “Information Circular”), approving a statutory arrangement (the “Arrangement”) under Division 5 of Part 9 of the Business Corporations Act (British Columbia) involving Trillium, all as more particularly described in the Information Circular. Management   For   For    
  2     To consider and, if deemed advisable, pass an advisory (non- binding) resolution on specified compensation that may become payable to the named executive officers of Trillium in connection with the Arrangement, all as more particularly described in the Information Circular. Management   For   For    
  CATALENT, INC.    
  Security 148806102       Meeting Type Annual  
  Ticker Symbol CTLT                  Meeting Date 28-Oct-2021  
  ISIN US1488061029       Agenda 935494411 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Madhavan Balachandran Management   For   For    
  1B.   Election of Director: Michael J. Barber Management   For   For    
  1C.   Election of Director: J. Martin Carroll Management   For   For    
  1D.   Election of Director: John Chiminski Management   For   For    
  1E.   Election of Director: Rolf Classon Management   For   For    
  1F.   Election of Director: Rosemary A. Crane Management   For   For    
  1G.   Election of Director: John Greisch Management   For   For    
  1H.   Election of Director: Christa Kreuzburg Management   For   For    
  1I.   Election of Director: Gregory T. Lucier Management   For   For    
  1J.   Election of Director: Donald E. Morel, Jr. Management   For   For    
  1K.   Election of Director: Jack Stahl Management   For   For    
  2.    Ratification of Appointment of Independent Auditor for Fiscal 2022. Management   For   For    
  3.    Advisory Vote to Approve Our Executive Compensation (Say-on-Pay). Management   For   For    
  4.    Advisory Vote on the Frequency of Advisory Votes in Respect of Executive Compensation. Management   1 Year   For    
  5.    Amend our Certificate of Incorporation to Remove the Limitation on Calling Shareholder Special Meetings. Management   For   For    
  6.    Amend our Certificate of Incorporation to Add a Federal Forum Selection Provision. Management   For   For    
  7.    Amend and Restate our Certificate of Incorporation to (i) Eliminate the Supermajority Vote Requirement for Amendments and (ii) Make Non-Substantive and Conforming Changes. Management   For   For    
  THE HAIN CELESTIAL GROUP, INC.    
  Security 405217100       Meeting Type Annual  
  Ticker Symbol HAIN                  Meeting Date 28-Oct-2021  
  ISIN US4052171000       Agenda 935495475 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Richard A. Beck Management   For   For    
  1B.   Election of Director: Celeste A. Clark Management   For   For    
  1C.   Election of Director: Dean Hollis Management   For   For    
  1D.   Election of Director: Shervin J. Korangy Management   For   For    
  1E.   Election of Director: Mark L. Schiller Management   For   For    
  1F.   Election of Director: Michael B. Sims Management   For   For    
  1G.   Election of Director: Glenn W. Welling Management   For   For    
  1H.   Election of Director: Dawn M. Zier Management   For   For    
  2.    Proposal to approve, on an advisory basis, named executive officer compensation. Management   For   For    
  3.    Proposal to ratify the appointment of Ernst & Young LLP to act as registered independent accountants of the Company for the fiscal year ending June 30, 2022. Management   For   For    
  4.    Stockholder proposal to require independent Board Chair. Shareholder   Against   For    
  CARDIOVASCULAR SYSTEMS, INC.    
  Security 141619106       Meeting Type Annual  
  Ticker Symbol CSII                  Meeting Date 11-Nov-2021  
  ISIN US1416191062       Agenda 935499877 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Class I Director to hold office until the 2024 Annual Meeting: Augustine Lawlor Management   For   For    
  1B.   Election of Class I Director to hold office until the 2024 Annual Meeting: Erik Paulsen Management   For   For    
  2.    To approve a 1,700,000 share increase to the number of shares of the Company’s common stock available for issuance under the Amended and Restated 2017 Equity Incentive Plan. Management   For   For    
  3.    To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for its fiscal year ending June 30, 2022. Management   For   For    
  4.    To approve, on an advisory basis, the compensation paid to our named executive officers as disclosed in the proxy statement. Management   For   For    
  ELECTROMED, INC.    
  Security 285409108       Meeting Type Annual  
  Ticker Symbol ELMD                  Meeting Date 12-Nov-2021  
  ISIN US2854091087       Agenda 935504779 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Stan K. Erickson       For   For    
      2 Gregory J. Fluet       For   For    
      3 Joseph L. Galatowitsch       For   For    
      4 Lee A. Jones       For   For    
      5 Kathleen S. Skarvan       For   For    
      6 Kathleen A. Tune       For   For    
      7 Andrea M. Walsh       For   For    
  2.    To ratify appointment of RSM US LLP as our independent registered public accounting firm. Management   For   For    
  3.    To approve, on a non-binding and advisory basis, our executive compensation. Management   For   For    
  CHR. HANSEN HOLDING A/S    
  Security K1830B107       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 24-Nov-2021  
  ISIN DK0060227585       Agenda 714848821 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  CMMT  VOTING INSTRUCTIONS FOR MOST MEETINGS ARE CAST BY THE REGISTRAR IN ACCORDANCE-WITH YOUR VOTING INSTRUCTIONS. FOR THE SMALL NUMBER OF MEETINGS WHERE THERE-IS NO REGISTRAR, YOUR VOTING INSTRUCTIONS WILL BE CAST BY THE CHAIRMAN OF THE-BOARD (OR A BOARD MEMBER) AS PROXY. THE CHAIRMAN (OR A BOARD MEMBER) MAY-CHOOSE TO ONLY CAST PRO-MANAGEMENT VOTING INSTRUCTIONS. TO GUARANTEE YOUR-VOTING INSTRUCTIONS AGAINST MANAGEMENT ARE CAST, YOU MAY SUBMIT A REQUEST TO-ATTEND THE MEETING IN PERSON. THE SUB CUSTODIAN BANKS OFFER REPRESENTATION-SERVICES FOR AN ADDED FEE, IF REQUESTED. Non-Voting            
  CMMT  SPLIT AND PARTIAL VOTING IS NOT AUTHORIZED FOR A BENEFICIAL OWNER IN THE-DANISH MARKET. Non-Voting            
  CMMT  A BENEFICIAL OWNER SIGNED POWER OF ATTORNEY (POA) IS REQUIRED TO LODGE YOUR- VOTING INSTRUCTIONS. IF NO POA IS SUBMITTED, YOUR INSTRUCTIONS MAY BE-REJECTED. Non-Voting            
  CMMT  VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN- BANK. IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTIONS MAY BE- REJECTED. Non-Voting            
  CMMT  PLEASE NOTE THAT IF YOU HOLD CREST DEPOSITORY INTERESTS (CDIS) AND-PARTICIPATE AT THIS MEETING, YOU (OR YOUR CREST SPONSORED MEMBER/CUSTODIAN)-WILL BE REQUIRED TO INSTRUCT A TRANSFER OF THE RELEVANT CDIS TO THE ESCROW-ACCOUNT SPECIFIED IN THE ASSOCIATED CORPORATE EVENT IN THE CREST SYSTEM. THIS-TRANSFER WILL NEED TO BE COMPLETED BY THE SPECIFIED CREST SYSTEM DEADLINE.-ONCE THIS TRANSFER HAS SETTLED, THE CDIS WILL BE BLOCKED IN THE CREST SYSTEM.-THE CDIS WILL BE RELEASED FROM ESCROW AS SOON AS PRACTICABLE ON THE BUSINESS-DAY PRIOR TO MEETING DATE UNLESS OTHERWISE SPECIFIED. IN ORDER FOR A VOTE TO- BE ACCEPTED, THE VOTED POSITION MUST BE BLOCKED IN THE REQUIRED ESCROW-ACCOUNT IN THE CREST SYSTEM. BY VOTING ON THIS MEETING, YOUR CREST SPONSORED-MEMBER/CUSTODIAN Non-Voting            
    MAY USE YOUR VOTE INSTRUCTION AS THE AUTHORIZATION TO TAKE-THE NECESSARY ACTION WHICH WILL INCLUDE TRANSFERRING YOUR INSTRUCTED POSITION-TO ESCROW. PLEASE CONTACT YOUR CREST SPONSORED MEMBER/CUSTODIAN DIRECTLY FOR-FURTHER INFORMATION ON THE CUSTODY PROCESS AND WHETHER OR NOT THEY REQUIRE-SEPARATE INSTRUCTIONS FROM YOU                  
  CMMT  PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE ‘IN FAVOR’ OR ‘ABSTAIN’-ONLY FOR RESOLUTION NUMBERS 7.A.A, 7.B.A TO 7.B.F AND 8.A. THANK YOU Non-Voting            
  1     REPORT ON THE COMPANY’S ACTIVITIES Non-Voting            
  2     APPROVAL OF THE 2020/21 ANNUAL REPORT Management   No Action        
  3     RESOLUTION ON THE APPROPRIATION OF PROFIT Management   No Action        
  4     PRESENTATION OF THE COMPANY’S 2020/21 REMUNERATION REPORT FOR AN ADVISORY VOTE Management   No Action        
  5     RESOLUTION ON REMUNERATION OF MEMBERS OF THE BOARD OF DIRECTORS Management   No Action        
  6.A   PROPOSALS FROM THE BOARD OF DIRECTORS: APPROVAL OF INDEMNIFICATION ARRANGEMENTS AND RELATED AMENDMENT OF THE REMUNERATION POLICY Management   No Action        
  7.A.A ELECTION OF A CHAIR OF THE BOARD OF DIRECTOR: DOMINIQUE REINICHE (RE-ELECTION) Management   No Action        
  7.B.A ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: JESPER BRANDGAARD (RE-ELECTION) Management   No Action        
  7.B.B ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: LUIS CANTARELL (RE-ELECTION) Management   No Action        
  7.B.C ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: LISE KAAE (RE-ELECTION) Management   No Action        
  7.B.D ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: HEIDI KLEINBACH-SAUTER (RE- ELECTION) Management   No Action        
  7.B.E ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: KEVIN LANE (RE-ELECTION) Management   No Action        
  7.B.F ELECTION OF OTHER MEMBER TO THE BOARD OF DIRECTORS: LILLIE LI VALEUR (RE-ELECTION) Management   No Action        
  8.A   ELECTION OF A COMPANY AUDITOR: RE-ELECTION OF PWC STATSAUTORISERET REVISIONSPARTNERSELSKAB Management   No Action        
  9     AUTHORISATION OF THE CHAIR OF THE ANNUAL GENERAL MEETING Management   No Action        
  CMMT  INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE CLASSIFIED AS AN- INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE II, YOU SHOULD BE-PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE VOTE INSTRUCTION-LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF DATA TO BROADRIDGE-OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED CLIENT SERVICE-REPRESENTATIVE FOR ASSISTANCE Non-Voting            
  CAMPBELL SOUP COMPANY    
  Security 134429109       Meeting Type Annual  
  Ticker Symbol CPB                   Meeting Date 01-Dec-2021  
  ISIN US1344291091       Agenda 935506367 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Fabiola R. Arredondo Management   For   For    
  1B.   Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Howard M. Averill Management   For   For    
  1C.   Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: John P. (JP) Bilbrey Management   For   For    
  1D.   Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Mark A. Clouse Management   For   For    
  1E.   Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Bennett Dorrance Management   For   For    
  1F.   Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Maria Teresa Hilado Management   For   For    
  1G.   Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Grant H. Hill Management   For   For    
  1H.   Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Sarah Hofstetter Management   For   For    
  1I.   Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Marc B. Lautenbach Management   For   For    
  1J.   Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Mary Alice D. Malone Management   For   For    
  1K.   Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Keith R. McLoughlin Management   For   For    
  1L.   Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Kurt T. Schmidt Management   For   For    
  1M.   Election of Director for a one-year term expiring at the 2022 Annual Meeting of Shareholders: Archbold D. van Beuren Management   For   For    
  2.    To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal 2022. Management   For   For    
  3.    To vote on an advisory resolution to approve the fiscal 2021 compensation of our named executive officers, commonly referred to as a “say on pay” vote. Management   For   For    
  4.    To vote on a shareholder proposal regarding simple majority vote. Shareholder   Against   For    
  5.    To vote on a shareholder proposal regarding virtual shareholder meetings. Shareholder   Against   For    
  MEDTRONIC PLC    
  Security G5960L103       Meeting Type Annual  
  Ticker Symbol MDT                   Meeting Date 09-Dec-2021  
  ISIN IE00BTN1Y115       Agenda 935510429 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director until the 2022 Annual General Meeting: Richard H. Anderson Management   For   For    
  1B.   Election of Director until the 2022 Annual General Meeting: Craig Arnold Management   For   For    
  1C.   Election of Director until the 2022 Annual General Meeting: Scott C. Donnelly Management   For   For    
  1D.   Election of Director until the 2022 Annual General Meeting: Andrea J. Goldsmith, Ph.D. Management   For   For    
  1E.   Election of Director until the 2022 Annual General Meeting: Randall J. Hogan, III Management   For   For    
  1F.   Election of Director until the 2022 Annual General Meeting: Kevin E. Lofton Management   For   For    
  1G.   Election of Director until the 2022 Annual General Meeting: Geoffrey S. Martha Management   For   For    
  1H.   Election of Director until the 2022 Annual General Meeting: Elizabeth G. Nabel, M.D. Management   For   For    
  1I.   Election of Director until the 2022 Annual General Meeting: Denise M. O’Leary Management   For   For    
  1J.   Election of Director until the 2022 Annual General Meeting: Kendall J. Powell Management   For   For    
  2.    Ratifying, in a non-binding vote, the appointment of PricewaterhouseCoopers LLP as the Company’s independent auditor for fiscal year 2022 and authorizing, in a binding vote, the Board of Directors, acting through the Audit Committee, to set the auditor’s remuneration. Management   For   For    
  3.    Approving, on an advisory basis, the Company’s executive compensation. Management   For   For    
  4.    Approving, on an advisory basis, the frequency of Say- on-Pay votes. Management   1 Year   For    
  5.    Approving the new 2021 Medtronic plc Long Term Incentive Plan. Management   Against   Against    
  6.    Renewing the Board of Directors’ authority to issue shares under Irish law. Management   For   For    
  7.    Renewing the Board of Directors’ authority to opt out of pre- emption rights under Irish law. Management   Against   Against    
  8.    Authorizing the Company and any subsidiary of the Company to make overseas market purchases of Medtronic ordinary shares. Management   For   For    
  VIATRIS INC.    
  Security 92556V106       Meeting Type Annual  
  Ticker Symbol VTRS                  Meeting Date 10-Dec-2021  
  ISIN US92556V1061       Agenda 935512219 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Class I Director each to hold office until the 2023 annual meeting: Neil Dimick Management   For   For    
  1B.   Election of Class I Director each to hold office until the 2023 annual meeting: Michael Goettler Management   For   For    
  1C.   Election of Class I Director each to hold office until the 2023 annual meeting: Ian Read Management   For   For    
  1D.   Election of Class I Director each to hold office until the 2023 annual meeting: Pauline van der Meer Mohr Management   For   For    
  2.    Approval, on non-binding advisory basis, of the 2020 compensation of the named executive officers of the Company (the “Say-on-Pay vote”). Management   For   For    
  3.    A non-binding advisory vote on the frequency of the Say- on-Pay vote. Management   1 Year   For    
  4.    Ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021. Management   For   For    
  UNITED NATURAL FOODS, INC.    
  Security 911163103       Meeting Type Annual  
  Ticker Symbol UNFI                  Meeting Date 11-Jan-2022  
  ISIN US9111631035       Agenda 935524997 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director to serve until the next annual meeting of stockholders: Eric F. Artz Management   For   For    
  1B.   Election of Director to serve until the next annual meeting of stockholders: Ann Torre Bates Management   For   For    
  1C.   Election of Director to serve until the next annual meeting of stockholders: Gloria R. Boyland Management   For   For    
  1D.   Election of Director to serve until the next annual meeting of stockholders: Denise M. Clark Management   For   For    
  1E.   Election of Director to serve until the next annual meeting of stockholders: J. Alexander Miller Douglas Management   For   For    
  1F.   Election of Director to serve until the next annual meeting of stockholders: Daphne J. Dufresne Management   For   For    
  1G.   Election of Director to serve until the next annual meeting of stockholders: Michael S. Funk Management   For   For    
  1H.   Election of Director to serve until the next annual meeting of stockholders: James L. Muehlbauer Management   For   For    
  1I.   Election of Director to serve until the next annual meeting of stockholders: Peter A. Roy Management   For   For    
  1J.   Election of Director to serve until the next annual meeting of stockholders: Jack Stahl Management   For   For    
  2.    Ratification of the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending July 30, 2022. Management   For   For    
  3.    To approve, on an advisory basis, our executive compensation. Management   For   For    
  BECTON, DICKINSON AND COMPANY    
  Security 075887109       Meeting Type Annual  
  Ticker Symbol BDX                   Meeting Date 25-Jan-2022  
  ISIN US0758871091       Agenda 935535128 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Catherine M. Burzik Management   For   For    
  1B.   Election of Director: Carrie L. Byington Management   For   For    
  1C.   Election of Director: R. Andrew Eckert Management   For   For    
  1D.   Election of Director: Claire M. Fraser Management   For   For    
  1E.   Election of Director: Jeffrey W. Henderson Management   For   For    
  1F.   Election of Director: Christopher Jones Management   For   For    
  1G.   Election of Director: Marshall O. Larsen Management   For   For    
  1H.   Election of Director: David F. Melcher Management   For   For    
  1I.   Election of Director: Thomas E. Polen Management   For   For    
  1J.   Election of Director: Claire Pomeroy Management   For   For    
  1K.   Election of Director: Timothy M. Ring Management   For   For    
  1L.   Election of Director: Bertram L. Scott Management   For   For    
  2.    Ratification of the selection of the independent registered public accounting firm. Management   For   For    
  3.    Advisory vote to approve named executive officer compensation. Management   For   For    
  4.    A shareholder proposal seeking to lower the ownership threshold required to call a special shareholders meeting, if properly presented at the meeting. Shareholder   Against   For    
  MERIDIAN BIOSCIENCE, INC.    
  Security 589584101       Meeting Type Annual  
  Ticker Symbol VIVO                  Meeting Date 26-Jan-2022  
  ISIN US5895841014       Agenda 935533910 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 JAMES M. ANDERSON       For   For    
      2 ANTHONY P. BIHL III       For   For    
      3 DWIGHT E. ELLINGWOOD       For   For    
      4 JACK KENNY       For   For    
      5 JOHN C. MCILWRAITH       For   For    
      6 JOHN M. RICE, JR.       For   For    
      7 CATHERINE A. SAZDANOFF       For   For    
      8 FELICIA WILLIAMS       For   For    
  2.    Ratification of the appointment of Ernst & Young LLP as Meridian’s independent registered public accounting firm for fiscal year 2022. Management   For   For    
  3.    Approval on an advisory basis of the compensation of named executive officers, as disclosed in the Proxy Statement (“Say-on-Pay” Proposal). Management   For   For    
  POST HOLDINGS, INC.    
  Security 737446104       Meeting Type Annual  
  Ticker Symbol POST                  Meeting Date 27-Jan-2022  
  ISIN US7374461041       Agenda 935528767 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Gregory L. Curl       For   For    
      2 Ellen F. Harshman       For   For    
      3 David P. Skarie       For   For    
  2.    Ratification of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the fiscal year ending September 30, 2022. Management   For   For    
  3.    Advisory approval of the Company’s executive compensation. Management   For   For    
  4.    Approval of the Post Holdings, Inc. 2021 Long-Term Incentive Plan. Management   For   For    
  ARENA PHARMACEUTICALS, INC.    
  Security 040047607       Meeting Type Special 
  Ticker Symbol ARNA                  Meeting Date 02-Feb-2022  
  ISIN US0400476075       Agenda 935540888 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    To adopt the Agreement and Plan of Merger, dated December 12, 2021 (the “Merger Agreement”), by and among Arena Pharmaceuticals, Inc. (“Arena”), Pfizer Inc., and Antioch Merger Sub, Inc. Management   For   For    
  2.    To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Arena’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement. Management   For   For    
  3.    To adjourn the Special Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the Special Meeting. Management   For   For    
  EDGEWELL PERSONAL CARE COMPANY    
  Security 28035Q102       Meeting Type Annual  
  Ticker Symbol EPC                   Meeting Date 04-Feb-2022  
  ISIN US28035Q1022       Agenda 935534380 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Robert W. Black Management   For   For    
  1B.   Election of Director: George R. Corbin Management   For   For    
  1C.   Election of Director: Carla C. Hendra Management   For   For    
  1D.   Election of Director: John C. Hunter, III Management   For   For    
  1E.   Election of Director: James C. Johnson Management   For   For    
  1F.   Election of Director: Rod R. Little Management   For   For    
  1G.   Election of Director: Joseph D. O’Leary Management   For   For    
  1H.   Election of Director: Rakesh Sachdev Management   For   For    
  1I.   Election of Director: Swan Sit Management   For   For    
  1J.   Election of Director: Gary K. Waring Management   For   For    
  2.    To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal 2022. Management   For   For    
  3.    To cast a non-binding advisory vote on executive compensation. Management   For   For    
  SURMODICS, INC.    
  Security 868873100       Meeting Type Annual  
  Ticker Symbol SRDX                  Meeting Date 10-Feb-2022  
  ISIN US8688731004       Agenda 935536271 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Ronald B. Kalich       For   For    
      2 Gary R. Maharaj       For   For    
  2.    Set the number of directors at six (6). Management   For   For    
  3.    Ratify the appointment of Deloitte & Touche LLP as Surmodics’ independent registered public accounting firm for fiscal year 2022. Management   For   For    
  4.    Approve, in a non-binding advisory vote, the Company’s executive compensation. Management   For   For    
  5.    Approve an amendment to the Surmodics, Inc. 2019 Equity Incentive Plan. Management   Against   Against    
  BELLRING BRANDS, INC.    
  Security 079823100       Meeting Type Annual  
  Ticker Symbol BRBR                  Meeting Date 11-Feb-2022  
  ISIN US0798231009       Agenda 935538136 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Chonda J Nwamu       For   For    
      2 Robert V Vitale       For   For    
  2.    Ratification of PricewaterhouseCoopers LLP as the Company’s independent Registered Public Accounting Firm for fiscal year ending September 30, 2022. Management   For   For    
  3.    Say on Pay - An Advisory vote approving executive compensation. Management   For   For    
  4.    Say When on Pay - Advisory vote on the approval of frequency of shareholder votes on Executive Compensation. Management   1 Year   For    
  INGLES MARKETS, INCORPORATED    
  Security 457030104       Meeting Type Annual  
  Ticker Symbol IMKTA                 Meeting Date 15-Feb-2022  
  ISIN US4570301048       Agenda 935539013 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Ernest E. Ferguson       For   For    
      2 John R. Lowden       For   For    
  2.    To approve, by non-binding vote, executive compensation, as disclosed in the Proxy Statement. Management   For   For    
  3.    Proposal to amend the Company’s Articles of Incorporation. Management   Against   Against    
  4.    Stockholder proposal concerning equal voting rights for each share. Shareholder   Against   For    
  5.    Stockholder proposal regarding cage free egg progress disclosure. Shareholder   Abstain   Against    
  BELLRING BRANDS, INC.    
  Security 079823100       Meeting Type Special 
  Ticker Symbol BRBR                  Meeting Date 08-Mar-2022  
  ISIN US0798231009       Agenda 935549660 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    To adopt the Transaction Agreement and Plan of Merger, dated as of October 26, 2021 (the “Transaction Agreement”), by and among BellRing Brands, Inc., Post Holdings, Inc., BellRing Distribution, LLC and BellRing Merger Sub Corporation in accordance with its terms and the Delaware General Corporation Law. Management   For   For    
  2.    To adjourn or postpone the special meeting, if necessary or appropriate, to solicit additional proxies if there are not sufficient votes at the time of the special meeting to adopt the Transaction Agreement in accordance with its terms and the Delaware General Corporation Law. Management   For   For    
  HOLOGIC, INC.    
  Security 436440101       Meeting Type Annual  
  Ticker Symbol HOLX                  Meeting Date 10-Mar-2022  
  ISIN US4364401012       Agenda 935543137 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Stephen P. MacMillan Management   For   For    
  1B.   Election of Director: Sally W. Crawford Management   For   For    
  1C.   Election of Director: Charles J. Dockendorff Management   For   For    
  1D.   Election of Director: Scott T. Garrett Management   For   For    
  1E.   Election of Director: Ludwig N. Hantson Management   For   For    
  1F.   Election of Director: Namal Nawana Management   For   For    
  1G.   Election of Director: Christiana Stamoulis Management   For   For    
  1H.   Election of Director: Amy M. Wendell Management   For   For    
  2.    A non-binding advisory resolution to approve executive compensation. Management   For   For    
  3.    Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for fiscal 2022. Management   For   For    
  AMERISOURCEBERGEN CORPORATION    
  Security 03073E105       Meeting Type Annual  
  Ticker Symbol ABC                   Meeting Date 10-Mar-2022  
  ISIN US03073E1055       Agenda 935545016 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Ornella Barra Management   For   For    
  1B.   Election of Director: Steven H. Collis Management   For   For    
  1C.   Election of Director: D. Mark Durcan Management   For   For    
  1D.   Election of Director: Richard W. Gochnauer Management   For   For    
  1E.   Election of Director: Lon R. Greenberg Management   For   For    
  1F.   Election of Director: Jane E. Henney, M.D. Management   For   For    
  1G.   Election of Director: Kathleen W. Hyle Management   For   For    
  1H.   Election of Director: Michael J. Long Management   For   For    
  1I.   Election of Director: Henry W. McGee Management   For   For    
  1J.   Election of Director: Dennis M. Nally Management   For   For    
  2.    Ratification of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal year 2022. Management   For   For    
  3.    Advisory vote to approve the compensation of named executive officers. Management   For   For    
  4.    Approval of the AmerisourceBergen Corporation 2022 Omnibus Incentive Plan. Management   Against   Against    
  5.    Stockholder proposal, if properly presented, to adopt a policy that no financial performance metric be adjusted to exclude legal or compliance costs in determining executive compensation. Shareholder   Abstain   Against    
  6.    Stockholder proposal, if properly presented, regarding the threshold for calling a special meeting. Shareholder   Against   For    
  DLH HOLDINGS CORP.    
  Security 23335Q100       Meeting Type Annual  
  Ticker Symbol DLHC                  Meeting Date 10-Mar-2022  
  ISIN US23335Q1004       Agenda 935545143 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 James P. Allen       For   For    
      2 Martin J. Delaney       For   For    
      3 Dr. Elder Granger       For   For    
      4 Dr. Frances M. Murphy       For   For    
      5 Zachary C. Parker       For   For    
      6 Frederick G. Wasserman       For   For    
      7 Austin J. Yerks III       For   For    
      8 Stephen J. Zelkowicz       For   For    
  2.    An Advisory Vote regarding the approval of compensation paid to our named Executive Officers. Management   For   For    
  3.    Ratification of Independent Registered Public Accounting Firm. Management   For   For    
  THE COOPER COMPANIES, INC.    
  Security 216648402       Meeting Type Annual  
  Ticker Symbol COO                   Meeting Date 16-Mar-2022  
  ISIN US2166484020       Agenda 935545496 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Colleen E. Jay Management   For   For    
  1B.   Election of Director: William A. Kozy Management   For   For    
  1C.   Election of Director: Jody S. Lindell Management   For   For    
  1D.   Election of Director: Teresa S. Madden Management   For   For    
  1E.   Election of Director: Gary S. Petersmeyer Management   For   For    
  1F.   Election of Director: Maria Rivas, M.D. Management   For   For    
  1G.   Election of Director: Robert S. Weiss Management   For   For    
  1H.   Election of Director: Albert G. White III Management   For   For    
  2.    Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for The Cooper Companies, Inc. for the fiscal year ending October 31, 2022. Management   For   For    
  3.    An advisory vote on the compensation of our named executive officers as presented in the Proxy Statement. Management   For   For    
  AGILENT TECHNOLOGIES, INC.    
  Security 00846U101       Meeting Type Annual  
  Ticker Symbol A                     Meeting Date 16-Mar-2022  
  ISIN US00846U1016       Agenda 935546296 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.1   Election of Director for a three-year term: Hans E. Bishop Management   For   For    
  1.2   Election of Director for a three-year term: Otis W. Brawley, M.D. Management   For   For    
  1.3   Election of Director for a three-year term: Mikael Dolsten, M.D., Ph.D. Management   For   For    
  2.    To approve, on a non-binding advisory basis, the compensation of our named executive officers. Management   For   For    
  3.    To ratify the Audit and Finance Committee’s appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm. Management   For   For    
  4.    To vote on a stockholder proposal regarding the right to call a special meeting, if properly presented at the meeting. Management   Against   For    
  SUNTORY BEVERAGE & FOOD LIMITED    
  Security J78186103       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 25-Mar-2022  
  ISIN JP3336560002       Agenda 715213182 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
    Please reference meeting materials. Non-Voting            
  1     Approve Appropriation of Surplus Management   For   For    
  2     Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations Management   For   For    
  3.1   Appoint a Director who is not Audit and Supervisory Committee Member Saito, Kazuhiro Management   For   For    
  3.2   Appoint a Director who is not Audit and Supervisory Committee Member Kimura, Josuke Management   For   For    
  3.3   Appoint a Director who is not Audit and Supervisory Committee Member Shekhar Mundlay Management   For   For    
  3.4   Appoint a Director who is not Audit and Supervisory Committee Member Peter Harding Management   For   For    
  3.5   Appoint a Director who is not Audit and Supervisory Committee Member Aritake, Kazutomo Management   For   For    
  3.6   Appoint a Director who is not Audit and Supervisory Committee Member Inoue, Yukari Management   For   For    
  4     Appoint a Substitute Director who is Audit and Supervisory Committee Member Amitani, Mitsuhiro Management   For   For    
  STANDARD BIOTOOLS INC.    
  Security 34385P108       Meeting Type Special 
  Ticker Symbol FLDM                  Meeting Date 01-Apr-2022  
  ISIN US34385P1084       Agenda 935555916 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    The adoption of an amendment to the Company’s Eighth Amended and Restated Certificate of Incorporation (described in the proxy materials accompanying this card) to, among other things, (1) increase the number of shares of common stock, par value $0.001 per share, of the Company that the Company is authorized to issue from two hundred million(200,000,000) shares to four hundred million (400,000,000) shares and (2) change the name of the Company to Standard BioTools Inc.(the “Charter Amendment”). Management   For   For    
  2.    Approval of issuance of (1) Series B-1 Convertible Preferred Stock, par value $0.001 per share, of Company (“Series B-1 Preferred Stock”) and Series B-2 Convertible Preferred Stock, par value $0.001 per share, (the “Series B-2 Preferred Stock”, and together with the Series B-1 Preferred Stock, the “Series B Preferred Stock”) issuable pursuant to the Purchase Agreements (2) Series B-1 Preferred Stock and Series B-2 Preferred Stock issuable pursuant to terms of the Loan Agreements (3) Common stock issuable upon conversion of Series B Preferred Stock. Management   For   For    
  3.    The approval of an adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to approve the Charter Amendment Proposal and the Private Placement Issuance Proposal at the time of the Special Meeting (the “Adjournment Proposal”). Management   For   For    
  NESTLE S.A.    
  Security H57312649       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 07-Apr-2022  
  ISIN CH0038863350       Agenda 715274635 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  CMMT  VOTING MUST BE LODGED WITH BENEFICIAL OWNER DETAILS AS PROVIDED BY YOUR- CUSTODIAN BANK. IF NO BENEFICIAL OWNER DETAILS ARE PROVIDED, YOUR INSTRUCTION-MAY BE REJECTED. Non-Voting            
  CMMT  PLEASE NOTE THAT THIS IS AN AMENDMENT TO MEETING ID 701444 DUE TO CHANGE IN- RECOMMENDATION FOR RESOLUTION 7. ALL VOTES RECEIVED ON THE PREVIOUS MEETING- WILL BE DISREGARDED IF VOTE DEADLINE EXTENSIONS ARE GRANTED. THEREFORE PLEASE- REINSTRUCT ON THIS MEETING NOTICE ON THE NEW JOB. IF HOWEVER VOTE DEADLINE- EXTENSIONS ARE NOT GRANTED IN THE MARKET, THIS MEETING WILL BE CLOSED AND-YOUR VOTE INTENTIONS ON THE ORIGINAL MEETING WILL BE APPLICABLE. PLEASE-ENSURE VOTING IS SUBMITTED PRIOR TO CUTOFF ON THE ORIGINAL MEETING, AND AS-SOON AS POSSIBLE ON THIS NEW AMENDED MEETING. THANK YOU Non-Voting            
  CMMT  PART 2 OF THIS MEETING IS FOR VOTING ON AGENDA AND MEETING ATTENDANCE-REQUESTS ONLY. PLEASE ENSURE THAT YOU HAVE FIRST VOTED IN FAVOUR OF THE-REGISTRATION OF SHARES IN PART 1 OF THE MEETING. IT IS A MARKET REQUIREMENT-FOR MEETINGS OF THIS TYPE THAT THE SHARES ARE REGISTERED AND MOVED TO A-REGISTERED LOCATION AT THE CSD, AND SPECIFIC POLICIES AT THE INDIVIDUAL-SUB- CUSTODIANS MAY VARY. UPON RECEIPT OF THE VOTE INSTRUCTION, IT IS POSSIBLE-THAT A MARKER MAY BE PLACED ON YOUR SHARES TO ALLOW FOR RECONCILIATION AND-RE- REGISTRATION FOLLOWING A TRADE.THEREFORE WHILST THIS DOES NOT PREVENT THE-TRADING OF SHARES, ANY THAT ARE REGISTERED MUST BE FIRST DEREGISTERED IF-REQUIRED FOR SETTLEMENT. DEREGISTRATION CAN AFFECT THE VOTING RIGHTS OF THOSE-SHARES. IF YOU HAVE CONCERNS REGARDING YOUR ACCOUNTS, PLEASE CONTACT YOUR-CLIENT REPRESENTATIVE Non-Voting            
  1.1   APPROVAL OF THE ANNUAL REVIEW, THE FINANCIAL STATEMENTS OF NESTLE S.A. AND THE CONSOLIDATED FINANCIAL STATEMENTS OF THE NESTLE GROUP FOR 2021 Management   No Action        
  1.2   ACCEPTANCE OF THE COMPENSATION REPORT 2021 (ADVISORY VOTE) Management   No Action        
  2     DISCHARGE TO THE MEMBERS OF THE BOARD OF DIRECTORS AND OF THE MANAGEMENT Management   No Action        
  3     APPROPRIATION OF PROFIT RESULTING FROM THE BALANCE SHEET OF NESTLE S.A. (PROPOSED DIVIDEND) FOR THE FINANCIAL YEAR 2021 Management   No Action        
  4.1.1 RE-ELECTION AS MEMBER AND CHAIRMAN OF THE BOARD OF DIRECTORS: PAUL BULCKE Management   No Action        
  4.1.2 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: ULF MARK SCHNEIDER Management   No Action        
  4.1.3 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: HENRI DE CASTRIES Management   No Action        
  4.1.4 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: RENATO FASSBIND Management   No Action        
  4.1.5 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: PABLO ISLA Management   No Action        
  4.1.6 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: EVA CHENG Management   No Action        
  4.1.7 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: PATRICK AEBISCHER Management   No Action        
  4.1.8 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: KIMBERLY A. ROSS Management   No Action        
  4.1.9 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: DICK BOER Management   No Action        
  4.110 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: DINESH PALIWAL Management   No Action        
  4.111 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: HANNE JIMENEZ DE MORA Management   No Action        
  4.112 RE-ELECTION AS MEMBER OF THE BOARD OF DIRECTORS: LINDIWE MAJELE SIBANDA Management   No Action        
  4.2.1 ELECTION TO THE BOARD OF DIRECTORS: CHRIS LEONG Management   No Action        
  4.2.2 ELECTION TO THE BOARD OF DIRECTORS: LUCA MAESTRI Management   No Action        
  4.3.1 ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: PABLO ISLA Management   No Action        
  4.3.2 ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: PATRICK AEBISCHER Management   No Action        
  4.3.3 ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: DICK BOER Management   No Action        
  4.3.4 ELECTION AS MEMBER OF THE COMPENSATION COMMITTEE: DINESH PALIWAL Management   No Action        
  4.4   ELECTION OF THE STATUTORY AUDITORS: ERNST AND YOUNG LTD, LAUSANNE BRANCH Management   No Action        
  4.5   ELECTION OF THE INDEPENDENT REPRESENTATIVE: HARTMANN DREYER, ATTORNEYS-AT-LAW Management   No Action        
  5.1   APPROVAL OF THE COMPENSATION OF THE BOARD OF DIRECTORS Management   No Action        
  5.2   APPROVAL OF THE COMPENSATION OF THE EXECUTIVE BOARD Management   No Action        
  6     CAPITAL REDUCTION (BY CANCELLATION OF SHARES) Management   No Action        
  7     IN THE EVENT OF ANY YET UNKNOWN NEW OR MODIFIED PROPOSAL BY A SHAREHOLDER DURING THE GENERAL MEETING, I INSTRUCT THE INDEPENDENT REPRESENTATIVE TO VOTE AS FOLLOWS: (YES = VOTE IN FAVOR OF ANY SUCH YET UNKNOWN PROPOSAL, NO = VOTE AGAINST ANY SUCH YET UNKNOWN PROPOSAL, ABSTAIN = ABSTAIN FROM VOTING) - THE BOARD OF DIRECTORS RECOMMENDS TO VOTE NO ON ANY SUCH YET UNKNOWN PROPOSAL Management   No Action        
  IQVIA HOLDINGS INC.    
  Security 46266C105       Meeting Type Annual  
  Ticker Symbol IQV                   Meeting Date 12-Apr-2022  
  ISIN US46266C1053       Agenda 935553710 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 John P. Connaughton       For   For    
      2 John G. Danhakl       For   For    
      3 James A. Fasano       For   For    
      4 Leslie Wims Morris       For   For    
  2.    Amendment to Certificate of Incorporation to declassify the Board of Directors over time and provide for the annual election of all directors. Management   For   For    
  3.    Advisory (non-binding) vote to approve executive compensation (say-on-pay). Management   For   For    
  4.    If properly presented, a shareholder proposal regarding majority voting in uncontested director elections. Management   Against   For    
  5.    The ratification of the appointment of PricewaterhouseCoopers LLP as IQVIA Holdings Inc.’s independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  SMITH & NEPHEW PLC    
  Security 83175M205       Meeting Type Annual  
  Ticker Symbol SNN                   Meeting Date 13-Apr-2022  
  ISIN US83175M2052       Agenda 935560448 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  O1    To receive the audited accounts Management   For   For    
  O2    To approve the Directors’ Remuneration Report (excluding policy) Management   For   For    
  O3    To declare a final dividend Management   For   For    
  O4    ELECTION AND RE-ELECTION OF DIRECTOR: Erik Engstrom Management   For   For    
  O5    ELECTION AND RE-ELECTION OF DIRECTOR: Robin Freestone Management   For   For    
  O6    ELECTION AND RE-ELECTION OF DIRECTOR: Jo Hallas Management   For   For    
  O7    ELECTION AND RE-ELECTION OF DIRECTOR: John Ma Management   For   For    
  O8    ELECTION AND RE-ELECTION OF DIRECTOR: Katarzyna Mazur-Hofsaess Management   For   For    
  O9    ELECTION AND RE-ELECTION OF DIRECTOR: Rick Medlock Management   For   For    
  O10   ELECTION AND RE-ELECTION OF DIRECTOR: Deepak Nath Management   For   For    
  O11   ELECTION AND RE-ELECTION OF DIRECTOR: Anne- Françoise Nesmes Management   For   For    
  O12   ELECTION AND RE-ELECTION OF DIRECTOR: Marc Owen Management   For   For    
  O13   ELECTION AND RE-ELECTION OF DIRECTOR: Roberto Quarta Management   For   For    
  O14   ELECTION AND RE-ELECTION OF DIRECTOR: Angie Risley Management   For   For    
  O15   ELECTION AND RE-ELECTION OF DIRECTOR: Bob White Management   For   For    
  O16   To re-appoint the Auditor Management   For   For    
  O17   To authorise Directors’ to determine the remuneration of the Auditor Management   For   For    
  O18   To renew the Directors’ authority to allot shares Management   For   For    
  O19   To approve the Smith+Nephew Sharesave Plan (2022) Management   For   For    
  O20   To approve the Smith+Nephew International Sharesave Plan (2022) Management   For   For    
  S21   To renew the Directors’ authority for the disapplication of the pre-emption rights Management   Withheld   Against    
  S22   To authorise the Directors’ to disapply pre-emption rights for the purposes of acquisitions or other capital investments Management   For   For    
  S23   To renew the Directors’ limited authority to make market purchases of the Company’s own shares Management   For   For    
  S24   To authorise general meetings to be held on 14 clear days’ notice Management   For   For    
  IDORSIA LTD    
  Security H3879B109       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 14-Apr-2022  
  ISIN CH0363463438       Agenda 715221949 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  CMMT  VOTING MUST BE LODGED WITH BENEFICIAL OWNER DETAILS AS PROVIDED BY YOUR- CUSTODIAN BANK. IF NO BENEFICIAL OWNER DETAILS ARE PROVIDED, YOUR INSTRUCTION-MAY BE REJECTED. Non-Voting            
  CMMT  PART 2 OF THIS MEETING IS FOR VOTING ON AGENDA AND MEETING ATTENDANCE-REQUESTS ONLY. PLEASE ENSURE THAT YOU HAVE FIRST VOTED IN FAVOUR OF THE-REGISTRATION OF SHARES IN PART 1 OF THE MEETING. IT IS A MARKET REQUIREMENT-FOR MEETINGS OF THIS TYPE THAT THE SHARES ARE REGISTERED AND MOVED TO A-REGISTERED LOCATION AT THE CSD, AND SPECIFIC POLICIES AT THE INDIVIDUAL-SUB- CUSTODIANS MAY VARY. UPON RECEIPT OF THE VOTE INSTRUCTION, IT IS POSSIBLE-THAT A MARKER MAY BE PLACED ON YOUR SHARES TO ALLOW FOR RECONCILIATION AND-RE- REGISTRATION FOLLOWING A TRADE. THEREFORE WHILST THIS DOES NOT PREVENT THE-TRADING OF SHARES, ANY THAT ARE REGISTERED MUST BE FIRST DEREGISTERED IF-REQUIRED FOR SETTLEMENT. DEREGISTRATION CAN AFFECT THE VOTING RIGHTS OF THOSE-SHARES. IF YOU HAVE CONCERNS REGARDING YOUR ACCOUNTS, PLEASE CONTACT YOUR-CLIENT REPRESENTATIVE Non-Voting            
  1.1   ACCEPT FINANCIAL STATEMENTS AND STATUTORY REPORTS Management   No Action        
  1.2   APPROVE REMUNERATION REPORT (NON-BINDING) Management   No Action        
  2     APPROVE TREATMENT OF NET LOSS Management   No Action        
  3     APPROVE DISCHARGE OF BOARD AND SENIOR MANAGEMENT Management   No Action        
  4     APPROVE INCREASE IN CONDITIONAL CAPITAL POOL TO CHF 2.8 MILLION TO COVER EXERCISE OF CONVERSION RIGHTS AND/OR WARRANTS Management   No Action        
  5.1.1 REELECT MATHIEU SIMON AS DIRECTOR Management   No Action        
  5.1.2 REELECT JOERN ALDAG AS DIRECTOR Management   No Action        
  5.1.3 REELECT JEAN-PAUL CLOZEL AS DIRECTOR Management   No Action        
  5.1.4 REELECT FELIX EHRAT AS DIRECTOR Management   No Action        
  5.1.5 REELECT SRISHTI GUPTA AS DIRECTOR Management   No Action        
  5.1.6 REELECT PETER KELLOGG AS DIRECTOR Management   No Action        
  5.1.7 REELECT SANDY MAHATME AS DIRECTOR Management   No Action        
  5.2   REELECT MATHIEU SIMON AS BOARD CHAIRMAN Management   No Action        
  5.3.1 REAPPOINT MATHIEU SIMON AS MEMBER OF THE COMPENSATION COMMITTEE Management   No Action        
  5.3.2 REAPPOINT FELIX EHRAT AS MEMBER OF THE COMPENSATION COMMITTEE Management   No Action        
  5.3.3 REAPPOINT SRISHTI GUPTA AS MEMBER OF THE COMPENSATION COMMITTEE Management   No Action        
  6.1   APPROVE REMUNERATION OF DIRECTORS IN THE AMOUNT OF CHF 1.3 MILLION Management   No Action        
  6.2   APPROVE REMUNERATION OF EXECUTIVE COMMITTEE IN THE AMOUNT OF CHF 17.22 MILLION Management   No Action        
  7     DESIGNATE BACHMANNPARTNER AG AS INDEPENDENT PROXY Management   No Action        
  8     RATIFY ERNST & YOUNG AG AS AUDITORS Management   No Action        
  HCA HEALTHCARE, INC.    
  Security 40412C101       Meeting Type Annual  
  Ticker Symbol HCA                   Meeting Date 21-Apr-2022  
  ISIN US40412C1018       Agenda 935561236 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Thomas F. Frist III Management   For   For    
  1B.   Election of Director: Samuel N. Hazen Management   For   For    
  1C.   Election of Director: Meg G. Crofton Management   For   For    
  1D.   Election of Director: Robert J. Dennis Management   For   For    
  1E.   Election of Director: Nancy-Ann DeParle Management   For   For    
  1F.   Election of Director: William R. Frist Management   For   For    
  1G.   Election of Director: Charles O. Holliday, Jr. Management   For   For    
  1H.   Election of Director: Hugh F. Johnston Management   For   For    
  1I.   Election of Director: Michael W. Michelson Management   For   For    
  1J.   Election of Director: Wayne J. Riley, M.D. Management   For   For    
  1K.   Election of Director: Andrea B. Smith Management   For   For    
  2.    To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  3.    Advisory vote to approve named executive officer compensation. Management   For   For    
  4.    Stockholder proposal, if properly presented at the meeting, regarding political spending disclosure. Shareholder   Abstain   Against    
  5.    Stockholder proposal, if properly presented at the meeting, regarding lobbying disclosure. Shareholder   Abstain   Against    
  DANONE SA    
  Security F12033134       Meeting Type MIX 
  Ticker Symbol         Meeting Date 26-Apr-2022  
  ISIN FR0000120644       Agenda 715377289 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  CMMT  FOR SHAREHOLDERS NOT HOLDING SHARES DIRECTLY WITH A FRENCH CUSTODIAN, VOTING- INSTRUCTIONS WILL BE FORWARDED TO YOUR GLOBAL CUSTODIAN ON VOTE DEADLINE-DATE. THE GLOBAL CUSTODIAN AS THE REGISTERED INTERMEDIARY WILL SIGN THE PROXY-CARD AND FORWARD TO THE LOCAL CUSTODIAN FOR LODGMENT. Non-Voting            
  CMMT  FOR FRENCH MEETINGS ‘ABSTAIN’ IS A VALID VOTING OPTION. FOR ANY ADDITIONAL- RESOLUTIONS RAISED AT THE MEETING THE VOTING INSTRUCTION WILL DEFAULT TO-‘AGAINST.’ IF YOUR CUSTODIAN IS COMPLETING THE PROXY CARD, THE VOTING-INSTRUCTION WILL DEFAULT TO THE PREFERENCE OF YOUR CUSTODIAN. Non-Voting            
  CMMT  VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN- BANK. IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTIONS MAY BE- REJECTED. Non-Voting            
  CMMT  07 APR 2022: DUE TO THE COVID19 CRISIS AND IN ACCORDANCE WITH THE PROVISIONS-ADOPTED BY THE FRENCH GOVERNMENT UNDER LAW NO. 2020- 1379 OF NOVEMBER 14,-2020, EXTENDED AND MODIFIED BY LAW NO 2020-1614 OF DECEMBER 18 2020; THE-GENERAL MEETING WILL TAKE PLACE BEHIND CLOSED DOORS WITHOUT THE PHYSICAL- PRESENCE OF SHAREHOLDERS. TO COMPLY WITH THESE LAWS, PLEASE DO NOT SUBMIT ANY- REQUESTS TO ATTEND THE MEETING IN PERSON. THE COMPANY ENCOURAGES ALL-SHAREHOLDERS TO REGULARLY CONSULT THE COMPANY WEBSITE TO VIEW ANY CHANGES TO-THIS POLICY AND PLEASE NOTE THAT IF YOU HOLD CREST DEPOSITORY INTERESTS-(CDIS) AND PARTICIPATE AT THIS MEETING, YOU (OR YOUR CREST SPONSORED-MEMBER/CUSTODIAN) WILL BE REQUIRED TO INSTRUCT A TRANSFER OF THE RELEVANT-CDIS TO THE ESCROW ACCOUNT SPECIFIED IN THE ASSOCIATED CORPORATE EVENT IN THE-CREST SYSTEM. THIS TRANSFER WILL NEED TO BE COMPLETED BY THE SPECIFIED CREST-SYSTEM DEADLINE. ONCE THIS TRANSFER HAS SETTLED, THE CDIS WILL BE BLOCKED IN-THE CREST SYSTEM. THE CDIS WILL TYPICALLY BE RELEASED FROM ESCROW AS SOON AS- PRACTICABLE ON RECORD DATE +1 DAY (OR ON Non-Voting            
    MEETING DATE +1 DAY IF NO RECORD-DATE APPLIES) UNLESS OTHERWISE SPECIFIED, AND ONLY AFTER THE AGENT HAS-CONFIRMED AVAILABILIY OF THE POSITION. IN ORDER FOR A VOTE TO BE ACCEPTED,-THE VOTED POSITION MUST BE BLOCKED IN THE REQUIRED ESCROW ACCOUNT IN THE-CREST SYSTEM. BY VOTING ON THIS MEETING, YOUR CREST SPONSORED- MEMBER/CUSTODIAN MAY USE YOUR VOTE INSTRUCTION AS THE AUTHORIZATION TO TAKE- THE NECESSARY ACTION WHICH WILL INCLUDE TRANSFERRING YOUR INSTRUCTED POSITION-TO ESCROW. PLEASE CONTACT YOUR CREST SPONSORED MEMBER/CUSTODIAN DIRECTLY FOR- FURTHER INFORMATION ON THE CUSTODY PROCESS AND WHETHER OR NOT THEY REQUIRE- SEPARATE INSTRUCTIONS FROM YOU                  
  CMMT  PLEASE NOTE THAT THIS IS AN AMENDMENT TO MEETING ID 712230 DUE TO RECEIPT OF-ADDITION OF RESOLUTION. A. ALL VOTES RECEIVED ON THE PREVIOUS MEETING WILL BE-DISREGARDED AND YOU WILL NEED TO REINSTRUCT ON THIS MEETING NOTICE. THANK YOU Non-Voting            
  1     APPROVAL OF THE CORPORATE FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2021 Management   No Action        
  2     APPROVAL OF THE CONSOLIDATED FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2021 Management   No Action        
  3     ALLOCATION OF INCOME FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2021 AND SETTING OF THE DIVIDEND AT 1.94 EURO PER SHARE Management   No Action        
  4     RATIFICATION OF THE CO-OPTATION OF VALERIE CHAPOULAUD-FLOQUET AS DIRECTOR, AS A REPLACEMENT FOR ISABELLE SEILLIER, WHO RESIGNED Management   No Action        
  5     APPOINTMENT OF ANTOINE DE SAINT-AFFRIQUE AS DIRECTOR Management   No Action        
  6     APPOINTMENT OF PATRICE LOUVET AS DIRECTOR Management   No Action        
  7     APPOINTMENT OF GERALDINE PICAUD AS DIRECTOR Management   No Action        
  8     APPOINTMENT OF SUSAN ROBERTS AS DIRECTOR Management   No Action        
  9     RENEWAL OF THE TERM OF OFFICE OF ERNST & YOUNG AUDIT AS STATUTORY AUDITOR Management   No Action        
  10    APPOINTMENT OF MAZARS & ASSOCIES AS STATUTORY AUDITOR, AS A REPLACEMENT FOR PRICEWATERHOUSECOOPERS AUDIT FIRM Management   No Action        
  11    APPROVAL OF AN AGREEMENT SUBJECT TO THE PROVISIONS OF ARTICLES L.225-38 AND FOLLOWING OF THE FRENCH COMMERCIAL CODE CONCLUDED BY THE COMPANY WITH VERONIQUE PENCHIENATI-BOSETTA Management   No Action        
  12    APPROVAL OF THE INFORMATION RELATING TO THE REMUNERATION OF CORPORATE OFFICERS MENTIONED IN SECTION I OF ARTICLE L.22-10-9 OF THE FRENCH COMMERCIAL CODE FOR THE FINANCIAL YEAR 2021 Management   No Action        
  13    APPROVAL OF THE REMUNERATION ELEMENTS PAID DURING OR AWARDED FOR THE FINANCIAL YEAR 31 DECEMBER 2021 TO VERONIQUE PENCHIENATI-BOSETTA, IN HER CAPACITY AS CHIEF EXECUTIVE OFFICER, BETWEEN 14 MARCH AND 14 SEPTEMBER 2021 Management   No Action        
  14    APPROVAL OF THE REMUNERATION ELEMENTS PAID DURING OR AWARDED FOR THE FINANCIAL YEAR 31 DECEMBER 2021 TO SHANE GRANT, IN HIS CAPACITY AS DEPUTY CHIEF EXECUTIVE OFFICER BETWEEN 14 MARCH AND 14 SEPTEMBER 2021 Management   No Action        
  15    APPROVAL OF THE REMUNERATION ELEMENTS PAID DURING OR AWARDED FOR THE FINANCIAL YEAR 31 DECEMBER 2021 TO ANTOINE DE SAINT- AFFRIQUE, CHIEF EXECUTIVE OFFICER AS OF 15 SEPTEMBER 2021 Management   No Action        
  16    APPROVAL OF THE REMUNERATION ELEMENTS PAID DURING OR AWARDED FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2021 TO GILLES SCHNEPP, CHAIRMAN OF THE BOARD OF DIRECTORS AS OF 14 MARCH 2021 Management   No Action        
  17    APPROVAL OF THE REMUNERATION POLICY FOR EXECUTIVE CORPORATE OFFICERS FOR THE FINANCIAL YEAR 2022 Management   No Action        
  18    APPROVAL OF THE REMUNERATION POLICY FOR THE CHAIRMAN OF THE BOARD OF DIRECTORS FOR THE FINANCIAL YEAR 2022 Management   No Action        
  19    APPROVAL OF THE REMUNERATION POLICY FOR DIRECTORS FOR THE FINANCIAL YEAR 2022 Management   No Action        
  20    AUTHORISATION TO BE GRANTED TO THE BOARD OF DIRECTORS IN ORDER TO PURCHASE, HOLD OR TRANSFER THE COMPANY’S SHARES Management   No Action        
  21    DELEGATION OF AUTHORITY TO THE BOARD OF DIRECTORS TO ISSUE COMMON SHARES AND TRANSFERABLE SECURITIES, WITH CANCELLATION OF THE PRE-EMPTIVE SUBSCRIPTION RIGHT, RESERVED FOR CATEGORIES OF BENEFICIARIES, CONSISTING OF EMPLOYEES WORKING IN FOREIGN COMPANIES OF THE DANONE GROUP, OR IN A SITUATION OF INTERNATIONAL MOBILITY, IN THE CONTEXT OF EMPLOYEE SHAREHOLDING OPERATIONS Management   No Action        
  22    AUTHORISATION GRANTED TO THE BOARD OF DIRECTORS TO PROCEED WITH ALLOCATION OF EXISTING PERFORMANCE SHARES OR PERFORMANCE SHARES TO BE ISSUED OF THE COMPANY, WITHOUT THE SHAREHOLDERS’ PRE- EMPTIVE SUBSCRIPTION RIGHT Management   No Action        
  23    AUTHORISATION GRANTED TO THE BOARD OF DIRECTORS TO PROCEED WITH ALLOCATION OF EXISTING SHARES OR SHARES TO BE ISSUED OF THE COMPANY NOT SUBJECT TO PERFORMANCE CONDITIONS, WITHOUT THE SHAREHOLDERS’ PRE- EMPTIVE SUBSCRIPTION RIGHT Management   No Action        
  24    AMENDMENT TO ARTICLE 19.II OF THE COMPANY’S BY-LAWS RELATING TO THE AGE LIMIT OF THE CHIEF EXECUTIVE OFFICER AND THE DEPUTY CHIEF EXECUTIVE OFFICER Management   No Action        
  25    AMENDMENT TO ARTICLE 18.I OF THE COMPANY’S BY-LAWS RELATING TO THE AGE LIMIT OF THE CHAIRMAN OF THE BOARD OF DIRECTORS Management   No Action        
  26    AMENDMENT TO ARTICLE 17 OF THE COMPANY’S BY-LAWS RELATING TO THE OBLIGATION OF HOLDING SHARES APPLICABLE TO DIRECTORS Management   No Action        
  27    POWERS TO CARRY OUT FORMALITIES Management   No Action        
  A     PLEASE NOT THAT THIS IS A SHAREHOLDER PROPOSAL: AMENDMENT TO PARAGRAPHS I AND III OF ARTICLE 18 OF THE COMPANY’S BY-LAWS ‘THE OFFICE OF THE BOARD - DELIBERATIONS’ Shareholder   No Action        
  CMMT  07 APR 2022: PLEASE NOTE THAT IMPORTANT ADDITIONAL MEETING INFORMATION IS-AVAILABLE BY CLICKING ON THE MATERIAL URL LINK:- https://fr.ftp.opendatasoft.com/datadila/JO/BALO/pdf/202 2/0404/202204042200706-.pdf AND PLEASE NOTE THAT THIS IS A REVISION DUE TO ADDITION OF COMMENT. IF-YOU HAVE ALREADY SENT IN YOUR VOTES FOR MID: 720555, PLEASE DO NOT VOTE AGAIN-UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU Non-Voting            
  CMMT  INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE CLASSIFIED AS AN- INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE II, YOU SHOULD BE-PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE VOTE INSTRUCTION-LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF DATA TO BROADRIDGE-OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED CLIENT SERVICE-REPRESENTATIVE FOR ASSISTANCE. THANK YOU Non-Voting            
  PERKINELMER, INC.    
  Security 714046109       Meeting Type Annual  
  Ticker Symbol PKI                   Meeting Date 26-Apr-2022  
  ISIN US7140461093       Agenda 935558811 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director for a term of one year: Peter Barrett, PhD Management   For   For    
  1B.   Election of Director for a term of one year: Samuel R. Chapin Management   For   For    
  1C.   Election of Director for a term of one year: Sylvie Grégoire, PharmD Management   For   For    
  1D.   Election of Director for a term of one year: Alexis P. Michas Management   For   For    
  1E.   Election of Director for a term of one year: Prahlad R. Singh, PhD Management   For   For    
  1F.   Election of Director for a term of one year: Michel Vounatsos Management   For   For    
  1G.   Election of Director for a term of one year: Frank Witney, PhD Management   For   For    
  1H.   Election of Director for a term of one year: Pascale Witz Management   For   For    
  2.    To ratify the selection of Deloitte & Touche LLP as PerkinElmer’s independent registered public accounting firm for the current fiscal year. Management   For   For    
  3.    To approve, by non-binding advisory vote, our executive compensation. Management   For   For    
  GALAPAGOS N V    
  Security 36315X101       Meeting Type Annual  
  Ticker Symbol GLPG                  Meeting Date 26-Apr-2022  
  ISIN US36315X1019       Agenda 935582420 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  E1    Amendments to the articles of association as a consequence of the choice for a one-tier board structure, as well as certain other amendments relating to specific matters set out in the articles of association of the Company. Management   For   For    
  E2    As a consequence of and subject to the introduction of a one- tier board structure, appointment of the members of the (former) supervisory board for the remaining term of their mandate as director in the board of directors. ...(due to space limits, see proxy material for full proposal). Management   For   For    
  E3    Proxy for coordination. Management   For   For    
  E4    Authorization to the board of directors. Management   For   For    
  E5    Proxy for the Crossroad Bank for Enterprises, counters for enterprises, registers of the enterprise court, administrative agencies and fiscal administrations. Management   For   For    
  A2    Acknowledgement and approval of the non-consolidated annual accounts of the Company for the financial year ended on 31 December 2021 and approval of the allocation of the annual result as proposed by the supervisory board. Management   For   For    
  A5    Acknowledgement and approval of the remuneration report. Management   Against   Against    
  A6    Acknowledgement and approval of the amended remuneration policy. Management   Against   Against    
  A7    Release from liability to be granted to the members of the supervisory board and the statutory auditor for the performance of their duties in the course of the financial year ended on 31 December 2021. Management   Against   Against    
  A9    Appointment of Stoffels IMC BV (permanently represented by Mr. Paul Stoffels) as director. Management   For   For    
  A10   Appointment of Jérôme Contamine as independent director. Management   For   For    
  A11   Appointment of Dan Baker as independent director. Management   For   For    
  BIO-RAD LABORATORIES, INC.    
  Security 090572207       Meeting Type Annual  
  Ticker Symbol BIO                   Meeting Date 26-Apr-2022  
  ISIN US0905722072       Agenda 935587545 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.1   Election of Director: Melinda Litherland Management   For   For    
  1.2   Election of Director: Arnold A. Pinkston Management   For   For    
  2.    PROPOSAL to ratify the selection of KPMG LLP to serve as the Company’s independent auditors. Management   For   For    
  GALAPAGOS N V    
  Security 36315X101       Meeting Type Annual  
  Ticker Symbol GLPG                  Meeting Date 26-Apr-2022  
  ISIN US36315X1019       Agenda 935606319 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  E1    Amendments to the articles of association as a consequence of the choice for a one-tier board structure, as well as certain other amendments relating to specific matters set out in the articles of association of the Company. Management   For   For    
  E2    As a consequence of and subject to the introduction of a one- tier board structure, appointment of the members of the (former) supervisory board for the remaining term of their mandate as director in the board of directors. ...(due to space limits, see proxy material for full proposal). Management   For   For    
  E3    Proxy for coordination. Management   For   For    
  E4    Authorization to the board of directors. Management   For   For    
  E5    Proxy for the Crossroad Bank for Enterprises, counters for enterprises, registers of the enterprise court, administrative agencies and fiscal administrations. Management   For   For    
  A2    Acknowledgement and approval of the non-consolidated annual accounts of the Company for the financial year ended on 31 December 2021 and approval of the allocation of the annual result as proposed by the supervisory board. Management   For   For    
  A5    Acknowledgement and approval of the remuneration report. Management   Against   Against    
  A6    Acknowledgement and approval of the amended remuneration policy. Management   Against   Against    
  A7    Release from liability to be granted to the members of the supervisory board and the statutory auditor for the performance of their duties in the course of the financial year ended on 31 December 2021. Management   Against   Against    
  A9    Appointment of Stoffels IMC BV (permanently represented by Mr. Paul Stoffels) as director. Management   For   For    
  A10   Appointment of Jérôme Contamine as independent director. Management   For   For    
  A11   Appointment of Dan Baker as independent director. Management   For   For    
  CALAVO GROWERS, INC.    
  Security 128246105       Meeting Type Annual  
  Ticker Symbol CVGW                  Meeting Date 27-Apr-2022  
  ISIN US1282461052       Agenda 935557198 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Farha Aslam       For   For    
      2 Marc L. Brown       For   For    
      3 Michael A. DiGregorio       For   For    
      4 Adriana G. Mendizabal       For   For    
      5 James D. Helin       For   For    
      6 Steven Hollister       For   For    
      7 Kathleen M. Holmgren       For   For    
      8 John M. Hunt       For   For    
      9 J. Link Leavens       For   For    
      10 Donald M. Sanders       For   For    
  2.    RATIFICATION OF APPOINTMENT OF DELOITTE & TOUCHE LLP AS INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF CALAVO GROWERS, INC. FOR THE YEAR ENDING OCTOBER 31, 2022. Management   For   For    
  3.    ADVISORY VOTE APPROVING THE EXECUTIVE COMPENSATION DISCLOSED IN THE ACCOMPANYING PROXY STATEMENT. Management   For   For    
  CIGNA CORPORATION    
  Security 125523100       Meeting Type Annual  
  Ticker Symbol CI                    Meeting Date 27-Apr-2022  
  ISIN US1255231003       Agenda 935562911 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: David M. Cordani Management   For   For    
  1B.   Election of Director: William J. DeLaney Management   For   For    
  1C.   Election of Director: Eric J. Foss Management   For   For    
  1D.   Election of Director: Elder Granger, MD, MG, USA (Retired) Management   For   For    
  1E.   Election of Director: Neesha Hathi Management   For   For    
  1F.   Election of Director: George Kurian Management   For   For    
  1G.   Election of Director: Kathleen M. Mazzarella Management   For   For    
  1H.   Election of Director: Mark B. McClellan, MD, PhD Management   For   For    
  1I.   Election of Director: Kimberly A. Ross Management   For   For    
  1J.   Election of Director: Eric C. Wiseman Management   For   For    
  1K.   Election of Director: Donna F. Zarcone Management   For   For    
  2.    Advisory approval of Cigna’s executive compensation. Management   For   For    
  3.    Ratification of the appointment of PricewaterhouseCoopers LLP as Cigna’s independent registered public accounting firm for 2022. Management   For   For    
  4.    Shareholder proposal - Special shareholder meeting improvement. Shareholder   Against   For    
  5.    Shareholder proposal - Gender pay gap report. Shareholder   Abstain   Against    
  6.    Shareholder proposal - Political contributions report. Shareholder   Abstain   Against    
  VERICEL CORPORATION    
  Security 92346J108       Meeting Type Annual  
  Ticker Symbol VCEL                  Meeting Date 27-Apr-2022  
  ISIN US92346J1088       Agenda 935564915 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Robert L. Zerbe       For   For    
      2 Alan L. Rubino       For   For    
      3 Heidi Hagen       For   For    
      4 Steven C. Gilman       For   For    
      5 Kevin F. McLaughlin       For   For    
      6 Paul K. Wotton       For   For    
      7 Dominick C. Colangelo       For   For    
      8 Lisa Wright       For   For    
  2.    To approve, on an advisory basis, the compensation of Vericel Corporation’s named executive officers. Management   For   For    
  3.    To ratify the appointment of PricewaterhouseCoopers LLP as Vericel Corporation’s independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  4.    To approve the adoption of Vericel Corporation’s 2022 Omnibus Incentive Plan. Management   Against   Against    
  SEMA4 HOLDINGS CORP.    
  Security 81663L101       Meeting Type Special 
  Ticker Symbol SMFR                  Meeting Date 27-Apr-2022  
  ISIN US81663L1017       Agenda 935602854 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    The Stock Consideration Issuance Proposal - For purposes of complying with applicable Nasdaq Stock Market (the “Nasdaq”) listing rules (the “Nasdaq Listing Rules”), to approve the issuance of the Company’s Class A common stock, par value $0.0001 per share (the “Class A common stock”), in connection with the Acquisition (as defined in the accompanying Proxy Statement) of GeneDx, Inc. as contemplated by the Agreement and Plan of Merger and Reorganization dated January 14, 2022 (the “Merger Agreement”) Management   For   For    
  2.    The PIPE Investment Proposal - For purposes of complying with the Nasdaq Listing Rules, to approve the issuance of the Class A common stock in connection with the PIPE Investment (as defined in the accompanying proxy statement) and as contemplated by the Subscription Agreements (as define in the accompanying proxy statement). Management   For   For    
  3.    The Special Designee Director Election Proposal - Assuming the Stock Consideration Issuance Proposal and the Charter Amendment Proposal are approved and adopted and the Acquisition is consummated, to appoint two directors who will become directors of the Company effective upon the consummation of the Acquisition. Management   For   For    
  4.    The Charter Amendment Proposal - To adopt an Amendment (the “Amendment”) to the Third Amended and Restated Certificate of Incorporation of the Company, in the form attached hereto as Annex B (the “Charter”), which increases the number of authorized shares of Class A common stock from 380,000,000 to 1,000,000,000. Management   For   For    
  5.    The Class I Director Election Proposal - To elect three Class I directors of the Company, each to serve a three- year term expiring at the Company’s 2025 annual meeting of stockholders and until such director’s successor is duly elected and qualified. Management   For   For    
  6.    The Auditor Ratification Proposal - To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  7.    Adjournment Proposal - To approve, if necessary, the adjournment of the Special Meeting to a later date or dates to permit further solicitation and votes of proxies in the event that there are insufficient votes for, or otherwise in connection with any of the proposals presented at the Special Meeting. Management   For   For    
  KERRY GROUP PLC    
  Security G52416107       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 28-Apr-2022  
  ISIN IE0004906560       Agenda 715303943 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  CMMT  VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN- BANK. IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTIONS MAY BE- REJECTED Non-Voting            
  CMMT  PLEASE NOTE THAT IF YOU ARE CLASSIFIED AS AN INTERMEDIARY CLIENT UNDER THE-SHAREHOLDER RIGHTS DIRECTIVE II, YOU SHOULD BE PROVIDING THE UNDERLYING-SHAREHOLDER INFORMATION AT THE VOTE INSTRUCTION LEVEL. IF YOU ARE UNSURE ON-HOW TO PROVIDE THIS LEVEL OF DATA TO BROADRIDGE OUTSIDE OF PROXYEDGE, PLEASE-SPEAK TO YOUR DEDICATED CLIENT SERVICE REPRESENTATIVE FOR ASSISTANCE” Non-Voting            
  01    TO REVIEW THE COMPANY’S AFFAIRS AND TO RECEIVE AND CONSIDER THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021, TOGETHER WITH THE REPORTS OF THE DIRECTORS AND THE AUDITORS THEREON Management   No Action        
  02    TO DECLARE A FINAL DIVIDEND AS RECOMMENDED BY THE DIRECTORS Management   No Action        
  03A   TO ELECT THE FOLLOWING DIRECTOR: MS FIONA DAWSON Management   No Action        
  03B   TO ELECT THE FOLLOWING DIRECTOR: MR MICHAEL KERR Management   No Action        
  04A   TO RE-ELECT THE FOLLOWING DIRECTOR: MR GERRY BEHAN Management   No Action        
  04B   TO RE-ELECT THE FOLLOWING DIRECTOR: DR HUGH BRADY Management   No Action        
  04C   TO RE-ELECT THE FOLLOWING DIRECTOR: DR KARIN DORREPAAL Management   No Action        
  04D   TO RE-ELECT THE FOLLOWING DIRECTOR: MS EMER GILVARRY Management   No Action        
  04E   TO RE-ELECT THE FOLLOWING DIRECTOR: MS MARGUERITE LARKIN Management   No Action        
  04F   TO RE-ELECT THE FOLLOWING DIRECTOR: MR TOM MORAN Management   No Action        
  04G   TO RE-ELECT THE FOLLOWING DIRECTOR: MR CHRISTOPHER ROGERS Management   No Action        
  04H   TO RE-ELECT THE FOLLOWING DIRECTOR: MR EDMOND SCANLON Management   No Action        
  04I   TO RE-ELECT THE FOLLOWING DIRECTOR: MR JINLONG WANG Management   No Action        
  05    TO AUTHORISE THE DIRECTORS TO DETERMINE THE REMUNERATION OF THE AUDITORS Management   No Action        
  06    TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING ORDINARY RESOLUTION: THAT UNTIL OTHERWISE DETERMINED BY THE COMPANY IN GENERAL MEETING THE NON-EXECUTIVE DIRECTORS BE PAID AS FEES IN RESPECT OF EACH YEAR COMMENCING WITH THE YEAR ENDED 31 DECEMBER 2022 SUCH SUM NOT EXCEEDING EUR 2,000,000 IN AGGREGATE IN ANY YEAR, AS THE DIRECTORS SHALL DETERMINE, WHICH SUM SHALL BE DIVIDED AMONGST THEM IN SUCH PROPORTION AS THEY SHALL DETERMINE Management   No Action        
  07    TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING ORDINARY RESOLUTION: TO RECEIVE AND CONSIDER THE DIRECTORS’ REMUNERATION REPORT (OTHER THAN THE REMUNERATION POLICY IN SECTION C) AS SET OUT ON PAGES 121 TO 151 OF THE ANNUAL REPORT FOR THE YEAR ENDED 31 DECEMBER 2021 Management   No Action        
  08    TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING ORDINARY RESOLUTION: THAT THE DIRECTORS BE AND ARE HEREBY GENERALLY AND UNCONDITIONALLY AUTHORISED TO EXERCISE ALL THE POWERS OF THE COMPANY TO ALLOT RELEVANT SECURITIES (WITHIN THE MEANING OF SECTION 1021 OF THE COMPANIES ACT, 2014), TO INCLUDE THE REISSUE OF TREASURY SHARES, IF ANY, PROVIDED THAT: - THE MAXIMUM AMOUNT OF RELEVANT SECURITIES WHICH MAY BE ALLOTTED UNDER THIS AUTHORITY SHALL NOT EXCEED AN AGGREGATE NOMINAL AMOUNT OF EUR 2,500,000; AND - THE AUTHORITY CONFERRED BY THIS RESOLUTION WILL EXPIRE ON THE EARLIER OF THE CONCLUSION OF THE 2023 AGM AND CLOSE OF BUSINESS ON 27 JULY 2023 UNLESS AND TO THE EXTENT THAT IT IS RENEWED, REVOKED OR EXTENDED PRIOR TO SUCH DATE, SAVE THAT THE COMPANY MAY BEFORE SUCH EXPIRY MAKE AN OFFER OR AGREEMENT WHICH WOULD OR MIGHT REQUIRE RELEVANT SECURITIES TO BE ALLOTTED AFTER SUCH EXPIRY, AND THE DIRECTORS MAY ALLOT RELEVANT SECURITIES IN PURSUANCE OF SUCH OFFER OR AGREEMENT, AS IF SUCH AUTHORITY HAD NOT EXPIRED Management   No Action        
  09    TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING SPECIAL RESOLUTION: SUBJECT TO RESOLUTION 8 HEREIN BEING PASSED, THAT THE DIRECTORS BE AND ARE HEREBY EMPOWERED PURSUANT TO ARTICLE 5 OF THE ARTICLES OF ASSOCIATION OF THE COMPANY AND SECTIONS 1022 AND 1023 OF THE COMPANIES ACT, 2014 TO ALLOT EQUITY SECURITIES (WITHIN THE MEANING Management   No Action        
    OF THE SAID SECTION 1023) FOR CASH, TO INCLUDE THE REISSUE OF TREASURY SHARES, IF ANY, AS IF SECTION 1022(1) OF THE SAID ACT DID NOT APPLY TO ANY SUCH ALLOTMENT, PROVIDED THAT: - THIS POWER SHALL BE LIMITED TO ALLOTMENTS OF UP TO AN AGGREGATE NOMINAL AMOUNT OF EUR 1,105,313 AND ALLOTMENTS IN CONNECTION WITH OR PURSUANT TO ANY RIGHTS ISSUE, OPEN OFFER OR OTHER INVITATION TO OR IN FAVOUR OF HOLDERS OF SHARES IN THE COMPANY IN PROPORTION AS NEARLY AS MAY BE TO SUCH HOLDERS’ HOLDINGS OF SUCH SHARES, SUBJECT TO SUCH LIMITS, EXCLUSIONS, ADJUSTMENTS OR OTHER ARRANGEMENTS AS THE DIRECTORS CONSIDER EXPEDIENT IN RELATION TO TREASURY SHARES, FRACTIONAL ENTITLEMENTS, RECORD DATES, LEGAL, REGULATORY OR PRACTICAL PROBLEMS UNDER THE LAWS OF OR THE REQUIREMENTS OF ANY RELEVANT REGULATORY BODY, SECURITIES MARKET OR STOCK EXCHANGE, IN ANY TERRITORY, OR ANY MATTER WHATSOEVER; AND - THE AUTHORITY CONFERRED BY THIS RESOLUTION WILL EXPIRE ON THE EARLIER OF THE CONCLUSION OF THE 2023 AGM AND CLOSE OF BUSINESS ON 27 JULY 2023 UNLESS AND TO THE EXTENT THAT IT IS RENEWED, REVOKED OR EXTENDED PRIOR TO SUCH DATE, SAVE THAT THE COMPANY MAY BEFORE SUCH EXPIRY MAKE AN OFFER OR AGREEMENT WHICH WOULD OR MIGHT REQUIRE EQUITY SECURITIES TO BE ALLOTTED AFTER SUCH EXPIRY, AND THE DIRECTORS MAY ALLOT EQUITY SECURITIES IN PURSUANCE OF SUCH AN OFFER OR AGREEMENT AS IF SUCH POWER HAD NOT EXPIRED                  
  10    TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING SPECIAL RESOLUTION: THAT SUBJECT TO RESOLUTIONS 8 AND 9 HEREIN BEING PASSED, THE DIRECTORS BE AND ARE HEREBY EMPOWERED PURSUANT TO SECTIONS 1022 AND 1023 OF THE COMPANIES ACT, 2014 TO ALLOT EQUITY SECURITIES (WITHIN THE MEANING OF THE SAID SECTION 1023) FOR CASH, TO INCLUDE THE REISSUE OF TREASURY SHARES, IF ANY, AS IF SECTION 1022(1) OF THE SAID ACT DID NOT APPLY TO ANY SUCH ALLOTMENT, PROVIDED THAT: - THIS POWER SHALL BE LIMITED TO ALLOTMENTS OF ADDITIONAL SHARES UP TO AN AGGREGATE NOMINAL AMOUNT OF EUR 1,105,313 IN CONNECTION WITH AN ACQUISITION OR SPECIFIED CAPITAL INVESTMENT WHICH IS ANNOUNCED CONTEMPORANEOUSLY WITH THE ALLOTMENT, OR WHICH WILL HAVE TAKEN PLACE IN THE PRECEDING SIX-MONTH PERIOD AND IS DISCLOSED IN THE ANNOUNCEMENT OF THE ALLOTMENT; AND - THE AUTHORITY CONFERRED BY THIS RESOLUTION SHALL EXPIRE ON THE Management   No Action        
    EARLIER OF THE CONCLUSION OF THE 2023 AGM AND CLOSE OF BUSINESS ON 27 JULY 2023 UNLESS AND TO THE EXTENT THAT IT IS RENEWED, REVOKED OR EXTENDED PRIOR TO SUCH DATE, SAVE THAT THE COMPANY MAY BEFORE SUCH EXPIRY MAKE AN OFFER OR AGREEMENT WHICH WOULD OR MIGHT REQUIRE EQUITY SECURITIES TO BE ALLOTTED AFTER SUCH EXPIRY, AND THE DIRECTORS MAY ALLOT EQUITY SECURITIES IN PURSUANCE OF SUCH AN OFFER OR AGREEMENT AS IF SUCH POWER HAD NOT EXPIRED                  
  11    TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING SPECIAL RESOLUTION: THAT THE COMPANY (AND ANY SUBSIDIARY OF THE COMPANY) BE AND IS HEREBY AUTHORISED TO MAKE MARKET PURCHASES AND OVERSEAS MARKET PURCHASES (AS DEFINED IN SECTION 1072 OF THE COMPANIES ACT, 2014 AND TO INCLUDE MAKING A CONTRACT OF PURCHASE WHICH IS OR MAY BE EXECUTED WHOLLY OR PARTLY AFTER THE EXPIRY OF THIS AUTHORITY) OF A ORDINARY SHARES IN THE CAPITAL OF THE COMPANY IN THE MANNER PROVIDED FOR AND WITHIN THE PRICE RANGES SET OUT IN THE ARTICLES OF ASSOCIATION OF THE COMPANY PROVIDED THAT: - THE MAXIMUM NUMBER OF A ORDINARY SHARES WHICH MAY BE ACQUIRED UNDER THIS AUTHORITY SHALL NOT EXCEED 5% OF THE A ORDINARY SHARES IN ISSUE AT THE DATE OF THE PASSING OF THIS RESOLUTION; AND - THE AUTHORITY CONFERRED BY THIS RESOLUTION SHALL EXPIRE ON THE EARLIER OF THE CONCLUSION OF THE 2023 AGM AND CLOSE OF BUSINESS ON 27 JULY 2023 UNLESS AND TO THE EXTENT THAT IT IS RENEWED, REVOKED OR EXTENDED PRIOR TO SUCH DATE, SAVE THAT THE COMPANY (OR ANY SUBSIDIARY) MAY MAKE SUCH A PURCHASE AFTER SUCH EXPIRY PURSUANT TO A CONTRACT OF PURCHASE CONCLUDED BEFORE SUCH EXPIRY Management   No Action        
  12    TO CONSIDER AND, IF THOUGHT FIT, PASS THE FOLLOWING SPECIAL RESOLUTION: THAT THE MEMORANDUM OF ASSOCIATION OF THE COMPANY DATED 28 APRIL 2022, WHICH HAS BEEN AVAILABLE FOR INSPECTION AT THE REGISTERED OFFICE OF THE COMPANY, AND ON THE COMPANY’S WEBSITE SINCE THE DATE OF THE NOTICE OF THIS ANNUAL GENERAL MEETING, BE AND IS HEREBY APPROVED AND ADOPTED AS THE NEW MEMORANDUM OF ASSOCIATION OF THE COMPANY IN SUBSTITUTION FOR, AND TO THE EXCLUSION OF, THE EXISTING MEMORANDUM OF ASSOCIATION OF THE COMPANY Management   No Action        
  CMMT  19 APR 2022: PLEASE NOTE THAT THIS IS A REVISION DUE TO CHANGE OF THE RECORD-DATE FROM 22 APR 2022 TO 24 APR 2022 AND CHANGE IN NUMBERING. IF YOU HAVE-ALREADY SENT IN YOUR VOTES, PLEASE DO NOT VOTE AGAIN UNLESS YOU DECIDE TO-AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU Non-Voting            
  INTUITIVE SURGICAL, INC.    
  Security 46120E602       Meeting Type Annual  
  Ticker Symbol ISRG                  Meeting Date 28-Apr-2022  
  ISIN US46120E6023       Agenda 935560765 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Craig H. Barratt, Ph.D. Management   For   For    
  1B.   Election of Director: Joseph C. Beery Management   For   For    
  1C.   Election of Director: Gary S. Guthart, Ph.D. Management   For   For    
  1D.   Election of Director: Amal M. Johnson Management   For   For    
  1E.   Election of Director: Don R. Kania, Ph.D. Management   For   For    
  1F.   Election of Director: Amy L. Ladd, M.D. Management   For   For    
  1G.   Election of Director: Keith R. Leonard, Jr. Management   For   For    
  1H.   Election of Director: Alan J. Levy, Ph.D. Management   For   For    
  1I.   Election of Director: Jami Dover Nachtsheim Management   For   For    
  1J.   Election of Director: Monica P. Reed, M.D. Management   For   For    
  1K.   Election of Director: Mark J. Rubash Management   For   For    
  2.    To approve, by advisory vote, the compensation of the Company’s Named Executive Officers. Management   For   For    
  3.    The ratification of appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  4.    To approve the Company’s Amended and Restated 2010 Incentive Award Plan. Management   Against   Against    
  PFIZER INC.    
  Security 717081103       Meeting Type Annual  
  Ticker Symbol PFE                   Meeting Date 28-Apr-2022  
  ISIN US7170811035       Agenda 935562062 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Ronald E. Blaylock Management   For   For    
  1B.   Election of Director: Albert Bourla Management   For   For    
  1C.   Election of Director: Susan Desmond-Hellmann Management   For   For    
  1D.   Election of Director: Joseph J. Echevarria Management   For   For    
  1E.   Election of Director: Scott Gottlieb Management   For   For    
  1F.   Election of Director: Helen H. Hobbs Management   For   For    
  1G.   Election of Director: Susan Hockfield Management   For   For    
  1H.   Election of Director: Dan R. Littman Management   For   For    
  1I.   Election of Director: Shantanu Narayen Management   For   For    
  1J.   Election of Director: Suzanne Nora Johnson Management   For   For    
  1K.   Election of Director: James Quincey Management   For   For    
  1L.   Election of Director: James C. Smith Management   For   For    
  2.    Ratify the selection of KPMG LLP as independent registered public accounting firm for 2022 Management   For   For    
  3.    2022 advisory approval of executive compensation Management   For   For    
  4.    Shareholder proposal regarding amending proxy access Shareholder   Against   For    
  5.    Shareholder proposal regarding report on political expenditures congruency Shareholder   Abstain   Against    
  6.    Shareholder proposal regarding report on transfer of intellectual property to potential COVID-19 manufacturers Shareholder   Abstain   Against    
  7.    Shareholder proposal regarding report on board oversight of risks related to anticompetitive practices Shareholder   Against   For    
  8.    Shareholder proposal regarding report on public health costs of protecting vaccine technology Shareholder   Abstain   Against    
  JOHNSON & JOHNSON    
  Security 478160104       Meeting Type Annual  
  Ticker Symbol JNJ                   Meeting Date 28-Apr-2022  
  ISIN US4781601046       Agenda 935562997 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Darius Adamczyk Management   For   For    
  1B.   Election of Director: Mary C. Beckerle Management   For   For    
  1C.   Election of Director: D. Scott Davis Management   For   For    
  1D.   Election of Director: Ian E. L. Davis Management   For   For    
  1E.   Election of Director: Jennifer A. Doudna Management   For   For    
  1F.   Election of Director: Joaquin Duato Management   For   For    
  1G.   Election of Director: Alex Gorsky Management   For   For    
  1H.   Election of Director: Marillyn A. Hewson Management   For   For    
  1I.   Election of Director: Hubert Joly Management   For   For    
  1J.   Election of Director: Mark B. McClellan Management   For   For    
  1K.   Election of Director: Anne M. Mulcahy Management   For   For    
  1L.   Election of Director: A. Eugene Washington Management   For   For    
  1M.   Election of Director: Mark A. Weinberger Management   For   For    
  1N.   Election of Director: Nadja Y. West Management   For   For    
  2.    Advisory Vote to Approve Named Executive Officer Compensation. Management   For   For    
  3.    Approval of the Company’s 2022 Long-Term Incentive Plan. Management   Against   Against    
  4.    Ratification of Appointment of PricewaterhouseCoopers LLP as the Independent Registered Public Accounting Firm for 2022. Management   For   For    
  5.    Proposal Withdrawn (Federal Securities Laws Mandatory Arbitration Bylaw). Shareholder   Abstain        
  6.    Civil Rights, Equity, Diversity & Inclusion Audit Proposal. Shareholder   Abstain   Against    
  7.    Third Party Racial Justice Audit. Shareholder   Abstain   Against    
  8.    Report on Government Financial Support and Access to COVID-19 Vaccines and Therapeutics. Shareholder   Abstain   Against    
  9.    Report on Public Health Costs of Protecting Vaccine Technology. Shareholder   Abstain   Against    
  10.   Discontinue Global Sales of Baby Powder Containing Talc. Shareholder   Abstain   Against    
  11.   Request for Charitable Donations Disclosure. Shareholder   Abstain   Against    
  12.   Third Party Review and Report on Lobbying Activities Alignment with Position on Universal Health Coverage. Shareholder   Abstain   Against    
  13.   Adopt Policy to Include Legal and Compliance Costs in Incentive Compensation Metrics. Shareholder   Abstain   Against    
  14.   CEO Compensation to Weigh Workforce Pay and Ownership. Shareholder   Abstain   Against    
  CHURCH & DWIGHT CO., INC.    
  Security 171340102       Meeting Type Annual  
  Ticker Symbol CHD                   Meeting Date 28-Apr-2022  
  ISIN US1713401024       Agenda 935566779 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director to serve for a term of one year: Bradlen S. Cashaw Management   For   For    
  1B.   Election of Director to serve for a term of one year: James R. Craigie Management   For   For    
  1C.   Election of Director to serve for a term of one year: Matthew T. Farrell Management   For   For    
  1D.   Election of Director to serve for a term of one year: Bradley C. Irwin Management   For   For    
  1E.   Election of Director to serve for a term of one year: Penry W. Price Management   For   For    
  1F.   Election of Director to serve for a term of one year: Susan G. Saideman Management   For   For    
  1G.   Election of Director to serve for a term of one year: Ravichandra K. Saligram Management   For   For    
  1H.   Election of Director to serve for a term of one year: Robert K. Shearer Management   For   For    
  1I.   Election of Director to serve for a term of one year: Janet S. Vergis Management   For   For    
  1J.   Election of Director to serve for a term of one year: Arthur B. Winkleblack Management   For   For    
  1K.   Election of Director to serve for a term of one year: Laurie J. Yoler Management   For   For    
  2.    An advisory vote to approve compensation of our named executive officers. Management   For   For    
  3.    Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for 2022. Management   For   For    
  4.    Proposal to approve an amendment and restatement of the Church & Dwight Co., Inc. Amended and Restated Omnibus Equity Compensation Plan. Management   For   For    
  5.    Stockholder Proposal - Special Shareholder Meeting Improvement. Shareholder   Against   For    
  KELLOGG COMPANY    
  Security 487836108       Meeting Type Annual  
  Ticker Symbol K                     Meeting Date 29-Apr-2022  
  ISIN US4878361082       Agenda 935557720 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director (term expires 2025): Rod Gillum Management   For   For    
  1B.   Election of Director (term expires 2025): Mary Laschinger Management   For   For    
  1C.   Election of Director (term expires 2025): Erica Mann Management   For   For    
  1D.   Election of Director (term expires 2025): Carolyn Tastad Management   For   For    
  2.    Advisory resolution to approve executive compensation. Management   For   For    
  3.    Ratification of the appointment of PricewaterhouseCoopers LLP as Kellogg’s independent registered public accounting firm for fiscal year 2022. Management   For   For    
  4.    Management proposal to approve the Kellogg Company 2022 Long-Term Incentive Plan. Management   For   For    
  5.    Shareowner proposal for CEO compensation to weigh workforce pay and ownership, if properly presented at the meeting. Shareholder   Abstain   Against    
  ABBOTT LABORATORIES    
  Security 002824100       Meeting Type Annual  
  Ticker Symbol ABT                   Meeting Date 29-Apr-2022  
  ISIN US0028241000       Agenda 935562909 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 R. J. Alpern       For   For    
      2 S. E. Blount       For   For    
      3 R. B. Ford       For   For    
      4 P. Gonzalez       For   For    
      5 M. A. Kumbier       For   For    
      6 D. W. McDew       For   For    
      7 N. McKinstry       For   For    
      8 W. A. Osborn       For   For    
      9 M. F. Roman       For   For    
      10 D. J. Starks       For   For    
      11 J. G. Stratton       For   For    
      12 G. F. Tilton       For   For    
  2.    Ratification of Ernst & Young LLP As Auditors Management   For   For    
  3.    Say on Pay - An Advisory Vote on the Approval of Executive Compensation Management   For   For    
  4.    Shareholder Proposal - Special Shareholder Meeting Threshold Shareholder   Against   For    
  5.    Shareholder Proposal - Independent Board Chairman Shareholder   Against   For    
  6.    Shareholder Proposal - Rule 10b5-1 Plans Shareholder   Against   For    
  7.    Shareholder Proposal - Lobbying Disclosure Shareholder   Abstain   Against    
  8.    Shareholder Proposal - Antimicrobial Resistance Report Shareholder   Against   For    
  ASTRAZENECA PLC    
  Security 046353108       Meeting Type Annual  
  Ticker Symbol AZN                   Meeting Date 29-Apr-2022  
  ISIN US0463531089       Agenda 935582317 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    To receive the Company’s Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2021 Management   For   For    
  2.    To confirm dividends Management   For   For    
  3.    To reappoint PricewaterhouseCoopers LLP as Auditor Management   For   For    
  4.    To authorise the Directors to agree the remuneration of the Auditor Management   For   For    
  5A.   Re-election of Director: Leif Johansson Management   For   For    
  5B.   Re-election of Director: Pascal Soriot Management   For   For    
  5C.   Election of Director: Aradhana Sarin Management   For   For    
  5D.   Re-election of Director: Philip Broadley Management   For   For    
  5E.   Re-election of Director: Euan Ashley Management   For   For    
  5F.   Re-election of Director: Michel Demaré Management   For   For    
  5G.   Re-election of Director: Deborah DiSanzo Management   For   For    
  5H.   Re-election of Director: Diana Layfield Management   For   For    
  5I.   Re-election of Director: Sheri McCoy Management   For   For    
  5J.   Re-election of Director: Tony Mok Management   For   For    
  5K.   Re-election of Director: Nazneen Rahman Management   For   For    
  5L.   Election of Director: Andreas Rummelt Management   For   For    
  5M.   Re-election of Director: Marcus Wallenberg Management   For   For    
  6.    To approve the Annual Report on Remuneration for the year ended 31 December 2021 Management   For   For    
  7.    To authorise limited political donations Management   For   For    
  8.    To authorise the Directors to allot shares Management   For   For    
  9.    To authorise the Directors to disapply pre-emption rights (Special Resolution) Management   Abstain   Against    
  10.   To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution) Management   For   For    
  11.   To authorise the Company to purchase its own shares (Special Resolution) Management   For   For    
  12.   To reduce the notice period for general meetings (Special Resolution) Management   For   For    
  13.   To extend the AstraZenca PLC 2012 Savings Related Share Option Scheme Management   For   For    
  ASTRAZENECA PLC    
  Security 046353108       Meeting Type Annual  
  Ticker Symbol AZN                   Meeting Date 29-Apr-2022  
  ISIN US0463531089       Agenda 935608729 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    To receive the Company’s Accounts, the Reports of the Directors and Auditor and the Strategic Report for the year ended 31 December 2021 Management   For   For    
  2.    To confirm dividends Management   For   For    
  3.    To reappoint PricewaterhouseCoopers LLP as Auditor Management   For   For    
  4.    To authorise the Directors to agree the remuneration of the Auditor Management   For   For    
  5A.   Re-election of Director: Leif Johansson Management   For   For    
  5B.   Re-election of Director: Pascal Soriot Management   For   For    
  5C.   Election of Director: Aradhana Sarin Management   For   For    
  5D.   Re-election of Director: Philip Broadley Management   For   For    
  5E.   Re-election of Director: Euan Ashley Management   For   For    
  5F.   Re-election of Director: Michel Demaré Management   For   For    
  5G.   Re-election of Director: Deborah DiSanzo Management   For   For    
  5H.   Re-election of Director: Diana Layfield Management   For   For    
  5I.   Re-election of Director: Sheri McCoy Management   For   For    
  5J.   Re-election of Director: Tony Mok Management   For   For    
  5K.   Re-election of Director: Nazneen Rahman Management   For   For    
  5L.   Election of Director: Andreas Rummelt Management   For   For    
  5M.   Re-election of Director: Marcus Wallenberg Management   For   For    
  6.    To approve the Annual Report on Remuneration for the year ended 31 December 2021 Management   For   For    
  7.    To authorise limited political donations Management   For   For    
  8.    To authorise the Directors to allot shares Management   For   For    
  9.    To authorise the Directors to disapply pre-emption rights (Special Resolution) Management   Abstain   Against    
  10.   To authorise the Directors to further disapply pre-emption rights for acquisitions and specified capital investments (Special Resolution) Management   For   For    
  11.   To authorise the Company to purchase its own shares (Special Resolution) Management   For   For    
  12.   To reduce the notice period for general meetings (Special Resolution) Management   For   For    
  13.   To extend the AstraZenca PLC 2012 Savings Related Share Option Scheme Management   For   For    
  BAXTER INTERNATIONAL INC.    
  Security 071813109       Meeting Type Annual  
  Ticker Symbol BAX                   Meeting Date 03-May-2022  
  ISIN US0718131099       Agenda 935566630 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: José (Joe) Almeida Management   For   For    
  1B.   Election of Director: Thomas F. Chen Management   For   For    
  1C.   Election of Director: Peter S. Hellman Management   For   For    
  1D.   Election of Director: Michael F. Mahoney Management   For   For    
  1E.   Election of Director: Patricia B. Morrison Management   For   For    
  1F.   Election of Director: Stephen N. Oesterle Management   For   For    
  1G.   Election of Director: Nancy M. Schlichting Management   For   For    
  1H.   Election of Director: Cathy R. Smith Management   For   For    
  1I.   Election of Director: Albert P.L. Stroucken Management   For   For    
  1J.   Election of Director: Amy A. Wendell Management   For   For    
  1K.   Election of Director: David S. Wilkes Management   For   For    
  2.    Advisory Vote to Approve Named Executive Officer Compensation Management   For   For    
  3.    Ratification of Appointment of Independent Registered Public Accounting Firm Management   For   For    
  4.    Vote to Approve a Certificate of Incorporation Amendment to Permit Stockholder Action by Written Consent Management   For   For    
  5.    Vote to Approve a Certificate of Incorporation Amendment to Lower the Special Meeting Threshold Management   For   For    
  6.    Stockholder Proposal - Special Shareholder Meeting Improvement Shareholder   Against   For    
  7.    Stockholder Proposal - Independent Board Chairman Shareholder   Against   For    
  BRISTOL-MYERS SQUIBB COMPANY    
  Security 110122108       Meeting Type Annual  
  Ticker Symbol BMY                   Meeting Date 03-May-2022  
  ISIN US1101221083       Agenda 935571782 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A)   Election of Director: Peter J. Arduini Management   For   For    
  1B)   Election of Director: Giovanni Caforio, M.D. Management   For   For    
  1C)   Election of Director: Julia A. Haller, M.D. Management   For   For    
  1D)   Election of Director: Manuel Hidalgo Medina, M.D., Ph.D. Management   For   For    
  1E)   Election of Director: Paula A. Price Management   For   For    
  1F)   Election of Director: Derica W. Rice Management   For   For    
  1G)   Election of Director: Theodore R. Samuels Management   For   For    
  1H)   Election of Director: Gerald L. Storch Management   For   For    
  1I)   Election of Director: Karen H. Vousden, Ph.D. Management   For   For    
  1J)   Election of Director: Phyllis R. Yale Management   For   For    
  2.    Advisory Vote to Approve the Compensation of our Named Executive Officers. Management   For   For    
  3.    Ratification of the Appointment of an Independent Registered Public Accounting Firm. Management   For   For    
  4.    Shareholder Proposal to Lower the Ownership Threshold for Special Shareholder Meetings to 10%. Shareholder   Against   For    
  5.    Shareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director. Shareholder   Against   For    
  MAPLE LEAF FOODS INC    
  Security 564905107       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 04-May-2022  
  ISIN CA5649051078       Agenda 715382660 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  CMMT  07 APR 2022: PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE ‘IN FAVOR’ OR-‘AGAINST’ ONLY FOR RESOLUTION 3 AND ‘IN FAVOR’ OR ‘ABSTAIN’ ONLY FOR-RESOLUTION NUMBERS 1.1 TO 1.10 AND 2. THANK YOU. Non-Voting            
  1.1   ELECTION OF DIRECTOR: WILLIAM E. AZIZ Management   For   For    
  1.2   ELECTION OF DIRECTOR: W. GEOFFREY BEATTIE Management   For   For    
  1.3   ELECTION OF DIRECTOR: RONALD G. CLOSE Management   For   For    
  1.4   ELECTION OF DIRECTOR: JEAN M. FRASER Management   For   For    
  1.5   ELECTION OF DIRECTOR: THOMAS P. HAYES Management   For   For    
  1.6   ELECTION OF DIRECTOR: TIMOTHY D. HOCKEY Management   For   For    
  1.7   ELECTION OF DIRECTOR: KATHERINE N. LEMON Management   For   For    
  1.8   ELECTION OF DIRECTOR: JONATHAN W.F. MCCAIN Management   For   For    
  1.9   ELECTION OF DIRECTOR: MICHAEL H. MCCAIN Management   For   For    
  1.10  ELECTION OF DIRECTOR: CAROL M. STEPHENSON Management   For   For    
  2     APPOINTMENT OF KPMG LLP, AS AUDITORS OF MAPLE LEAF FOODS INC. FOR THE ENSUING YEAR AND AUTHORIZING THE DIRECTORS TO FIX THEIR REMUNERATION Management   For   For    
  3     TO APPROVE, ON AN ADVISORY AND NON-BINDING BASIS, MAPLE LEAF FOODS INC.’S APPROACH TO EXECUTIVE COMPENSATION Management   For   For    
  CMMT  07 APR 2022: PLEASE NOTE THAT THIS IS A REVISION DUE TO MODIFICATION OF-COMMENT. IF YOU HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO NOT VOTE AGAIN-UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU Non-Voting            
  INTERNATIONAL FLAVORS & FRAGRANCES INC.    
  Security 459506101       Meeting Type Annual  
  Ticker Symbol IFF                   Meeting Date 04-May-2022  
  ISIN US4595061015       Agenda 935567163 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director for a one-year term expiring at the 2023 Annual Meeting: Kathryn J. Boor Management   For   For    
  1B.   Election of Director for a one-year term expiring at the 2023 Annual Meeting: Edward D. Breen Management   For   For    
  1C.   Election of Director for a one-year term expiring at the 2023 Annual Meeting: Barry A. Bruno Management   For   For    
  1D.   Election of Director for a one-year term expiring at the 2023 Annual Meeting: Frank Clyburn Management   For   For    
  1E.   Election of Director for a one-year term expiring at the 2023 Annual Meeting: Carol Anthony Davidson Management   For   For    
  1F.   Election of Director for a one-year term expiring at the 2023 Annual Meeting: Michael L. Ducker Management   For   For    
  1G.   Election of Director for a one-year term expiring at the 2023 Annual Meeting: Roger W. Ferguson, Jr. Management   For   For    
  1H.   Election of Director for a one-year term expiring at the 2023 Annual Meeting: John F. Ferraro Management   For   For    
  1I.   Election of Director for a one-year term expiring at the 2023 Annual Meeting: Christina Gold Management   For   For    
  1J.   Election of Director for a one-year term expiring at the 2023 Annual Meeting: Ilene Gordon Management   For   For    
  1K.   Election of Director for a one-year term expiring at the 2023 Annual Meeting: Matthias J. Heinzel Management   For   For    
  1L.   Election of Director for a one-year term expiring at the 2023 Annual Meeting: Dale F. Morrison Management   For   For    
  1M.   Election of Director for a one-year term expiring at the 2023 Annual Meeting: Kåre Schultz Management   For   For    
  1N.   Election of Director for a one-year term expiring at the 2023 Annual Meeting: Stephen Williamson Management   For   For    
  2.    Ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2022 fiscal year. Management   For   For    
  3.    Approve, on an advisory basis, the compensation of our named executive officers in 2021. Management   For   For    
  PEPSICO, INC.    
  Security 713448108       Meeting Type Annual  
  Ticker Symbol PEP                   Meeting Date 04-May-2022  
  ISIN US7134481081       Agenda 935567997 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Segun Agbaje Management   For   For    
  1B.   Election of Director: Shona L. Brown Management   For   For    
  1C.   Election of Director: Cesar Conde Management   For   For    
  1D.   Election of Director: Ian Cook Management   For   For    
  1E.   Election of Director: Edith W. Cooper Management   For   For    
  1F.   Election of Director: Dina Dublon Management   For   For    
  1G.   Election of Director: Michelle Gass Management   For   For    
  1H.   Election of Director: Ramon L. Laguarta Management   For   For    
  1I.   Election of Director: Dave Lewis Management   For   For    
  1J.   Election of Director: David C. Page Management   For   For    
  1K.   Election of Director: Robert C. Pohlad Management   For   For    
  1L.   Election of Director: Daniel Vasella Management   For   For    
  1M.   Election of Director: Darren Walker Management   For   For    
  1N.   Election of Director: Alberto Weisser Management   For   For    
  2.    Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for fiscal year 2022. Management   For   For    
  3.    Advisory approval of the Company’s executive compensation. Management   For   For    
  4.    Shareholder Proposal - Independent Board Chairman. Shareholder   Against   For    
  5.    Shareholder Proposal - Report on Global Public Policy and Political Influence Outside the U.S. Shareholder   Abstain   Against    
  6.    Shareholder Proposal - Report on Public Health Costs. Shareholder   Abstain   Against    
  CONFORMIS, INC.    
  Security 20717E101       Meeting Type Annual  
  Ticker Symbol CFMS                  Meeting Date 04-May-2022  
  ISIN US20717E1010       Agenda 935568204 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Mark A. Augusti       For   For    
      2 Carrie Bienkowski       For   For    
      3 Gary P. Fischetti       For   For    
  2.    To approve an amendment to the Company’s restated certificate of incorporation to effect a reverse stock split of our common stock. Management   For   For    
  3.    To approve the compensation of the Company’s named executive officers. Management   For   For    
  4.    To ratify the selection of Grant Thornton LLP as Conformis’ independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  STRYKER CORPORATION    
  Security 863667101       Meeting Type Annual  
  Ticker Symbol SYK                   Meeting Date 04-May-2022  
  ISIN US8636671013       Agenda 935568711 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A)   Election of Director: Mary K. Brainerd Management   For   For    
  1B)   Election of Director: Giovanni Caforio, M.D. Management   For   For    
  1C)   Election of Director: Srikant M. Datar, Ph.D. Management   For   For    
  1D)   Election of Director: Allan C. Golston (Lead Independent Director) Management   For   For    
  1E)   Election of Director: Kevin A. Lobo (Chair of the Board, Chief Executive Officer and President) Management   For   For    
  1F)   Election of Director: Sherilyn S. McCoy Management   For   For    
  1G)   Election of Director: Andrew K. Silvernail Management   For   For    
  1H)   Election of Director: Lisa M. Skeete Tatum Management   For   For    
  1I)   Election of Director: Ronda E. Stryker Management   For   For    
  1J)   Election of Director: Rajeev Suri Management   For   For    
  2)    Ratification of Appointment of our Independent Registered Public Accounting Firm. Management   For   For    
  3)    Advisory Vote to Approve Named Executive Officer Compensation. Management   For   For    
  4)    Shareholder Proposal to Amend Proxy Access Terms. Shareholder   Abstain   Against    
  GILEAD SCIENCES, INC.    
  Security 375558103       Meeting Type Annual  
  Ticker Symbol GILD                  Meeting Date 04-May-2022  
  ISIN US3755581036       Agenda 935570134 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Jacqueline K. Barton, Ph.D. Management   For   For    
  1B.   Election of Director: Jeffrey A. Bluestone, Ph.D. Management   For   For    
  1C.   Election of Director: Sandra J. Horning, M.D. Management   For   For    
  1D.   Election of Director: Kelly A. Kramer Management   For   For    
  1E.   Election of Director: Kevin E. Lofton Management   For   For    
  1F.   Election of Director: Harish Manwani Management   For   For    
  1G.   Election of Director: Daniel P. O’Day Management   For   For    
  1H.   Election of Director: Javier J. Rodriguez Management   For   For    
  1I.   Election of Director: Anthony Welters Management   For   For    
  2.    To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  3.    To approve, on an advisory basis, the compensation of our Named Executive Officers as presented in the Proxy Statement. Management   For   For    
  4.    To approve the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Management   Against   Against    
  5.    To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board adopt a policy that the Chairperson of the Board of Directors be an independent director. Shareholder   Against   For    
  6.    To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board include one member from Gilead’s non-management employees. Shareholder   Against   For    
  7.    To vote on a stockholder proposal, if properly presented at the meeting, requesting a 10% threshold to call a special stockholder meeting. Shareholder   Against   For    
  8.    To vote on a stockholder proposal, if properly presented at the meeting, requesting that the Board publish a third- party review of Gilead’s lobbying activities. Shareholder   Abstain   Against    
  9.    To vote on a stockholder proposal, if properly presented at the meeting, requesting a Board report on oversight of risks related to anticompetitive practices. Shareholder   Abstain   Against    
  UNILEVER PLC    
  Security 904767704       Meeting Type Annual  
  Ticker Symbol UL                    Meeting Date 04-May-2022  
  ISIN US9047677045       Agenda 935580010 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    To receive the Report and Accounts for the year ended 31 December 2021. Management   For   For    
  2.    To approve the Directors’ Remuneration Report. Management   For   For    
  3.    To re-elect Mr N Andersen as a Non-Executive Director. Management   For   For    
  4.    To re-elect Dr J Hartmann as a Non-Executive Director. Management   For   For    
  5.    To re-elect Mr A Jope as an Executive Director. Management   For   For    
  6.    To re-elect Ms A Jung as a Non-Executive Director. Management   For   For    
  7.    To re-elect Ms S Kilsby as a Non-Executive Director. Management   For   For    
  8.    To re-elect Mr S Masiyiwa as a Non-Executive Director. Management   For   For    
  9.    To re-elect Professor Y Moon as a Non-Executive Director. Management   For   For    
  10.   To re-elect Mr G Pitkethly as an Executive Director. Management   For   For    
  11.   To re-elect Mr F Sijbesma as a Non-Executive Director. Management   For   For    
  12.   To elect Mr A Hennah as a Non-Executive Director. Management   For   For    
  13.   To elect Mrs R Lu as a Non-Executive Director. Management   For   For    
  14.   To reappoint KPMG LLP as Auditors of the Company. Management   For   For    
  15.   To authorise the Directors to fix the remuneration of the Auditors. Management   For   For    
  16.   To authorise Political Donations and expenditure. Management   For   For    
  17.   To renew the authority to Directors to issue shares. Management   For   For    
  18.   To renew the authority to Directors to disapply pre- emption rights. Management   Abstain   Against    
  19.   To renew the authority to Directors to disapply pre- emption rights for the purposes of acquisitions or capital investments. Management   For   For    
  20.   To renew the authority to the Company to purchase its own shares. Management   For   For    
  21.   To shorten the notice period for General Meetings. Management   For   For    
  THE KRAFT HEINZ COMPANY    
  Security 500754106       Meeting Type Annual  
  Ticker Symbol KHC                   Meeting Date 05-May-2022  
  ISIN US5007541064       Agenda 935569561 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Gregory E. Abel Management   For   For    
  1B.   Election of Director: John T. Cahill Management   For   For    
  1C.   Election of Director: João M. Castro-Neves Management   For   For    
  1D.   Election of Director: Lori Dickerson Fouché Management   For   For    
  1E.   Election of Director: Timothy Kenesey Management   For   For    
  1F.   Election of Director: Alicia Knapp Management   For   For    
  1G.   Election of Director: Elio Leoni Sceti Management   For   For    
  1H.   Election of Director: Susan Mulder Management   For   For    
  1I.   Election of Director: James Park Management   For   For    
  1J.   Election of Director: Miguel Patricio Management   For   For    
  1K.   Election of Director: John C. Pope Management   For   For    
  2.    Advisory vote to approve executive compensation. Management   For   For    
  3.    Advisory vote on the frequency of holding an advisory vote to approve executive compensation. Management   1 Year   For    
  4.    Ratification of the selection of PricewaterhouseCoopers LLP as our independent auditors for 2022. Management   For   For    
  5.    Stockholder Proposal - Report on water risk, if properly presented. Shareholder   Abstain   Against    
  BOSTON SCIENTIFIC CORPORATION    
  Security 101137107       Meeting Type Annual  
  Ticker Symbol BSX                   Meeting Date 05-May-2022  
  ISIN US1011371077       Agenda 935569941 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Nelda J. Connors Management   For   For    
  1B.   Election of Director: Charles J. Dockendorff Management   For   For    
  1C.   Election of Director: Yoshiaki Fujimori Management   For   For    
  1D.   Election of Director: Donna A. James Management   For   For    
  1E.   Election of Director: Edward J. Ludwig Management   For   For    
  1F.   Election of Director: Michael F. Mahoney Management   For   For    
  1G.   Election of Director: David J. Roux Management   For   For    
  1H.   Election of Director: John E. Sununu Management   For   For    
  1I.   Election of Director: David S. Wichmann Management   For   For    
  1J.   Election of Director: Ellen M. Zane Management   For   For    
  2.    To approve, on a non-binding, advisory basis, named executive officer compensation. Management   For   For    
  3.    To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2022 fiscal year. Management   For   For    
  4.    To approve an amendment and restatement of our 2006 Global Employee Stock Ownership Plan (to be renamed as our Employee Stock Purchase Plan), as previously amended and restated, including a request for 10,000,000 additional shares. Management   For   For    
  PERRIGO COMPANY PLC    
  Security G97822103       Meeting Type Annual  
  Ticker Symbol PRGO                  Meeting Date 06-May-2022  
  ISIN IE00BGH1M568       Agenda 935567339 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Bradley A. Alford Management   For   For    
  1B.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Orlando D. Ashford Management   For   For    
  1C.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Katherine C. Doyle Management   For   For    
  1D.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Adriana Karaboutis Management   For   For    
  1E.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Murray S. Kessler Management   For   For    
  1F.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Jeffrey B. Kindler Management   For   For    
  1G.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Erica L. Mann Management   For   For    
  1H.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Donal O’Connor Management   For   For    
  1I.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Geoffrey M. Parker Management   For   For    
  1J.   Election of Director to hold office until the 2023 Annual General Meeting of Shareholders: Theodore R. Samuels Management   For   For    
  2.    Ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company’s independent auditor, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor Management   For   For    
  3.    Advisory vote on executive compensation Management   For   For    
  4.    Amend the Company’s Long-Term Incentive Plan Management   For   For    
  5.    Renew the Board’s authority to issue shares under Irish law Management   For   For    
  6.    Renew the Board’s authority to opt-out of statutory pre- emption rights under Irish law Management   Against   Against    
  ABBVIE INC.    
  Security 00287Y109       Meeting Type Annual  
  Ticker Symbol ABBV                  Meeting Date 06-May-2022  
  ISIN US00287Y1091       Agenda 935568141 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 William H.L. Burnside       For   For    
      2 Thomas C. Freyman       For   For    
      3 Brett J. Hart       For   For    
      4 Edward J. Rapp       For   For    
  2.    Ratification of Ernst & Young LLP as AbbVie’s independent registered public accounting firm for 2022 Management   For   For    
  3.    Say on Pay - An advisory vote on the approval of executive compensation Management   For   For    
  4.    Approval of a management proposal regarding amendment of the certificate of incorporation to eliminate supermajority voting Management   For   For    
  5.    Stockholder Proposal - to Adopt a Policy to Require Independent Chairman Shareholder   Against   For    
  6.    Stockholder Proposal - to Seek Shareholder Approval of Certain Termination Pay Arrangements Shareholder   Against   For    
  7.    Stockholder Proposal - to Issue a Report on Board Oversight of Competition Practices Shareholder   Against   For    
  8.    Stockholder Proposal - to Issue an Annual Report on Political Spending Shareholder   Abstain   Against    
  COLGATE-PALMOLIVE COMPANY    
  Security 194162103       Meeting Type Annual  
  Ticker Symbol CL                    Meeting Date 06-May-2022  
  ISIN US1941621039       Agenda 935571338 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Director: John P. Bilbrey Management   For   For    
  1b.   Election of Director: John T. Cahill Management   For   For    
  1c.   Election of Director: Lisa M. Edwards Management   For   For    
  1d.   Election of Director: C. Martin Harris Management   For   For    
  1e.   Election of Director: Martina Hund-Mejean Management   For   For    
  1f.   Election of Director: Kimberly A. Nelson Management   For   For    
  1g.   Election of Director: Lorrie M. Norrington Management   For   For    
  1h.   Election of Director: Michael B. Polk Management   For   For    
  1i.   Election of Director: Stephen I. Sadove Management   For   For    
  1j.   Election of Director: Noel R. Wallace Management   For   For    
  2.    Ratify selection of PricewaterhouseCoopers LLP as Colgate’s independent registered public accounting firm. Management   For   For    
  3.    Advisory vote on executive compensation. Management   For   For    
  4.    Stockholder proposal regarding shareholder ratification of termination pay. Shareholder   Against   For    
  5.    Stockholder proposal regarding charitable donation disclosure. Shareholder   Abstain   Against    
  TENET HEALTHCARE CORPORATION    
  Security 88033G407       Meeting Type Annual  
  Ticker Symbol THC                   Meeting Date 06-May-2022  
  ISIN US88033G4073       Agenda 935571453 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Ronald A. Rittenmeyer Management   For   For    
  1B.   Election of Director: J. Robert Kerrey Management   For   For    
  1C.   Election of Director: James L. Bierman Management   For   For    
  1D.   Election of Director: Richard W. Fisher Management   For   For    
  1E.   Election of Director: Meghan M. FitzGerald Management   For   For    
  1F.   Election of Director: Cecil D. Haney Management   For   For    
  1G.   Election of Director: Christopher S. Lynch Management   For   For    
  1H.   Election of Director: Richard J. Mark Management   For   For    
  1I.   Election of Director: Tammy Romo Management   For   For    
  1J.   Election of Director: Saumya Sutaria Management   For   For    
  1K.   Election of Director: Nadja Y. West Management   For   For    
  2.    To vote to approve, on an advisory basis, the Company’s executive compensation. Management   For   For    
  3.    To vote to approve the First Amendment to the Tenet Healthcare 2019 Stock Incentive Plan. Management   For   For    
  4.    To ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accountants for the year ending December 31, 2022. Management   For   For    
  TACTILE SYSTEMS TECHNOLOGY, INC.    
  Security 87357P100       Meeting Type Annual  
  Ticker Symbol TCMD                  Meeting Date 09-May-2022  
  ISIN US87357P1003       Agenda 935576679 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Valerie Asbury       For   For    
      2 Bill Burke       For   For    
      3 Sheri Dodd       For   For    
      4 Raymond Huggenberger       For   For    
      5 Deepti Jain       For   For    
      6 Daniel Reuvers       For   For    
      7 Brent Shafer       For   For    
  2.    Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  3.    Approve, on an advisory basis, the 2021 compensation of our named executive officers. Management   For   For    
  DANAHER CORPORATION    
  Security 235851102       Meeting Type Annual  
  Ticker Symbol DHR                   Meeting Date 10-May-2022  
  ISIN US2358511028       Agenda 935575057 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Rainer M. Blair Management   For   For    
  1B.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Linda Filler Management   For   For    
  1C.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Teri List Management   For   For    
  1D.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Walter G. Lohr, Jr. Management   For   For    
  1E.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Jessica L. Mega, MD, MPH Management   For   For    
  1F.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Mitchell P. Rales Management   For   For    
  1G.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Steven M. Rales Management   For   For    
  1H.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Pardis C. Sabeti, MD, D. PHIL Management   For   For    
  1I.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: A. Shane Sanders Management   For   For    
  1J.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: John T. Schwieters Management   For   For    
  1K.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Alan G. Spoon Management   For   For    
  1L.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Raymond C. Stevens, Ph.D Management   For   For    
  1M.   Election of Director to hold office until the 2023 Annual Meeting of Shareholders: Elias A. Zerhouni, MD Management   For   For    
  2.    To ratify the selection of Ernst & Young LLP as Danaher’s independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  3.    To approve on an advisory basis the Company’s named executive officer compensation. Management   For   For    
  4.    To act upon a shareholder proposal requesting that Danaher amend its governing documents to reduce the percentage of shares required for shareholders to call a special meeting of shareholders from 25% to 10%. Shareholder   Against   For    
  CHARLES RIVER LABORATORIES INTL., INC.    
  Security 159864107       Meeting Type Annual  
  Ticker Symbol CRL                   Meeting Date 10-May-2022  
  ISIN US1598641074       Agenda 935585464 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: James C. Foster Management   For   For    
  1B.   Election of Director: Nancy C. Andrews Management   For   For    
  1C.   Election of Director: Robert Bertolini Management   For   For    
  1D.   Election of Director: Deborah T. Kochevar Management   For   For    
  1E.   Election of Director: George Llado, Sr. Management   For   For    
  1F.   Election of Director: Martin W. MacKay Management   For   For    
  1G.   Election of Director: George E. Massaro Management   For   For    
  1H.   Election of Director: C. Richard Reese Management   For   For    
  1I.   Election of Director: Richard F. Wallman Management   For   For    
  1J.   Election of Director: Virginia M. Wilson Management   For   For    
  2.    Advisory approval of 2021 Executive Compensation Management   For   For    
  3.    Ratification of PricewaterhouseCoopers LLC as independent registered accounting public firm for 2022 Management   For   For    
  CVS HEALTH CORPORATION    
  Security 126650100       Meeting Type Annual  
  Ticker Symbol CVS                   Meeting Date 11-May-2022  
  ISIN US1266501006       Agenda 935576972 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Fernando Aguirre Management   For   For    
  1B.   Election of Director: C. David Brown II Management   For   For    
  1C.   Election of Director: Alecia A. DeCoudreaux Management   For   For    
  1D.   Election of Director: Nancy-Ann M. DeParle Management   For   For    
  1E.   Election of Director: Roger N. Farah Management   For   For    
  1F.   Election of Director: Anne M. Finucane Management   For   For    
  1G.   Election of Director: Edward J. Ludwig Management   For   For    
  1H.   Election of Director: Karen S. Lynch Management   For   For    
  1I.   Election of Director: Jean-Pierre Millon Management   For   For    
  1J.   Election of Director: Mary L. Schapiro Management   For   For    
  1K.   Election of Director: William C. Weldon Management   For   For    
  2.    Ratification of the appointment of our independent registered public accounting firm for 2022. Management   For   For    
  3.    Say on Pay, a proposal to approve, on an advisory basis, the Company’s executive compensation. Management   For   For    
  4.    Stockholder proposal for reducing our ownership threshold to request a special stockholder meeting. Shareholder   Against   For    
  5.    Stockholder proposal regarding our independent Board Chair. Shareholder   Against   For    
  6.    Stockholder proposal on civil rights and non- discrimination audit focused on “non-diverse” employees. Shareholder   Abstain   Against    
  7.    Stockholder proposal requesting paid sick leave for all employees. Shareholder   Abstain   Against    
  8.    Stockholder proposal regarding a report on the public health costs of our food business to diversified portfolios. Shareholder   Abstain   Against    
  LABORATORY CORP. OF AMERICA HOLDINGS    
  Security 50540R409       Meeting Type Annual  
  Ticker Symbol LH                    Meeting Date 11-May-2022  
  ISIN US50540R4092       Agenda 935577479 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Kerrii B. Anderson Management   For   For    
  1B.   Election of Director: Jean-Luc Bélingard Management   For   For    
  1C.   Election of Director: Jeffrey A. Davis Management   For   For    
  1D.   Election of Director: D. Gary Gilliland, M.D., Ph.D. Management   For   For    
  1E.   Election of Director: Garheng Kong, M.D., Ph.D. Management   For   For    
  1F.   Election of Director: Peter M. Neupert Management   For   For    
  1G.   Election of Director: Richelle P. Parham Management   For   For    
  1H.   Election of Director: Adam H. Schechter Management   For   For    
  1I.   Election of Director: Kathryn E. Wengel Management   For   For    
  1J.   Election of Director: R. Sanders Williams, M.D. Management   For   For    
  2.    To approve, by non-binding vote, executive compensation. Management   For   For    
  3.    Ratification of the appointment of Deloitte and Touche LLP as Laboratory Corporation of America Holdings’ independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  4.    Shareholder proposal seeking an amendment to our governing documents relating to procedural requirements in connection with shareholders’ rights to call a special meeting. Shareholder   Against   For    
  NUVASIVE, INC.    
  Security 670704105       Meeting Type Annual  
  Ticker Symbol NUVA                  Meeting Date 11-May-2022  
  ISIN US6707041058       Agenda 935580832 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.1   Election of Class III Director: Robert F. Friel Management   For   For    
  1.2   Election of Class III Director: Daniel J. Wolterman Management   For   For    
  2.    Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  3.    Approval of a non-binding advisory resolution regarding the compensation of the Company’s named executive officers for the fiscal year ended December 31, 2021. Management   For   For    
  AVANTOR, INC.    
  Security 05352A100       Meeting Type Annual  
  Ticker Symbol AVTR                  Meeting Date 12-May-2022  
  ISIN US05352A1007       Agenda 935575463 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Juan Andres Management   For   For    
  1B.   Election of Director: John Carethers Management   For   For    
  1C.   Election of Director: Matthew Holt Management   For   For    
  1D.   Election of Director: Lan Kang Management   For   For    
  1E.   Election of Director: Joseph Massaro Management   For   For    
  1F.   Election of Director: Mala Murthy Management   For   For    
  1G.   Election of Director: Jonathan Peacock Management   For   For    
  1H.   Election of Director: Michael Severino Management   For   For    
  1I.   Election of Director: Christi Shaw Management   For   For    
  1J.   Election of Director: Michael Stubblefield Management   For   For    
  1K.   Election of Director: Gregory Summe Management   For   For    
  2.    Ratification of the Appointment of Deloitte & Touche LLP as the Company’s independent registered accounting firm for 2022. Management   For   For    
  3.    Approve, on an Advisory Basis, Named Executive Officer Compensation. Management   For   For    
  ZIMMER BIOMET HOLDINGS, INC.    
  Security 98956P102       Meeting Type Annual  
  Ticker Symbol ZBH                   Meeting Date 13-May-2022  
  ISIN US98956P1021       Agenda 935568139 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Christopher B. Begley Management   For   For    
  1B.   Election of Director: Betsy J. Bernard Management   For   For    
  1C.   Election of Director: Michael J. Farrell Management   For   For    
  1D.   Election of Director: Robert A. Hagemann Management   For   For    
  1E.   Election of Director: Bryan C. Hanson Management   For   For    
  1F.   Election of Director: Arthur J. Higgins Management   For   For    
  1G.   Election of Director: Maria Teresa Hilado Management   For   For    
  1H.   Election of Director: Syed Jafry Management   For   For    
  1I.   Election of Director: Sreelakshmi Kolli Management   For   For    
  1J.   Election of Director: Michael W. Michelson Management   For   For    
  2.    Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2022. Management   For   For    
  3.    Approve, on a non-binding advisory basis, named executive officer compensation (“Say on Pay”). Management   For   For    
  CHEMED CORPORATION    
  Security 16359R103       Meeting Type Annual  
  Ticker Symbol CHE                   Meeting Date 16-May-2022  
  ISIN US16359R1032       Agenda 935607412 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Director: Kevin J. McNamara Management   For   For    
  1b.   Election of Director: Ron DeLyons Management   For   For    
  1c.   Election of Director: Joel F. Gemunder Management   For   For    
  1d.   Election of Director: Patrick P. Grace Management   For   For    
  1e.   Election of Director: Christopher J. Heaney Management   For   For    
  1f.   Election of Director: Thomas C. Hutton Management   For   For    
  1g.   Election of Director: Andrea R. Lindell Management   For   For    
  1h.   Election of Director: Thomas P. Rice Management   For   For    
  1i.   Election of Director: Donald E. Saunders Management   For   For    
  1j.   Election of Director: George J. Walsh III Management   For   For    
  2.    Approval and Adoption of the 2022 Stock Icentive Plan. Management   Against   Against    
  3.    Ratification of Audit Committee’s selection of PricewaterhouseCoopers LLP as independent accountants for 2022. Management   For   For    
  4.    Advisory vote to approve executive compensation. Management   For   For    
  QUIDEL CORPORATION    
  Security 74838J101       Meeting Type Special 
  Ticker Symbol QDEL                  Meeting Date 16-May-2022  
  ISIN US74838J1016       Agenda 935618009 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    To approve and adopt the Business Combination Agreement (the “BCA”), dated December 22, 2021, by and among Quidel Corporation (“Quidel”), Ortho Clinical Diagnostics Holdings plc, Coronado Topco, Inc. (“Topco”), Orca Holdco, Inc. (“U.S. Holdco Sub”) and Laguna Merger Sub, Inc., each wholly owned subsidiaries of Topco, and Orca Holdco 2, Inc., a wholly owned subsidiary of U.S. Holdco Sub, including the Quidel Merger (as defined in the joint proxy statement/prospectus) and the transactions contemplated thereby (the “Merger Proposal”) Management   For   For    
  2.    To approve, on a non-binding, advisory basis, certain compensation arrangements for Quidel’s named executive officers in connection with the BCA Management   For   For    
  3.    To approve any motion to adjourn the Special Meeting to another time or place, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Merger Proposal Management   For   For    
  4.    DIRECTOR Management            
      1 Douglas C. Bryant       For   For    
      2 Kenneth F. Buechler       For   For    
      3 Edward L. Michael       For   For    
      4 Mary Lake Polan       For   For    
      5 Ann D. Rhoads       For   For    
      6 Matthew W. Strobeck       For   For    
      7 Kenneth J. Widder       For   For    
      8 Joseph D. Wilkins Jr.       For   For    
  5.    To approve, on an advisory basis, the compensation of Quidel’s named executive officers Management   For   For    
  6.    To ratify the selection of Ernst & Young LLP as Quidel’s independent registered public accounting firm for the fiscal year ending December 31, 2022 Management   For   For    
  7.    To approve an amendment and restatement of Quidel’s 2018 Equity Incentive Plan (the “2018 Plan”) to increase the number of shares of Quidel common stock available under the 2018 Plan Management   For   For    
  8.    To approve an amendment and restatement of Quidel’s 1983 Employee Stock Purchase Plan (the “1983 ESPP”) to increase the number of shares of Quidel common stock available under the 1983 ESPP Management   For   For    
  ICU MEDICAL, INC.    
  Security 44930G107       Meeting Type Annual  
  Ticker Symbol ICUI                  Meeting Date 17-May-2022  
  ISIN US44930G1076       Agenda 935577126 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Vivek Jain       For   For    
      2 George A. Lopez, M.D.       For   For    
      3 David C. Greenberg       For   For    
      4 Elisha W. Finney       For   For    
      5 David F. Hoffmeister       For   For    
      6 Donald M. Abbey       For   For    
      7 Laurie Hernandez       For   For    
      8 Kolleen T. Kennedy       For   For    
      9 William Seeger       For   For    
  2.    To ratify the selection of Deloitte & Touche LLP as auditors for the Company for the year ending December 31, 2022. Management   For   For    
  3.    To approve named executive officer compensation on an advisory basis. Management   For   For    
  AMGEN INC.    
  Security 031162100       Meeting Type Annual  
  Ticker Symbol AMGN                  Meeting Date 17-May-2022  
  ISIN US0311621009       Agenda 935580729 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director for a term of expiring at the 2023 annual meeting: Dr. Wanda M. Austin Management   For   For    
  1B.   Election of Director for a term of expiring at the 2023 annual meeting: Mr. Robert A. Bradway Management   For   For    
  1C.   Election of Director for a term of expiring at the 2023 annual meeting: Dr. Brian J. Druker Management   For   For    
  1D.   Election of Director for a term of expiring at the 2023 annual meeting: Mr. Robert A. Eckert Management   For   For    
  1E.   Election of Director for a term of expiring at the 2023 annual meeting: Mr. Greg C. Garland Management   For   For    
  1F.   Election of Director for a term of expiring at the 2023 annual meeting: Mr. Charles M. Holley, Jr. Management   For   For    
  1G.   Election of Director for a term of expiring at the 2023 annual meeting: Dr. S. Omar Ishrak Management   For   For    
  1H.   Election of Director for a term of expiring at the 2023 annual meeting: Dr. Tyler Jacks Management   For   For    
  1I.   Election of Director for a term of expiring at the 2023 annual meeting: Ms. Ellen J. Kullman Management   For   For    
  1J.   Election of Director for a term of expiring at the 2023 annual meeting: Ms. Amy E. Miles Management   For   For    
  1K.   Election of Director for a term of expiring at the 2023 annual meeting: Dr. Ronald D. Sugar Management   For   For    
  1L.   Election of Director for a term of expiring at the 2023 annual meeting: Dr. R. Sanders Williams Management   For   For    
  2.    Advisory vote to approve our executive compensation. Management   For   For    
  3.    To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the fiscal year ending December 31, 2022. Management   For   For    
  PERSONALIS, INC.    
  Security 71535D106       Meeting Type Annual  
  Ticker Symbol PSNL                  Meeting Date 17-May-2022  
  ISIN US71535D1063       Agenda 935589169 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.1   Election of Director: A. Blaine Bowman Management   For   For    
  1.2   Election of Director: Karin Eastham Management   For   For    
  2.    Ratification of the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  3.    Approval, on a non-binding, advisory basis, of the compensation of the Company’s named executive officers, as disclosed in the proxy statement accompanying this notice. Management   For   For    
  4.    Indication, on a non-binding, advisory basis, of the preferred frequency of stockholder advisory votes on the compensation of the Company’s named executive officers. Management   3 Years   For    
  ORASURE TECHNOLOGIES, INC.    
  Security 68554V108       Meeting Type Annual  
  Ticker Symbol OSUR                  Meeting Date 17-May-2022  
  ISIN US68554V1089       Agenda 935593942 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   ELECTION OF Class I DIRECTOR (Expiring 2025): Eamonn P. Hobbs Management   For   For    
  1B.   ELECTION OF Class I DIRECTOR (Expiring 2025): David J. Shulkin, M.D. Management   For   For    
  2.    Ratification of Appointment of KPMG LLP as the Independent Registered Public Accounting Firm for Fiscal Year 2022. Management   For   For    
  3.    Advisory (Non-Binding) Vote to Approve Executive Compensation. Management   For   For    
  4.    Approval of Amendment and Restatement of the Company’s Stock Award Plan to Increase the Shares Authorized for Issuance Thereunder. Management   Against   Against    
  INFUSYSTEM HOLDINGS, INC.    
  Security 45685K102       Meeting Type Annual  
  Ticker Symbol INFU                  Meeting Date 17-May-2022  
  ISIN US45685K1025       Agenda 935597104 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Ralph Boyd       For   For    
      2 Richard Dilorio       For   For    
      3 Paul Gendron       For   For    
      4 Carrie Lachance       For   For    
      5 Gregg Lehman       For   For    
      6 Christopher Sansone       For   For    
      7 Scott Shuda       For   For    
  2.    Approval, on an advisory basis, of the Company’s executive compensation. Management   For   For    
  3.    Ratification of the appointment of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  AURINIA PHARMACEUTICALS INC.    
  Security 05156V102       Meeting Type Annual  
  Ticker Symbol AUPH                  Meeting Date 17-May-2022  
  ISIN CA05156V1022       Agenda 935624456 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1     DIRECTOR Management            
      1 Dr. George M. Milne       For   For    
      2 Mr. Peter Greenleaf       For   For    
      3 Dr. David R.W. Jayne       For   For    
      4 Mr. Joseph P. Hagan       For   For    
      5 Dr. Daniel G. Billen       For   For    
      6 Mr. R. H. MacKay-Dunn       For   For    
      7 Ms. Jill Leversage       For   For    
      8 Mr. Timothy P. Walbert       For   For    
      9 Dr. Brinda Balakrishnan       For   For    
  2     Appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm until the close of the 2023 annual general meeting of shareholders or until a successor is appointed. Management   For   For    
  3     To approve, on a non-binding advisory basis, a “say on pay” resolution regarding the Company’s executive compensation set forth in the Company’s Proxy Statement/Circular. Management   For   For    
  ANTHEM, INC.    
  Security 036752103       Meeting Type Annual  
  Ticker Symbol ANTM                  Meeting Date 18-May-2022  
  ISIN US0367521038       Agenda 935576720 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.1   Election of Director: Susan D. DeVore Management   For   For    
  1.2   Election of Director: Bahija Jallal Management   For   For    
  1.3   Election of Director: Ryan M. Schneider Management   For   For    
  1.4   Election of Director: Elizabeth E. Tallett Management   For   For    
  2.    Advisory vote to approve the compensation of our named executive officers. Management   For   For    
  3.    To ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2022. Management   For   For    
  4.    To approve an amendment to our Articles of Incorporation to change our name to Elevance Health, Inc. Management   For   For    
  5.    Shareholder proposal to prohibit political funding. Shareholder   Against   For    
  6.    Shareholder proposal requesting a racial impact audit and report. Shareholder   Abstain   Against    
  OPTION CARE HEALTH, INC.    
  Security 68404L201       Meeting Type Annual  
  Ticker Symbol OPCH                  Meeting Date 18-May-2022  
  ISIN US68404L2016       Agenda 935578899 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Anita M. Allemand       For   For    
      2 John J. Arlotta       For   For    
      3 Elizabeth Q. Betten       For   For    
      4 Elizabeth D. Bierbower       For   For    
      5 Natasha Deckmann       For   For    
      6 Aaron Friedman       For   For    
      7 David W. Golding       For   For    
      8 Harry M. J. Kraemer Jr.       For   For    
      9 R. Carter Pate       For   For    
      10 John C. Rademacher       For   For    
      11 Nitin Sahney       For   For    
      12 Timothy Sullivan       For   For    
      13 Mark Vainisi       For   For    
  2.    To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  3.    To approve, on a non-binding advisory basis, our executive compensation. Management   For   For    
  ELANCO ANIMAL HEALTH INCORPORATED    
  Security 28414H103       Meeting Type Annual  
  Ticker Symbol ELAN                  Meeting Date 18-May-2022  
  ISIN US28414H1032       Agenda 935584119 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Director: Kapila K. Anand Management   For   For    
  1b.   Election of Director: John P. Bilbrey Management   For   For    
  1c.   Election of Director: Scott D. Ferguson Management   For   For    
  1d.   Election of Director: Paul Herendeen Management   For   For    
  1e.   Election of Director: Lawrence E. Kurzius Management   For   For    
  2.    Ratification of the appointment of Ernst & Young LLP as the company’s independent registered public accounting firm for 2022. Management   For   For    
  3.    Advisory vote on the approval of executive compensation. Management   For   For    
  4.    Approval of the Elanco Animal Health Incorporated Employee Stock Purchase Plan. Management   For   For    
  5.    Approval of amendments to the company’s Amended and Restated Articles of Incorporation to eliminate supermajority voting requirements. Management   For   For    
  6.    Approval of amendments to the company’s Amended and Restated Articles of Incorporation to eliminate legacy parent provisions. Management   For   For    
  THERMO FISHER SCIENTIFIC INC.    
  Security 883556102       Meeting Type Annual  
  Ticker Symbol TMO                   Meeting Date 18-May-2022  
  ISIN US8835561023       Agenda 935585058 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of director: Marc N. Casper Management   For   For    
  1B.   Election of director: Nelson J. Chai Management   For   For    
  1C.   Election of director: Ruby R. Chandy Management   For   For    
  1D.   Election of director: C. Martin Harris Management   For   For    
  1E.   Election of director: Tyler Jacks Management   For   For    
  1F.   Election of director: R. Alexandra Keith Management   For   For    
  1G.   Election of director: Jim P. Manzi Management   For   For    
  1H.   Election of director: James C. Mullen Management   For   For    
  1I.   Election of director: Lars R. Sorensen Management   For   For    
  1J.   Election of director: Debora L. Spar Management   For   For    
  1K.   Election of director: Scott M. Sperling Management   For   For    
  1L.   Election of director: Dion J. Weisler Management   For   For    
  2.    An advisory vote to approve named executive officer compensation. Management   For   For    
  3.    Ratification of the Audit Committee’s selection of PricewaterhouseCoopers LLP as the Company’s independent auditors for 2022. Management   For   For    
  MONDELEZ INTERNATIONAL, INC.    
  Security 609207105       Meeting Type Annual  
  Ticker Symbol MDLZ                  Meeting Date 18-May-2022  
  ISIN US6092071058       Agenda 935587379 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Lewis W.K. Booth Management   For   For    
  1B.   Election of Director: Charles E. Bunch Management   For   For    
  1C.   Election of Director: Ertharin Cousin Management   For   For    
  1D.   Election of Director: Lois D. Juliber Management   For   For    
  1E.   Election of Director: Jorge S. Mesquita Management   For   For    
  1F.   Election of Director: Jane Hamilton Nielsen Management   For   For    
  1G.   Election of Director: Christiana S. Shi Management   For   For    
  1H.   Election of Director: Patrick T. Siewert Management   For   For    
  1I.   Election of Director: Michael A. Todman Management   For   For    
  1J.   Election of Director: Dirk Van de Put Management   For   For    
  2.    Advisory Vote to Approve Executive Compensation. Management   For   For    
  3.    Ratification of PricewaterhouseCoopers LLP as Independent Registered Public Accountants for Fiscal Year Ending December 31, 2022. Management   For   For    
  4.    Conduct and Publish Racial Equity Audit. Shareholder   Abstain   Against    
  5.    Require Independent Chair of the Board. Shareholder   Against   For    
  VERTEX PHARMACEUTICALS INCORPORATED    
  Security 92532F100       Meeting Type Annual  
  Ticker Symbol VRTX                  Meeting Date 18-May-2022  
  ISIN US92532F1003       Agenda 935588042 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Sangeeta Bhatia Management   For   For    
  1B.   Election of Director: Lloyd Carney Management   For   For    
  1C.   Election of Director: Alan Garber Management   For   For    
  1D.   Election of Director: Terrence Kearney Management   For   For    
  1E.   Election of Director: Reshma Kewalramani Management   For   For    
  1F.   Election of Director: Yuchun Lee Management   For   For    
  1G.   Election of Director: Jeffrey Leiden Management   For   For    
  1H.   Election of Director: Margaret McGlynn Management   For   For    
  1I.   Election of Director: Diana McKenzie Management   For   For    
  1J.   Election of Director: Bruce Sachs Management   For   For    
  1K.   Election of Director: Suketu Upadhyay Management   For   For    
  2.    Ratification of Ernst & Young LLP as independent Registered Public Accounting firm for the year ending December 31, 2022. Management   For   For    
  3.    Advisory vote to approve named executive office compensation. Management   For   For    
  4.    Approval of an amendment and restatement of our 2013 Stock and Option Plan to increase the number of shares authorized for issuance under this plan by 13.5 million shares. Management   Against   Against    
  HENRY SCHEIN, INC.    
  Security 806407102       Meeting Type Annual  
  Ticker Symbol HSIC                  Meeting Date 18-May-2022  
  ISIN US8064071025       Agenda 935592306 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Mohamad Ali Management   For   For    
  1B.   Election of Director: Stanley M. Bergman Management   For   For    
  1C.   Election of Director: James P. Breslawski Management   For   For    
  1D.   Election of Director: Deborah Derby Management   For   For    
  1E.   Election of Director: Joseph L. Herring Management   For   For    
  1F.   Election of Director: Kurt P. Kuehn Management   For   For    
  1G.   Election of Director: Philip A. Laskawy Management   For   For    
  1H.   Election of Director: Anne H. Margulies Management   For   For    
  1I.   Election of Director: Mark E. Mlotek Management   For   For    
  1J.   Election of Director: Steven Paladino Management   For   For    
  1K.   Election of Director: Carol Raphael Management   For   For    
  1L.   Election of Director: E. Dianne Rekow, DDS, Ph.D. Management   For   For    
  1M.   Election of Director: Scott Serota Management   For   For    
  1N.   Election of Director: Bradley T. Sheares, Ph.D. Management   For   For    
  1O.   Election of Director: Reed V. Tuckson, M.D., FACP Management   For   For    
  2.    Proposal to approve, by non-binding vote, the 2021 compensation paid to the Company’s Named Executive Officers. Management   For   For    
  3.    Proposal to ratify the selection of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  INTEGER HOLDINGS CORPORATION    
  Security 45826H109       Meeting Type Annual  
  Ticker Symbol ITGR                  Meeting Date 18-May-2022  
  ISIN US45826H1095       Agenda 935592700 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director for a one-year term: Sheila Antrum Management   For   For    
  1B.   Election of Director for a one-year term: Pamela G. Bailey Management   For   For    
  1C.   Election of Director for a one-year term: Cheryl C. Capps Management   For   For    
  1D.   Election of Director for a one-year term: Joseph W. Dziedzic Management   For   For    
  1E.   Election of Director for a one-year term: James F. Hinrichs Management   For   For    
  1F.   Election of Director for a one-year term: Jean Hobby Management   For   For    
  1G.   Election of Director for a one-year term: Tyrone Jeffers Management   For   For    
  1H.   Election of Director for a one-year term: M. Craig Maxwell Management   For   For    
  1I.   Election of Director for a one-year term: Filippo Passerini Management   For   For    
  1J.   Election of Director for a one-year term: Donald J. Spence Management   For   For    
  1K.   Election of Director for a one-year term: William B. Summers, Jr Management   For   For    
  2.    To ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for Integer Holdings Corporation for fiscal year 2022. Management   For   For    
  3.    To approve, on an advisory basis, the compensation of our named executive officers. Management   For   For    
  QUEST DIAGNOSTICS INCORPORATED    
  Security 74834L100       Meeting Type Annual  
  Ticker Symbol DGX                   Meeting Date 18-May-2022  
  ISIN US74834L1008       Agenda 935621107 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.1   Election of Director: Tracey C. Doi Management   For   For    
  1.2   Election of Director: Vicky B. Gregg Management   For   For    
  1.3   Election of Director: Wright L. Lassiter III Management   For   For    
  1.4   Election of Director: Timothy L. Main Management   For   For    
  1.5   Election of Director: Denise M. Morrison Management   For   For    
  1.6   Election of Director: Gary M. Pfeiffer Management   For   For    
  1.7   Election of Director: Timothy M. Ring Management   For   For    
  1.8   Election of Director: Stephen H. Rusckowski Management   For   For    
  1.9   Election of Director: Gail R. Wilensky Management   For   For    
  2.    An advisory resolution to approve the executive officer compensation disclosed in the Company’s 2022 proxy statement Management   For   For    
  3.    Ratification of the appointment of our independent registered public accounting firm for 2022 Management   For   For    
  4.    To adopt an amendment to the Company’s Certificate of Incorporation to allow stockholders to act by non- unanimous written consent Management   For   For    
  5.    To adopt an amendment to the Company’s Certificate of Incorporation to permit stockholders holding 15% or more of the Company’s common stock to request that the Company call a special meeting of stockholders Management   For   For    
  6.    Stockholder proposal regarding the right to call a special meeting of stockholders Shareholder   Against   For    
  ZOETIS INC.    
  Security 98978V103       Meeting Type Annual  
  Ticker Symbol ZTS                   Meeting Date 19-May-2022  
  ISIN US98978V1035       Agenda 935591176 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Paul M. Bisaro Management   For   For    
  1B.   Election of Director: Frank A. D’Amelio Management   For   For    
  1C.   Election of Director: Michael B. McCallister Management   For   For    
  2.    Advisory vote to approve our executive compensation. Management   For   For    
  3.    Approval of an Amendment and Restatement of our 2013 Equity and Incentive Plan. Management   For   For    
  4.    Ratification of appointment of KPMG LLP as our independent registered public accounting firm for 2022. Management   For   For    
  5.    Approval of an amendment to our Restated Certificate of Incorporation to eliminate supermajority voting provisions and certain provisions related to Pfizer Inc. Management   For   For    
  6.    Approval of an amendment to our Restated Certificate of Incorporation to declassify the Board of Directors. Management   For   For    
  MEDPACE HOLDINGS, INC.    
  Security 58506Q109       Meeting Type Annual  
  Ticker Symbol MEDP                  Meeting Date 20-May-2022  
  ISIN US58506Q1094       Agenda 935589791 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 August J. Troendle       For   For    
      2 Ashley M. Keating       For   For    
  2.    To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  3.    To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2022 Annual Meeting. Management   For   For    
  MERCK & CO., INC.    
  Security 58933Y105       Meeting Type Annual  
  Ticker Symbol MRK                   Meeting Date 24-May-2022  
  ISIN US58933Y1055       Agenda 935591570 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Douglas M. Baker, Jr. Management   For   For    
  1B.   Election of Director: Mary Ellen Coe Management   For   For    
  1C.   Election of Director: Pamela J. Craig Management   For   For    
  1D.   Election of Director: Robert M. Davis Management   For   For    
  1E.   Election of Director: Kenneth C. Frazier Management   For   For    
  1F.   Election of Director: Thomas H. Glocer Management   For   For    
  1G.   Election of Director: Risa J. Lavizzo-Mourey, M.D. Management   For   For    
  1H.   Election of Director: Stephen L. Mayo, Ph.D. Management   For   For    
  1I.   Election of Director: Paul B. Rothman, M.D. Management   For   For    
  1J.   Election of Director: Patricia F. Russo Management   For   For    
  1K.   Election of Director: Christine E. Seidman, M.D. Management   For   For    
  1L.   Election of Director: Inge G. Thulin Management   For   For    
  1M.   Election of Director: Kathy J. Warden Management   For   For    
  1N.   Election of Director: Peter C. Wendell Management   For   For    
  2.    Non-binding advisory vote to approve the compensation of our named executive officers. Management   For   For    
  3.    Ratification of the appointment of the Company’s independent registered public accounting firm for 2022. Management   For   For    
  4.    Shareholder proposal regarding an independent board chairman. Shareholder   Against   For    
  5.    Shareholder proposal regarding access to COVID-19 products. Shareholder   Abstain   Against    
  6.    Shareholder proposal regarding lobbying expenditure disclosure. Shareholder   Abstain   Against    
  WATERS CORPORATION    
  Security 941848103       Meeting Type Annual  
  Ticker Symbol WAT                   Meeting Date 24-May-2022  
  ISIN US9418481035       Agenda 935598497 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.1   Election of Director: Dr. Udit Batra, Ph.D. Management   For   For    
  1.2   Election of Director: Linda Baddour Management   For   For    
  1.3   Election of Director: Edward Conard Management   For   For    
  1.4   Election of Director: Dr. Pearl S. Huang, Ph.D. Management   For   For    
  1.5   Election of Director: Wei Jiang Management   For   For    
  1.6   Election of Director: Christopher A. Kuebler Management   For   For    
  1.7   Election of Director: Dr. Flemming Ornskov, M.D., M.P.H. Management   For   For    
  1.8   Election of Director: Thomas P. Salice Management   For   For    
  2.    To ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  3.    To approve, by non-binding vote, executive compensation. Management   For   For    
  INTRICON CORPORATION    
  Security 46121H109       Meeting Type Special 
  Ticker Symbol IIN                   Meeting Date 24-May-2022  
  ISIN US46121H1095       Agenda 935639964 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    To (a) approve and adopt the Agreement and Plan of Merger, dated 2/27/22 (as amended, the “Merger Agreement”), by and among Intricon (“Intricon”), IIN Holding Company LLC (“Parent”), and IC Merger Sub Inc., a wholly owned subsidiary of Parent (“Merger Sub”), and (b) pursuant to the Merger Agreement, approve the merger of Merger Sub with and into Intricon, as a result of which the separate corporate existence of Merger Sub will cease, with Intricon continuing as the surviving corporation (the “Merger”) and a wholly owned subsidiary of Parent. Management   For   For    
  2.    To approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Intricon Corporation’s named executive officers that is based on or otherwise is related to the Merger Agreement and the transactions contemplated by the Merger Agreement. Management   For   For    
  3.    To approve any proposal to adjourn the Special Meeting from time to time, if necessary or appropriate as determined in the discretion of the Board of Directors of Intricon Corporation to solicit additional proxies if there are insufficient votes to approve and adopt the Merger Agreement and approve the Merger at the time of the Special Meeting. Management   For   For    
  SPROUTS FARMERS MARKET, INC.    
  Security 85208M102       Meeting Type Annual  
  Ticker Symbol SFM                   Meeting Date 25-May-2022  
  ISIN US85208M1027       Agenda 935586961 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Kristen E. Blum       For   For    
      2 Jack L. Sinclair       For   For    
  2.    To vote on a non-binding advisory resolution to approve the compensation paid to our named executive officers for fiscal 2021 (“say-on-pay”). Management   For   For    
  3.    To approve the Sprouts Farmers Market, Inc. 2022 Omnibus Incentive Compensation Plan. Management   For   For    
  4.    To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending January 1, 2023. Management   For   For    
  AXOGEN, INC.    
  Security 05463X106       Meeting Type Annual  
  Ticker Symbol AXGN                  Meeting Date 25-May-2022  
  ISIN US05463X1063       Agenda 935596962 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Karen Zaderej       For   For    
      2 Gregory Freitag       For   For    
      3 Dr. Mark Gold       For   For    
      4 John H. Johnson       For   For    
      5 Alan M. Levine       For   For    
      6 Guido Neels       For   For    
      7 Paul Thomas       For   For    
      8 Amy Wendell       For   For    
  2.    To ratify the selection of Deloitte & Touche LLP as our independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  3.    To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s Proxy Statement. Management   For   For    
  4.    To approve the Axogen, Inc. Second Amended and Restated 2019 Long-Term Incentive Plan. Management   Against   Against    
  5.    To approve an amendment to the Axogen, Inc. Amended and Restated Bylaws. Management   Against   Against    
  NATERA, INC.    
  Security 632307104       Meeting Type Annual  
  Ticker Symbol NTRA                  Meeting Date 25-May-2022  
  ISIN US6323071042       Agenda 935603755 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Roy Baynes       For   For    
      2 James Healy       For   For    
      3 Gail Marcus       For   For    
  2.    To ratify the appointment of Ernst & Young LLP as Natera, Inc.’s independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  3.    To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.’s named executive officers as disclosed in the proxy statement. Management   For   For    
  DENTSPLY SIRONA INC.    
  Security 24906P109       Meeting Type Annual  
  Ticker Symbol XRAY                  Meeting Date 25-May-2022  
  ISIN US24906P1093       Agenda 935603870 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Eric K. Brandt Management   For   For    
  1B.   Election of Director: Donald M. Casey Jr. Management   Abstain   Against    
  1C.   Election of Director: Willie A. Deese Management   For   For    
  1D.   Election of Director: John P. Groetelaars Management   For   For    
  1E.   Election of Director: Betsy D. Holden Management   For   For    
  1F.   Election of Director: Clyde R. Hosein Management   For   For    
  1G.   Election of Director: Harry M. Kraemer Jr. Management   For   For    
  1H.   Election of Director: Gregory T. Lucier Management   For   For    
  1I.   Election of Director: Leslie F. Varon Management   For   For    
  1J.   Election of Director: Janet S. Vergis Management   For   For    
  1K.   Election of Director: Dorothea Wenzel Management   For   For    
  2.    Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accountants for 2022. Management   For   For    
  3.    Approval, by non-binding vote, of the Company’s executive compensation. Management   For   For    
  4.    Approval of the Amendment to the Fifth Amended and Restated By- Laws to Designate the Exclusive Forum for the Adjudication of Certain Legal Matters. Management   For   For    
  PACIFIC BIOSCIENCES OF CALIFORNIA, INC.    
  Security 69404D108       Meeting Type Annual  
  Ticker Symbol PACB                  Meeting Date 25-May-2022  
  ISIN US69404D1081       Agenda 935605014 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.1   Election of Class III Director: David Botstein, Ph.D. Management   For   For    
  1.2   Election of Class III Director: William Ericson Management   For   For    
  1.3   Election of Class III Director: Kathy Ordoñez Management   For   For    
  2.    Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  3.    Approval of an amendment of our 2020 Equity Incentive Plan to increase the number of shares reserved thereunder. Management   Against   Against    
  FLOWERS FOODS, INC.    
  Security 343498101       Meeting Type Annual  
  Ticker Symbol FLO                   Meeting Date 26-May-2022  
  ISIN US3434981011       Agenda 935596594 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director to serve for a term of one year: George E. Deese Management   For   For    
  1B.   Election of Director to serve for a term of one year: Edward J. Casey, Jr. Management   For   For    
  1C.   Election of Director to serve for a term of one year: Thomas C. Chubb, III Management   For   For    
  1D.   Election of Director to serve for a term of one year: Rhonda Gass Management   For   For    
  1E.   Election of Director to serve for a term of one year: Benjamin H. Griswold, IV Management   For   For    
  1F.   Election of Director to serve for a term of one year: Margaret G. Lewis Management   For   For    
  1G.   Election of Director to serve for a term of one year: W. Jameson McFadden Management   For   For    
  1H.   Election of Director to serve for a term of one year: A. Ryals McMullian Management   For   For    
  1I.   Election of Director to serve for a term of one year: James T. Spear Management   For   For    
  1J.   Election of Director to serve for a term of one year: Melvin T. Stith, Ph.D. Management   For   For    
  1K.   Election of Director to serve for a term of one year: Terry S. Thomas Management   For   For    
  1L.   Election of Director to serve for a term of one year: C. Martin Wood III Management   For   For    
  2.    To approve by advisory vote the compensation of the company’s named executive officers. Management   For   For    
  3.    To ratify the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for Flowers Foods, Inc. for the fiscal year ending December 31, 2022. Management   For   For    
  4.    To consider a shareholder proposal regarding political contribution disclosure, if properly presented at the annual meeting. Shareholder   Abstain   Against    
  STERICYCLE, INC.    
  Security 858912108       Meeting Type Annual  
  Ticker Symbol SRCL                  Meeting Date 26-May-2022  
  ISIN US8589121081       Agenda 935598411 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Robert S. Murley Management   For   For    
  1B.   Election of Director: Cindy J. Miller Management   For   For    
  1C.   Election of Director: Brian P. Anderson Management   For   For    
  1D.   Election of Director: Lynn D. Bleil Management   For   For    
  1E.   Election of Director: Thomas F. Chen Management   For   For    
  1F.   Election of Director: J. Joel Hackney, Jr. Management   For   For    
  1G.   Election of Director: Stephen C. Hooley Management   For   For    
  1H.   Election of Director: Kay G. Priestly Management   For   For    
  1I.   Election of Director: James L. Welch Management   For   For    
  2.    Advisory vote to approve executive compensation Management   For   For    
  3.    Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2022 Management   For   For    
  4.    Stockholder proposal entitled Special Shareholder Meeting Improvement Shareholder   Against   For    
  5.    Stockholder proposal related to a civil rights audit Shareholder   Abstain   Against    
  TELADOC HEALTH, INC.    
  Security 87918A105       Meeting Type Annual  
  Ticker Symbol TDOC                  Meeting Date 26-May-2022  
  ISIN US87918A1051       Agenda 935600862 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director for a term of one year: Karen L. Daniel Management   For   For    
  1B.   Election of Director for a term of one year: Sandra L. Fenwick Management   For   For    
  1C.   Election of Director for a term of one year: William H. Frist, M.D. Management   For   For    
  1D.   Election of Director for a term of one year: Jason Gorevic Management   For   For    
  1E.   Election of Director for a term of one year: Catherine A. Jacobson Management   For   For    
  1F.   Election of Director for a term of one year: Thomas G. McKinley Management   For   For    
  1G.   Election of Director for a term of one year: Kenneth H. Paulus Management   For   For    
  1H.   Election of Director for a term of one year: David L. Shedlarz Management   For   For    
  1I.   Election of Director for a term of one year: Mark Douglas Smith, M.D., MBA Management   For   For    
  1J.   Election of Director for a term of one year: David B. Snow, Jr. Management   For   For    
  2.    Approve, on an advisory basis, the compensation of Teladoc Health’s named executive officers. Management   For   For    
  3.    Ratify the appointment of Ernst & Young LLP as Teladoc Health’s independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  4.    Approve an amendment to Teladoc Health’s Certificate of Incorporation to permit holders of at least 15% net long ownership in voting power of Teladoc Health’s outstanding capital stock to call special meetings. Management   For   For    
  NEURONETICS, INC.    
  Security 64131A105       Meeting Type Annual  
  Ticker Symbol STIM                  Meeting Date 26-May-2022  
  ISIN US64131A1051       Agenda 935601218 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 John Bakewell       For   For    
      2 Robert Cascella       For   For    
      3 Sheryl Conley       For   For    
      4 Wilfred Jaeger       For   For    
      5 Glenn Muir       For   For    
      6 Megan Rosengarten       For   For    
      7 Bruce Shook       For   For    
      8 Keith J. Sullivan       For   For    
  2.    Ratification of the selection of KPMG LLP as our independent registered public accounting firm. Management   For   For    
  ILLUMINA, INC.    
  Security 452327109       Meeting Type Annual  
  Ticker Symbol ILMN                  Meeting Date 26-May-2022  
  ISIN US4523271090       Agenda 935603921 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Frances Arnold, Ph.D. Management   For   For    
  1B.   Election of Director: Francis A. deSouza Management   For   For    
  1C.   Election of Director: Caroline D. Dorsa Management   For   For    
  1D.   Election of Director: Robert S. Epstein, M.D. Management   For   For    
  1E.   Election of Director: Scott Gottlieb, M.D. Management   For   For    
  1F.   Election of Director: Gary S. Guthart, Ph.D. Management   For   For    
  1G.   Election of Director: Philip W. Schiller Management   For   For    
  1H.   Election of Director: Susan E. Siegel Management   For   For    
  1I.   Election of Director: John W. Thompson Management   For   For    
  2.    To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending January 1, 2023. Management   For   For    
  3.    To approve, on an advisory basis, the compensation of the named executive officers as disclosed in the Proxy Statement. Management   For   For    
  4.    To approve, on an advisory basis, a stockholder proposal regarding the right of stockholders to call special meetings. Shareholder   Against   For    
  5.    To approve an amendment to our Amended and Restated Certificate of Incorporation to permit stockholders to call special meetings. Management   For   For    
  BERKELEY LIGHTS, INC.    
  Security 084310101       Meeting Type Annual  
  Ticker Symbol BLI                   Meeting Date 26-May-2022  
  ISIN US0843101017       Agenda 935623353 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Jessica Hopfield, Ph.D.       For   For    
      2 Igor Khandros, Ph.D.       For   For    
      3 Michael Moritz       For   For    
  2.    Ratification of the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022; Management   For   For    
  3.    An advisory vote on the frequency of future advisory votes to approve the compensation paid to our named executive officers; and Management   1 Year   For    
  IRHYTHM TECHNOLOGIES, INC.    
  Security 450056106       Meeting Type Annual  
  Ticker Symbol IRTC                  Meeting Date 26-May-2022  
  ISIN US4500561067       Agenda 935638431 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 C. Noel Bairey Merz MD*       For   For    
      2 Mark J. Rubash*       For   For    
      3 Renee Budig*       For   For    
      4 Abhijit Y. Talwalkar#       For   For    
      5 Bruce G. Bodaken#       For   For    
      6 Ralph Synderman, M.D.#       For   For    
  2.    To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022. Management   For   For    
  3.    Advisory vote to approve Named Executive Officer Compensation. Management   For   For    
  CARECLOUD, INC.    
  Security 14167R100       Meeting Type Annual  
  Ticker Symbol MTBC                  Meeting Date 01-Jun-2022  
  ISIN US14167R1005       Agenda 935610887 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1)    DIRECTOR Management            
      1 A. Hadi Chaudhry       For   For    
      2 John N. Daly       For   For    
      3 Mahmud Haq       For   For    
      4 Cameron P. Munter       For   For    
  2)    To amend CareCloud, Inc.’s (the “Company”) certificate of incorporation to increase the Company’s authorized shares of common stock from twenty-nine million shares to thirty-five million shares. Management   For   For    
  3)    To amend the Company’s certificate of incorporation to increase the Company’s authorized shares of preferred stock from seven million shares to fifteen million shares. Management   For   For    
  4)    To amend the Company’s Amended and Restated Equity Incentive Plan (the “Equity Plan”) to increase the number of shares of the Company’s common stock issuable under the plan from 4,851,000 shares to 5,851,000 shares. Management   Against   Against    
  5)    To amend the Company’s Equity Plan to add 200,000 shares of the Company’s Series B Preferred Stock issuable under the plan. Management   For   For    
  NEOGENOMICS, INC.    
  Security 64049M209       Meeting Type Annual  
  Ticker Symbol NEO                   Meeting Date 02-Jun-2022  
  ISIN US64049M2098       Agenda 935603541 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Director: Lynn A. Tetrault Management   For   For    
  1B.   Election of Director: Bruce K. Crowther Management   For   For    
  1C.   Election of Director: David J. Daly Management   For   For    
  1D.   Election of Director: Dr. Alison L. Hannah Management   For   For    
  1E.   Election of Director: Stephen M. Kanovsky Management   For   For    
  1F.   Election of Director: Michael A. Kelly Management   For   For    
  1G.   Election of Director: Rachel A. Stahler Management   For   For    
  2.    Approval, on an advisory basis, of the Compensation Paid to the Company’s Named Executive Officers. Management   For   For    
  3.    Approval of the Third Amendment of the Amended and Restated Employee Stock Purchase Plan. Management   For   For    
  4.    Ratification of the Appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm. Management   For   For    
  GLOBUS MEDICAL, INC.    
  Security 379577208       Meeting Type Annual  
  Ticker Symbol GMED                  Meeting Date 02-Jun-2022  
  ISIN US3795772082       Agenda 935614291 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Director: David C. Paul Management   For   For    
  1b.   Election of Director: Daniel T. Lemaitre Management   For   For    
  1c.   Election of Director: Ann D. Rhoads Management   For   For    
  2.    The approval of the amendment to the 2021 Equity Incentive Plan. Management   Against   Against    
  3.    To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  4.    To approve, in an advisory vote, the compensation of the Company’s named executive officers (the Say-on-Pay Vote). Management   For   For    
  GLAUKOS CORPORATION    
  Security 377322102       Meeting Type Annual  
  Ticker Symbol GKOS                  Meeting Date 02-Jun-2022  
  ISIN US3773221029       Agenda 935616889 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Mark J. Foley       For   For    
      2 David F. Hoffmeister       For   For    
      3 Gilbert H. Kliman, M.D.       For   For    
  2.    Approval, on an advisory basis, of the compensation of the Company’s named executive officers. Management   For   For    
  3.    Ratification of the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  SAREPTA THERAPEUTICS INC.    
  Security 803607100       Meeting Type Annual  
  Ticker Symbol SRPT                  Meeting Date 02-Jun-2022  
  ISIN US8036071004       Agenda 935634508 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.1   Election of Class I Director to hold office until the 2024 Annual meeting: Kathryn Boor, Ph.D. Management   For   For    
  1.2   Election of Class I Director to hold office until the 2024 Annual meeting: Michael Chambers Management   For   For    
  1.3   Election of Class I Director to hold office until the 2024 Annual meeting: Douglas S. Ingram Management   For   For    
  1.4   Election of Class I Director to hold office until the 2024 Annual meeting: Hans Wigzell, M.D., Ph.D. Management   For   For    
  2.    To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation. Management   For   For    
  3.    To approve an amendment to the Company’s 2018 Equity Incentive Plan (the “2018 Plan”) to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2018 Plan by 2,500,000 shares to 10,687,596 shares. Management   Against   Against    
  4.    To ratify the selection of KPMG LLP as the Company’s independent registered public accounting firm for the current year ending December 31, 2022. Management   For   For    
  SMILEDIRECTCLUB, INC.    
  Security 83192H106       Meeting Type Annual  
  Ticker Symbol SDC                   Meeting Date 03-Jun-2022  
  ISIN US83192H1068       Agenda 935618934 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Jordan Katzman       For   For    
      2 Steven Katzman       For   For    
  2.    Ratification of Ernst & Young LLP as the company’s independent registered accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  3.    Advisory vote to approve the company’s named executive officer compensation. Management   For   For    
  4.    Advisory vote on the frequency of holding an advisory vote on the company’s named executive officer compensation. Management   1 Year   For    
  INVITAE CORPORATION    
  Security 46185L103       Meeting Type Annual  
  Ticker Symbol NVTA                  Meeting Date 06-Jun-2022  
  ISIN US46185L1035       Agenda 935616550 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Class III Director: Eric Aguiar, M.D. Management   For   For    
  1b.   Election of Class III Director: Sean E. George, Ph.D. Management   For   For    
  2.    Amendment to our certificate of incorporation to increase the number of authorized shares of our common stock from 400,000,000 shares to 600,000,000 shares. Management   For   For    
  3.    Approval of, on a non-binding advisory basis, the compensation paid by us to our named executive officers. Management   For   For    
  4.    Ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  5.    Stockholder proposal to elect each director annually, if properly presented at the annual meeting. Shareholder   Against   For    
  UnitedHealth Group    
  Security 91324P102       Meeting Type Annual  
  Ticker Symbol UNH                   Meeting Date 06-Jun-2022  
  ISIN US91324P1021       Agenda 935618453 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Director: Timothy P. Flynn Management   For   For    
  1b.   Election of Director: Paul R. Garcia Management   For   For    
  1c.   Election of Director: Stephen J. Hemsley Management   For   For    
  1d.   Election of Director: Michele J. Hooper Management   For   For    
  1e.   Election of Director: F. William McNabb III Management   For   For    
  1f.   Election of Director: Valerie C. Montgomery Rice, M.D. Management   For   For    
  1g.   Election of Director: John H. Noseworthy, M.D. Management   For   For    
  1h.   Election of Director: Andrew Witty Management   For   For    
  2.    Advisory approval of the Company’s executive compensation. Management   For   For    
  3.    Ratification of the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2022. Management   For   For    
  4.    If properly presented at the 2022 Annual Meeting of Shareholders, the shareholder proposal seeking shareholder ratification of termination pay. Shareholder   Against   For    
  5.    If properly presented at the 2022 Annual Meeting of Shareholders, the shareholder proposal regarding political contributions congruency report. Shareholder   Abstain   Against    
  ORTHOFIX MEDICAL INC.    
  Security 68752M108       Meeting Type Annual  
  Ticker Symbol OFIX                  Meeting Date 06-Jun-2022  
  ISIN US68752M1080       Agenda 935622945 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.1   Election of Director: Wayne Burris Management   For   For    
  1.2   Election of Director: Catherine M. Burzik Management   For   For    
  1.3   Election of Director: Jason M. Hannon Management   For   For    
  1.4   Election of Director: James F. Hinrichs Management   For   For    
  1.5   Election of Director: Lilly Marks Management   For   For    
  1.6   Election of Director: Michael E. Paolucci Management   For   For    
  1.7   Election of Director: Jon C. Serbousek Management   For   For    
  1.8   Election of Director: John E. Sicard Management   For   For    
  1.9   Election of Director: Thomas A. West Management   For   For    
  2.    Advisory and non-binding resolution on the compensation of Orthofix Medical Inc.’s named executive officers. Management   For   For    
  3.    Approval of Amendment No. 3 to the Orthofix Medical Inc. Amended and Restated 2012 Long-Term Incentive Plan. Management   Against   Against    
  4.    Ratification of the selection of Ernst & Young LLP as the independent registered public accounting firm for Orthofix Medical Inc. and its subsidiaries for the fiscal year ending December 31, 2022. Management   For   For    
  ORGANON & CO.    
  Security 68622V106       Meeting Type Annual  
  Ticker Symbol OGN                   Meeting Date 07-Jun-2022  
  ISIN US68622V1061       Agenda 935629177 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Class I Director: Robert Essner Management   For   For    
  1b.   Election of Class I Director: Shelly Lazarus Management   For   For    
  1c.   Election of Class I Director: Cynthia M. Patton Management   For   For    
  1d.   Election of Class I Director: Grace Puma Management   For   For    
  2.    Approve, on a non-binding advisory basis, the compensation of Organon’s Named Executive Officers. Management   For   For    
  3.    Approve, on a non-binding advisory basis, the frequency of future votes to approve the compensation of Organon’s Named Executive Officers. Management   1 Year   For    
  4.    Ratify the appointment of PricewaterhouseCoopers LLP as Organon’s independent registered public accounting firm for 2022. Management   For   For    
  ACADIA PHARMACEUTICALS INC.    
  Security 004225108       Meeting Type Annual  
  Ticker Symbol ACAD                  Meeting Date 07-Jun-2022  
  ISIN US0042251084       Agenda 935657796 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Laura A. Brege       For   For    
      2 Stephen R. Davis       For   For    
      3 Elizabeth A. Garofalo       For   For    
  2.    To approve an amendment to the Company’s 2010 Equity Incentive Plan, as amended, to, among other things, increase the aggregate number of shares of common stock authorized for issuance under the plan by 6,000,000 shares. Management   Against   Against    
  3.    To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in this proxy statement. Management   For   For    
  4.    To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  GERRESHEIMER AG    
  Security D2852S109       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 08-Jun-2022  
  ISIN DE000A0LD6E6       Agenda 715545868 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  CMMT  VOTING MUST BE LODGED WITH SHAREHOLDER DETAILS AS PROVIDED BY YOUR CUSTODIAN.-IF NO SHAREHOLDER DETAILS ARE PROVIDED, YOUR INSTRUCTION MAY BE REJECTED. Non-Voting            
  CMMT  FROM 10TH FEBRUARY, BROADRIDGE WILL CODE ALL AGENDAS FOR GERMAN MEETINGS IN-ENGLISH ONLY. IF YOU WISH TO SEE THE AGENDA IN GERMAN, THIS WILL BE MADE-AVAILABLE AS A LINK UNDER THE ‘MATERIAL URL’ DROPDOWN AT THE TOP OF THE-BALLOT. THE GERMAN AGENDAS FOR ANY EXISTING OR PAST MEETINGS WILL REMAIN IN-PLACE. FOR FURTHER INFORMATION, PLEASE CONTACT YOUR CLIENT SERVICE- REPRESENTATIVE. Non-Voting            
  CMMT  ACCORDING TO GERMAN LAW, IN CASE OF SPECIFIC CONFLICTS OF INTEREST IN- CONNECTION WITH SPECIFIC ITEMS OF THE AGENDA FOR THE GENERAL MEETING YOU ARE- NOT ENTITLED TO EXERCISE YOUR VOTING RIGHTS. FURTHER, YOUR VOTING RIGHT MIGHT-BE EXCLUDED WHEN YOUR SHARE IN VOTING RIGHTS HAS REACHED CERTAIN THRESHOLDS-AND YOU HAVE NOT COMPLIED WITH ANY OF YOUR MANDATORY VOTING RIGHTS-NOTIFICATIONS PURSUANT TO THE GERMAN SECURITIES TRADING ACT (WPHG). FOR-QUESTIONS IN THIS REGARD PLEASE CONTACT YOUR CLIENT SERVICE REPRESENTATIVE-FOR CLARIFICATION. IF YOU DO NOT HAVE ANY INDICATION REGARDING SUCH CONFLICT-OF INTEREST, OR ANOTHER EXCLUSION FROM VOTING, PLEASE SUBMIT YOUR VOTE AS- USUAL. Non-Voting            
  CMMT  INFORMATION ON COUNTER PROPOSALS CAN BE FOUND DIRECTLY ON THE ISSUER’S-WEBSITE (PLEASE REFER TO THE MATERIAL URL SECTION OF THE APPLICATION). IF YOU-WISH TO ACT ON THESE ITEMS, YOU WILL NEED TO REQUEST A MEETING ATTEND AND-VOTE YOUR SHARES DIRECTLY AT THE COMPANY’S MEETING. COUNTER PROPOSALS CANNOT-BE REFLECTED ON THE BALLOT ON PROXYEDGE. Non-Voting            
  CMMT  “INTERMEDIARY CLIENTS ONLY - PLEASE NOTE THAT IF YOU ARE CLASSIFIED AS AN- INTERMEDIARY CLIENT UNDER THE SHAREHOLDER RIGHTS DIRECTIVE II, YOU SHOULD BE-PROVIDING THE UNDERLYING SHAREHOLDER INFORMATION AT THE VOTE INSTRUCTION-LEVEL. IF YOU ARE UNSURE ON HOW TO PROVIDE THIS LEVEL OF DATA TO BROADRIDGE-OUTSIDE OF PROXYEDGE, PLEASE SPEAK TO YOUR DEDICATED CLIENT SERVICE-REPRESENTATIVE FOR ASSISTANCE” Non-Voting            
  1     RECEIVE FINANCIAL STATEMENTS AND STATUTORY REPORTS FOR SHORT FISCAL YEAR 2021 Non-Voting            
  2     APPROVE ALLOCATION OF INCOME AND DIVIDENDS OF EUR 1.25 PER SHARE Management   No Action        
  3     APPROVE DISCHARGE OF MANAGEMENT BOARD FOR FISCAL YEAR 2021 Management   No Action        
  4     APPROVE DISCHARGE OF SUPERVISORY BOARD FOR FISCAL YEAR 2021 Management   No Action        
  5     RATIFY DELOITTE GMBH AS AUDITORS FOR FISCAL YEAR 2022 AND FOR THE REVIEW OF INTERIM FINANCIAL STATEMENTS FOR THE FIRST HALF OF FISCAL YEAR 2022 Management   No Action        
  6.1   ELECT AXEL HERBERG TO THE SUPERVISORY BOARD Management   No Action        
  6.2   ELECT ANDREA ABT TO THE SUPERVISORY BOARD Management   No Action        
  6.3   ELECT ANNETTE KOEHLER TO THE SUPERVISORY BOARD Management   No Action        
  6.4   ELECT KARIN DORREPAAL TO THE SUPERVISORY BOARD Management   No Action        
  6.5   ELECT PETER NOE TO THE SUPERVISORY BOARD Management   No Action        
  6.6   ELECT UDO VETTER TO THE SUPERVISORY BOARD Management   No Action        
  CMMT  28 APR 2022: PLEASE NOTE THAT THIS IS A REVISION DUE TO CHANGE IN NUMBERING-OF RESOLUTION 6.6. IF YOU HAVE ALREADY SENT IN YOUR VOTES, PLEASE DO NOT VOTE-AGAIN UNLESS YOU DECIDE TO AMEND YOUR ORIGINAL INSTRUCTIONS. THANK YOU Non-Voting            
  CHINA MENGNIU DAIRY CO LTD    
  Security G21096105       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 08-Jun-2022  
  ISIN KYG210961051       Agenda 715650075 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  CMMT  PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2022/ 0516/2022051600491.pdf-AND- https://www1.hkexnews.hk/listedco/listconews/sehk/2022/ 0516/2022051600500.pdf Non-Voting            
  CMMT  PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE ‘IN FAVOR’ OR ‘AGAINST’ FOR- ALL RESOLUTIONS, ABSTAIN IS NOT A VOTING OPTION ON THIS MEETING. Non-Voting            
  1     TO REVIEW AND CONSIDER THE AUDITED FINANCIAL STATEMENTS AND THE REPORTS OF THE DIRECTORS AND THE INDEPENDENT AUDITORS FOR THE YEAR ENDED 31 DECEMBER 2021 Management   For   For    
  2     TO APPROVE THE PROPOSED FINAL DIVIDEND OF RMB0.381 PER SHARE FOR THE YEAR ENDED 31 DECEMBER 2021 Management   For   For    
  3.A   TO RE-ELECT MR. CHEN LANG AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION Management   Against   Against    
  3.B   TO RE-ELECT MS. WANG YAN AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HER REMUNERATION Management   For   For    
  3.C   TO RE-ELECT MR. ZHANG PING AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION Management   For   For    
  3.D   TO RE-ELECT MR. WANG XI AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION Management   For   For    
  3.E   TO RE-ELECT MR. YIH DIETER (ALIAS YIH LAI TAK, DIETER) AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION Management   For   For    
  3.F   TO RE-ELECT MR. LI MICHAEL HANKIN AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION Management   For   For    
  3.G   TO RE-ELECT MR. GE JUN AS DIRECTOR AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX HIS REMUNERATION Management   For   For    
  4     TO APPOINT KPMG AS THE AUDITORS OF THE COMPANY AND AUTHORISE THE BOARD OF DIRECTORS OF THE COMPANY TO FIX THEIR REMUNERATION FOR THE YEAR ENDING 31 DECEMBER 2022 Management   For   For    
  5     ORDINARY RESOLUTION NO. 5 SET OUT IN THE NOTICE OF AGM (TO GIVE A GENERAL MANDATE TO THE DIRECTORS TO REPURCHASE SHARES IN THE COMPANY NOT EXCEEDING 10% OF THE ISSUED SHARE CAPITAL OF THE COMPANY) Management   For   For    
  6     ORDINARY RESOLUTION NO. 6 SET OUT IN THE NOTICE OF AGM (TO GIVE A GENERAL MANDATE TO THE DIRECTORS TO ALLOT, ISSUE AND DEAL WITH ADDITIONAL SHARES NOT EXCEEDING 10% OF THE ISSUED SHARE CAPITAL OF THE COMPANY) Management   Against   Against    
  7     SPECIAL RESOLUTION NO. 7 SET OUT IN THE NOTICE OF AGM (TO APPROVE THE PROPOSED AMENDMENTS TO THE EXISTING MEMORANDUM OF ASSOCIATION AND ARTICLES OF ASSOCIATION OF THE COMPANY AND THE ADOPTION OF THE NEW MEMORANDUM OF ASSOCIATION AND ARTICLES OF ASSOCIATION OF THE COMPANY) Management   Against   Against    
  PARATEK PHARMACEUTICALS, INC.    
  Security 699374302       Meeting Type Annual  
  Ticker Symbol PRTK                  Meeting Date 08-Jun-2022  
  ISIN US6993743029       Agenda 935613845 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Thomas J. Dietz, Ph.D.       For   For    
      2 Timothy R. Franson M.D.       For   For    
      3 Evan Loh, M.D.       For   For    
  2.    To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  2SEVENTY BIO, INC.    
  Security 901384107       Meeting Type Annual  
  Ticker Symbol TSVT                  Meeting Date 08-Jun-2022  
  ISIN US9013841070       Agenda 935618871 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Nick Leschly       For   For    
      2 Ramy Ibrahim, M.D.       For   For    
  2.    To ratify the selection of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  DAVITA INC.    
  Security 23918K108       Meeting Type Annual  
  Ticker Symbol DVA                   Meeting Date 09-Jun-2022  
  ISIN US23918K1088       Agenda 935626474 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Director: Pamela M. Arway Management   For   For    
  1b.   Election of Director: Charles G. Berg Management   For   For    
  1c.   Election of Director: Barbara J. Desoer Management   For   For    
  1d.   Election of Director: Paul J. Diaz Management   For   For    
  1e.   Election of Director: Jason M. Hollar Management   For   For    
  1f.   Election of Director: Gregory J. Moore, MD, PhD Management   For   For    
  1g.   Election of Director: John M. Nehra Management   For   For    
  1h.   Election of Director: Javier J. Rodriguez Management   For   For    
  1i.   Election of Director: Phyllis R. Yale Management   For   For    
  2.    To ratify the appointment of KPMG LLP as our independent registered public accounting firm for fiscal year 2022. Management   For   For    
  3.    To approve, on an advisory basis, the compensation of our named executive officers. Management   For   For    
  4.    Stockholder proposal regarding political contributions disclosure, if properly presented at the meeting. Shareholder   Abstain   Against    
  SOVOS BRANDS INC.    
  Security 84612U107       Meeting Type Annual  
  Ticker Symbol SOVO                  Meeting Date 09-Jun-2022  
  ISIN US84612U1079       Agenda 935627109 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of the Class I Director to serve until the 2025 Annual Meeting: Todd R. Lachman Management   For   For    
  1b.   Election of the Class I Director to serve until the 2025 Annual Meeting: Neha U. Mathur Management   For   For    
  1c.   Election of the Class I Director to serve until the 2025 Annual Meeting: Valarie L. Sheppard Management   For   For    
  2.    Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022 Management   For   For    
  SILK ROAD MEDICAL, INC.    
  Security 82710M100       Meeting Type Annual  
  Ticker Symbol SILK                  Meeting Date 09-Jun-2022  
  ISIN US82710M1009       Agenda 935628024 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Elizabeth H. Weatherman       For   For    
      2 Donald J. Zurbay       For   For    
  2.    To approve Named Executive Officer Compensation on an advisory basis. Management   For   For    
  3.    To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022. Management   For   For    
  EXACT SCIENCES CORPORATION    
  Security 30063P105       Meeting Type Annual  
  Ticker Symbol EXAS                  Meeting Date 09-Jun-2022  
  ISIN US30063P1057       Agenda 935632629 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Kevin Conroy       For   For    
      2 Shacey Petrovic       For   For    
      3 Katherine Zanotti       For   For    
  2.    To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2022. Management   For   For    
  3.    To approve, on an advisory basis, the compensation of our named executive officers. Management   For   For    
  4.    To approve Amendment No. 1 to the Exact Sciences Corporation 2019 Omnibus Long-Term Incentive Plan. Management   Against   Against    
  5.    To approve the Amended and Restated Exact Sciences Corporation 2010 Employee Stock Purchase Plan. Management   For   For    
  6.    The Shareholder Proposal concerning proxy access. Shareholder   Abstain   Against    
  EVOLENT HEALTH, INC.    
  Security 30050B101       Meeting Type Annual  
  Ticker Symbol EVH                   Meeting Date 09-Jun-2022  
  ISIN US30050B1017       Agenda 935634142 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Director: Craig Barbarosh Management   For   For    
  1b.   Election of Director: Kim Keck Management   For   For    
  1c.   Election of Director: Cheryl Scott Management   For   For    
  1d.   Election of Director: Frank Williams Management   For   For    
  1e.   Election of Director: Seth Blackley Management   For   For    
  1f.   Election of Director: David Farner Management   For   For    
  1g.   Election of Director: Peter Grua Management   For   For    
  2.    Proposal to ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  3.    Proposal to approve the compensation of our named executive officers for 2021 on an advisory basis. Management   For   For    
  REGENERON PHARMACEUTICALS, INC.    
  Security 75886F107       Meeting Type Annual  
  Ticker Symbol REGN                  Meeting Date 10-Jun-2022  
  ISIN US75886F1075       Agenda 935620383 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Director: Bonnie L. Bassler, Ph.D. Management   For   For    
  1b.   Election of Director: Michael S. Brown, M.D. Management   For   For    
  1c.   Election of Director: Leonard S. Schleifer, M.D., Ph.D. Management   For   For    
  1d.   Election of Director: George D. Yancopoulos, M.D., Ph.D. Management   For   For    
  2.    Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  3.    Proposal to approve, on an advisory basis, executive compensation. Management   For   For    
  TINGYI (CAYMAN ISLANDS) HOLDING CORP    
  Security G8878S103       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 13-Jun-2022  
  ISIN KYG8878S1030       Agenda 715578665 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  CMMT  PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2022/ 0426/2022042600353.pdf- https://www1.hkexnews.hk/listedco/listconews/sehk/2022/ 0426/2022042600369.pdf Non-Voting            
  CMMT  PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE ‘IN FAVOR’ OR ‘AGAINST’ FOR- ALL RESOLUTIONS, ABSTAIN IS NOT A VOTING OPTION ON THIS MEETING. Non-Voting            
  1     TO RECEIVE AND CONSIDER THE AUDITED ACCOUNTS AND THE REPORTS OF THE DIRECTORS AND AUDITORS FOR THE YEAR ENDED 31 DECEMBER 2021 Management   For   For    
  2     TO APPROVE THE PAYMENT OF A FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2021 Management   For   For    
  3     TO APPROVE THE PAYMENT OF A SPECIAL FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2021 Management   For   For    
  4     TO RE-ELECT MR. YUKO TAKAHASHI AS AN EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HIS REMUNERATION Management   Against   Against    
  5     TO RE-ELECT MS. TSENG CHIEN AS AN EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HER REMUNERATION Management   For   For    
  6     TO RE-ELECT MR. HSU, SHIN-CHUN AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR AND TO AUTHORIZE THE DIRECTORS TO FIX HIS REMUNERATION Management   Against   Against    
  7     TO RE-APPOINT AUDITORS OF THE COMPANY AND AUTHORISE THE DIRECTORS TO FIX THEIR REMUNERATION Management   For   For    
  8     TO CONSIDER AND APPROVE THE GENERAL MANDATE TO ISSUE SHARES Management   Against   Against    
  9     TO CONSIDER AND APPROVE THE GENERAL MANDATE TO BUY BACK SHARES OF THE COMPANY Management   For   For    
  10    TO CONSIDER AND APPROVE THAT THE TOTAL NUMBER OF SHARES WHICH ARE BOUGHT BACK BY THE COMPANY SHALL BE ADDED TO THE TOTAL NUMBER OF SHARES WHICH MAY BE ALLOTED PURSUANT TO THE GENERAL MANDATE FOR ISSUE OF SHARES Management   Against   Against    
  TINGYI (CAYMAN ISLANDS) HOLDING CORP    
  Security G8878S103       Meeting Type ExtraOrdinary General Meeting
  Ticker Symbol         Meeting Date 13-Jun-2022  
  ISIN KYG8878S1030       Agenda 715596536 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  CMMT  PLEASE NOTE THAT SHAREHOLDERS ARE ALLOWED TO VOTE ‘IN FAVOR’ OR ‘AGAINST’ FOR- ALL RESOLUTIONS, ABSTAIN IS NOT A VOTING OPTION ON THIS MEETING. Non-Voting            
  CMMT  PLEASE NOTE THAT THE COMPANY NOTICE AND PROXY FORM ARE AVAILABLE BY CLICKING-ON THE URL LINKS:- https://www1.hkexnews.hk/listedco/listconews/sehk/2022/ 0428/2022042800698.pdf-AND- https://www1.hkexnews.hk/listedco/listconews/sehk/2022/ 0428/2022042800822.pdf Non-Voting            
  1     TO APPROVE THE TINGZHENG SUPPLY AGREEMENT, THE TRANSACTIONS CONTEMPLATED THEREUNDER AND THE RELEVANT ANNUAL CAPS Management   For   For    
  2     TO APPROVE THE MARINE VISION SUPPLY AGREEMENT, THE TRANSACTIONS CONTEMPLATED THEREUNDER AND THE RELEVANT ANNUAL CAPS Management   For   For    
  3     TO APPROVE THE TING TONG LOGISTICS AGREEMENT, THE TRANSACTIONS CONTEMPLATED THEREUNDER AND THE RELEVANT ANNUAL CAPS Management   For   For    
  GOODRX HOLDINGS, INC.    
  Security 38246G108       Meeting Type Annual  
  Ticker Symbol GDRX                  Meeting Date 14-Jun-2022  
  ISIN US38246G1085       Agenda 935623858 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Christopher Adams       For   For    
      2 Trevor Bezdek       For   For    
      3 Adam Karol       For   For    
  2.    Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  3.    Approval, on an advisory (non-binding) basis, of the frequency of future advisory votes on the compensation of the Company’s named executive officers. Management   1 Year   For    
  GLOBAL BLOOD THERAPEUTICS, INC.    
  Security 37890U108       Meeting Type Annual  
  Ticker Symbol GBT                   Meeting Date 14-Jun-2022  
  ISIN US37890U1088       Agenda 935632035 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Ted W. Love, M.D.       For   For    
      2 Glenn F. Pierce, MD PhD       For   For    
      3 Dawn A. Svoronos       For   For    
  2.    Approval, on a non-binding, advisory basis, of the compensation of the Company’s named executive officers as disclosed in the proxy statement. Management   For   For    
  3.    Ratification of the appointment of KPMG LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022. Management   For   For    
  INCYTE CORPORATION    
  Security 45337C102       Meeting Type Annual  
  Ticker Symbol INCY                  Meeting Date 15-Jun-2022  
  ISIN US45337C1027       Agenda 935620713 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.1   Election of Director: Julian C. Baker Management   For   For    
  1.2   Election of Director: Jean-Jacques Bienaimé Management   For   For    
  1.3   Election of Director: Otis W. Brawley Management   For   For    
  1.4   Election of Director: Paul J. Clancy Management   For   For    
  1.5   Election of Director: Jacqualyn A. Fouse Management   For   For    
  1.6   Election of Director: Edmund P. Harrigan Management   For   For    
  1.7   Election of Director: Katherine A. High Management   For   For    
  1.8   Election of Director: Hervé Hoppenot Management   For   For    
  2.    Approve, on a non-binding, advisory basis, the compensation of the Company’s named executive officers. Management   For   For    
  3.    Ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for 2022. Management   For   For    
  GUARDANT HEALTH, INC.    
  Security 40131M109       Meeting Type Annual  
  Ticker Symbol GH                    Meeting Date 15-Jun-2022  
  ISIN US40131M1099       Agenda 935621424 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1A.   Election of Class I Director: Vijaya Gadde Management   For   For    
  1B.   Election of Class I Director: Myrtle Potter Management   For   For    
  2.    Ratification of the appointment of Ernst & Young LLP as Guardant Health, Inc.’s independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  3.    Non-binding advisory vote to approve Guardant Health, Inc.’s named executive officer compensation. Management   For   For    
  CAREDX, INC.    
  Security 14167L103       Meeting Type Annual  
  Ticker Symbol CDNA                  Meeting Date 15-Jun-2022  
  ISIN US14167L1035       Agenda 935629999 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Fred E Cohen MD, DPhil       For   For    
      2 Christine M. Cournoyer       For   For    
      3 William A. Hagstrom       For   For    
  2.    Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022. Management   For   For    
  3.    Approval, on an advisory basis, of the compensation of our named executive officers. Management   For   For    
  EHEALTH, INC.    
  Security 28238P109       Meeting Type Annual  
  Ticker Symbol EHTH                  Meeting Date 15-Jun-2022  
  ISIN US28238P1093       Agenda 935634952 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 A. John Hass       For   For    
      2 Francis S. Soistman       For   For    
      3 Aaron C. Tolson       For   For    
  2.    Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm of eHealth, Inc. for the fiscal year ending December 31, 2022. Management   For   For    
  3.    Approval, on an advisory basis, of the compensation of the Named Executive Officers of eHealth, Inc. Management   For   For    
  4.    Approval of an amendment to eHealth, Inc.’s 2014 Equity Incentive Plan to increase the maximum number of shares that may be issued by 3,000,000 shares. Management   Against   Against    
  CUTERA, INC.    
  Security 232109108       Meeting Type Annual  
  Ticker Symbol CUTR                  Meeting Date 15-Jun-2022  
  ISIN US2321091082       Agenda 935636677 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Director: Gregory A. Barrett Management   For   For    
  1b.   Election of Director: Sheila A. Hopkins Management   For   For    
  1c.   Election of Director: David H. Mowry Management   For   For    
  1d.   Election of Director: Timothy J. O’Shea Management   For   For    
  1e.   Election of Director: Juliane T. Park Management   For   For    
  1f.   Election of Director: J. Daniel Plants Management   For   For    
  1g.   Election of Director: Joseph E. Whitters Management   For   For    
  1h.   Election of Director: Janet L. Widmann Management   For   For    
  1i.   Election of Director: Katherine S. Zanotti Management   For   For    
  2.    Ratification of BDO USA, LLP as the Independent Registered Public Accounting Firm for the fiscal year ending December 31, 2022. Management   For   For    
  3.    Non-binding advisory vote on the compensation of Named Executive Officers. Management   For   For    
  4.    Approval of the amendment and restatement of our 2019 Equity Incentive Plan to increase the total shares available for issuance under the 2019 Equity Incentive Plan by 600,000 shares. Management   Against   Against    
  STANDARD BIOTOOLS INC.    
  Security 34385P108       Meeting Type Annual  
  Ticker Symbol LAB                   Meeting Date 15-Jun-2022  
  ISIN US34385P1084       Agenda 935637845 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Laura M. Clague       For   For    
      2 Frank Witney       For   For    
  2.    To approve our executive compensation program for the year ended December 31, 2021, on an advisory (non- binding) basis. Management   For   For    
  3.    To ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  GRITSTONE BIO, INC.    
  Security 39868T105       Meeting Type Annual  
  Ticker Symbol GRTS                  Meeting Date 17-Jun-2022  
  ISIN US39868T1051       Agenda 935626234 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Andrew Allen, M.D., PhD       For   For    
      2 Naiyer Rizvi, M.D.       For   For    
  2.    The ratification of the selection, by the audit committee of our board of directors, of Ernst & Young LLP, as our independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  NANOSTRING TECHNOLOGIES, INC.    
  Security 63009R109       Meeting Type Annual  
  Ticker Symbol NSTG                  Meeting Date 17-Jun-2022  
  ISIN US63009R1095       Agenda 935638289 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Dana Rollison, Ph.D.       For   For    
      2 William D. Young       For   For    
  2.    To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the year ending December 31, 2022. Management   For   For    
  3.    To approve, on an advisory basis, the compensation of our named executive officers. Management   For   For    
  4.    To approve the NanoString Technologies, Inc. 2022 Equity Incentive Plan. Management   Against   Against    
  5.    To approve, on an advisory basis, a stockholder proposal to elect each director annually. Shareholder   Abstain        
  KIKKOMAN CORPORATION    
  Security J32620106       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 21-Jun-2022  
  ISIN JP3240400006       Agenda 715716974 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
    Please reference meeting materials. Non-Voting            
  1     Approve Appropriation of Surplus Management   For   For    
  2     Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations Management   For   For    
  3.1   Appoint a Director Mogi, Yuzaburo Management   Against   Against    
  3.2   Appoint a Director Horikiri, Noriaki Management   For   For    
  3.3   Appoint a Director Nakano, Shozaburo Management   For   For    
  3.4   Appoint a Director Yamazaki, Koichi Management   For   For    
  3.5   Appoint a Director Shimada, Masanao Management   For   For    
  3.6   Appoint a Director Mogi, Osamu Management   For   For    
  3.7   Appoint a Director Matsuyama, Asahi Management   For   For    
  3.8   Appoint a Director Kamiyama, Takao Management   For   For    
  3.9   Appoint a Director Fukui, Toshihiko Management   For   For    
  3.10  Appoint a Director Inokuchi, Takeo Management   For   For    
  3.11  Appoint a Director Iino, Masako Management   For   For    
  3.12  Appoint a Director Sugiyama, Shinsuke Management   For   For    
  4     Appoint a Corporate Auditor Kajikawa, Toru Management   For   For    
  5     Appoint a Substitute Corporate Auditor Endo, Kazuyoshi Management   For   For    
  6     Approve Details of the Compensation to be received by Corporate Officers Management   For   For    
  7     Approve Details of the Stock Compensation to be received by Directors Management   For   For    
  8     Approve Delegation of Authority to the Board of Directors to Use Free Share Acquisition Rights Management   Against   Against    
  VAPOTHERM, INC.    
  Security 922107107       Meeting Type Annual  
  Ticker Symbol VAPO                  Meeting Date 21-Jun-2022  
  ISIN US9221071072       Agenda 935641022 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.1   Election of Director to serve until the 2025 annual meeting: Joseph Army Management   For   For    
  1.2   Election of Director to serve until the 2025 annual meeting: James Liken Management   For   For    
  1.3   Election of Director to serve until the 2025 annual meeting: Elizabeth Weatherman Management   For   For    
  2.    To approve, on an advisory (non-binding) basis, our executive compensation. Management   For   For    
  3.    To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022. Management   For   For    
  BAUSCH HEALTH COMPANIES, INC.    
  Security 071734107       Meeting Type Annual  
  Ticker Symbol BHC                   Meeting Date 21-Jun-2022  
  ISIN CA0717341071       Agenda 935644838 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Director: Thomas J. Appio Management   For   For    
  1b.   Election of Director: Richard U. De Schutter Management   For   For    
  1c.   Election of Director: Brett Icahn Management   For   For    
  1d.   Election of Director: Dr. Argeris (Jerry) N. Karabelas Management   For   For    
  1e.   Election of Director: Sarah B. Kavanagh Management   For   For    
  1f.   Election of Director: Steven D. Miller Management   For   For    
  1g.   Election of Director: Dr. Richard C. Mulligan Management   For   For    
  1h.   Election of Director: Joseph C. Papa Management   For   For    
  1i.   Election of Director: Robert N. Power Management   For   For    
  1j.   Election of Director: Russel C. Robertson Management   For   For    
  1k.   Election of Director: Thomas W. Ross, Sr. Management   For   For    
  1l.   Election of Director: Amy B. Wechsler, M.D. Management   For   For    
  2.    The approval, in an advisory vote, of the compensation of our Named Executive Officers. Management   For   For    
  3.    The approval of an amendment and restatement of the Company’s Amended and Restated 2014 Omnibus Incentive Plan. Management   Withheld   Against    
  4.    The appointment of PricewaterhouseCoopers LLP to serve as the Company’s auditor until the close of the 2023 Annual Meeting of Shareholders and to authorize the Board to fix the auditor’s remuneration. Management   For   For    
  YAKULT HONSHA CO.,LTD.    
  Security J95468120       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 22-Jun-2022  
  ISIN JP3931600005       Agenda 715727876 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
    Please reference meeting materials. Non-Voting            
  1     Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations Management   For   For    
  2.1   Appoint a Director Narita, Hiroshi Management   For   For    
  2.2   Appoint a Director Wakabayashi, Hiroshi Management   For   For    
  2.3   Appoint a Director Ishikawa, Fumiyasu Management   For   For    
  2.4   Appoint a Director Doi, Akifumi Management   For   For    
  2.5   Appoint a Director Hayashida, Tetsuya Management   For   For    
  2.6   Appoint a Director Ito, Masanori Management   For   For    
  2.7   Appoint a Director Hirano, Susumu Management   For   For    
  2.8   Appoint a Director Imada, Masao Management   For   For    
  2.9   Appoint a Director Hirano, Koichi Management   For   For    
  2.10  Appoint a Director Yasuda, Ryuji Management   For   For    
  2.11  Appoint a Director Tobe, Naoko Management   For   For    
  2.12  Appoint a Director Shimbo, Katsuyoshi Management   For   For    
  2.13  Appoint a Director Nagasawa, Yumiko Management   For   For    
  2.14  Appoint a Director Naito, Manabu Management   For   For    
  2.15  Appoint a Director Akutsu, Satoshi Management   For   For    
  BLUEBIRD BIO, INC.    
  Security 09609G100       Meeting Type Annual  
  Ticker Symbol BLUE                  Meeting Date 22-Jun-2022  
  ISIN US09609G1004       Agenda 935641123 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Class III Director: Nick Leschly Management   For   For    
  1b.   Election of Class III Director: Najoh Tita-Reid Management   For   For    
  2.    To approve, on a non-binding, advisory basis, the compensation paid to the Company’s named executive officers. Management   For   For    
  3.    To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  PETIQ, INC.    
  Security 71639T106       Meeting Type Annual  
  Ticker Symbol PETQ                  Meeting Date 22-Jun-2022  
  ISIN US71639T1060       Agenda 935646301 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Class II Director to serve until the third Annual Meeting: Larry Bird Management   Abstain   Against    
  1b.   Election of Class II Director to serve until the third Annual Meeting: Mark First Management   For   For    
  1c.   Election of Class II Director to serve until the third Annual Meeting: Scott Huff Management   For   For    
  2.    To ratify the selection of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022. Management   For   For    
  3.    To approve, on an advisory, non-binding basis, the compensation of our named executive officers. Management   For   For    
  4.    To approve the amendment and restatement of our Amended and Restated 2017 Omnibus Incentive Plan. Management   Against   Against    
  5.    To amend our Amended and Restated Certificate of Incorporation to eliminate supermajority provisions. Management   For   For    
  6.    To amend our Amended and Restated Certificate of Incorporation to declassify our Board of Directors. Management   For   For    
  TEVA PHARMACEUTICAL INDUSTRIES LIMITED    
  Security 881624209       Meeting Type Annual  
  Ticker Symbol TEVA                  Meeting Date 23-Jun-2022  
  ISIN US8816242098       Agenda 935630978 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Director: Amir Elstein Management   For   For    
  1b.   Election of Director: Roberto A. Mignone Management   For   For    
  1c.   Election of Director: Dr. Perry D. Nisen Management   For   For    
  1d.   Election of Director: Dr. Tal Zaks Management   For   For    
  2.    To approve, on a non-binding advisory basis, the compensation for Teva’s named executive officers. Management   For   For    
  3.    To approve Teva’s Compensation Policy with respect to the Terms of Office and Employment of Teva’s Executive Officers and Directors. Management   For   For    
  3A.   Regarding proposal 3, please indicate when you vote whether or not you are a controlling shareholder of Teva and whether or not you have a personal benefit or other interest in this proposal* Mark “for” = yes or “against” = no. Management   Against        
  4.    To approve amendments to Teva’s Articles of Association. Management   For   For    
  5.    To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva’s independent registered public accounting firm until Teva’s 2023 annual meeting of shareholders. Management   For   For    
  THE KROGER CO.    
  Security 501044101       Meeting Type Annual  
  Ticker Symbol KR                    Meeting Date 23-Jun-2022  
  ISIN US5010441013       Agenda 935647416 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Nora A. Aufreiter       For   For    
      2 Kevin M. Brown       For   For    
      3 Elaine L. Chao       For   For    
      4 Anne Gates       For   For    
      5 Karen M. Hoguet       For   For    
      6 W. Rodney McMullen       For   For    
      7 Clyde R. Moore       For   For    
      8 Ronald L. Sargent       For   For    
      9 J. Amanda Sourry Knox       For   For    
      10 Mark S. Sutton       For   For    
      11 Ashok Vemuri       For   For    
  2.    To approve our executive compensation, on an advisory basis Management   For   For    
  3.    To ratify the selection of our independent auditor for fiscal year 2022 Management   For   For    
  4.    To approve additional shares under the 2019 Long-Term Incentive Plan Management   Against   Against    
  5.    Shareholder Proposal - Recyclability of Packaging Shareholder   Abstain   Against    
  6.    Shareholder Proposal - Report on Protection of Farmworkers Shareholder   Abstain   Against    
  7.    Shareholder Proposal - Report on Elimination of HFCs Shareholder   Abstain   Against    
  8.    Shareholder Proposal - Report on Workforce Strategy Shareholder   Abstain   Against    
  ORGANOGENESIS HOLDINGS INC    
  Security 68621F102       Meeting Type Annual  
  Ticker Symbol ORGO                  Meeting Date 23-Jun-2022  
  ISIN US68621F1021       Agenda 935654752 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.    DIRECTOR Management            
      1 Alan A. Ades       For   For    
      2 Robert Ades       For   For    
      3 Michael J. Driscoll       For   For    
      4 Prathyusha Duraibabu       For   For    
      5 David Erani       For   For    
      6 Jon Giacomin       For   For    
      7 Gary S. Gillheeney, Sr.       For   For    
      8 Michele Korfin       For   For    
      9 Arthur S. Leibowitz       For   For    
      10 Glenn H. Nussdorf       For   For    
      11 Gilberto Quintero       For   For    
  2.    Approval, on an advisory basis, of the compensation paid to our named executive officers, as disclosed in the Company’s proxy statement for its 2022 annual meeting of shareholders. Management   For   For    
  3.    Approval, on an advisory basis, of the frequency of holding an advisory vote on the compensation paid to our named executive officers. Management   1 Year   For    
  4.    Approval of an amendment to our certificate of incorporation to remove a provision that states that directors may only be removed for cause. Management   For   For    
  5.    Approval of an amendment to our 2018 Equity Incentive Plan to increase the number of shares of Class A common stock reserved for issuance thereunder by 7,826,970 shares. Management   Against   Against    
  6.    Appointment of RSM US LLP as independent registered public accounting firm for fiscal year 2022. Management   For   For    
  TEVA PHARMACEUTICAL INDUSTRIES LIMITED    
  Security 881624209       Meeting Type Annual  
  Ticker Symbol TEVA                  Meeting Date 23-Jun-2022  
  ISIN US8816242098       Agenda 935657859 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1a.   Election of Director: Amir Elstein Management   For   For    
  1b.   Election of Director: Roberto A. Mignone Management   For   For    
  1c.   Election of Director: Dr. Perry D. Nisen Management   For   For    
  1d.   Election of Director: Dr. Tal Zaks Management   For   For    
  2.    To approve, on a non-binding advisory basis, the compensation for Teva’s named executive officers. Management   For   For    
  3.    To approve Teva’s Compensation Policy with respect to the Terms of Office and Employment of Teva’s Executive Officers and Directors. Management   For   For    
  3A.   Regarding proposal 3, please indicate when you vote whether or not you are a controlling shareholder of Teva and whether or not you have a personal benefit or other interest in this proposal* Mark “for” = yes or “against” = no. Management   Against        
  4.    To approve amendments to Teva’s Articles of Association. Management   For   For    
  5.    To appoint Kesselman & Kesselman, a member of PricewaterhouseCoopers International Ltd., as Teva’s independent registered public accounting firm until Teva’s 2023 annual meeting of shareholders. Management   For   For    
  MORINAGA MILK INDUSTRY CO.,LTD.    
  Security J46410114       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 29-Jun-2022  
  ISIN JP3926800008       Agenda 715745761 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
    Please reference meeting materials. Non-Voting            
  1     Approve Appropriation of Surplus Management   For   For    
  2     Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations Management   For   For    
  3.1   Appoint a Director Miyahara, Michio Management   For   For    
  3.2   Appoint a Director Onuki, Yoichi Management   For   For    
  3.3   Appoint a Director Okawa, Teiichiro Management   For   For    
  3.4   Appoint a Director Minato, Tsuyoshi Management   For   For    
  3.5   Appoint a Director Yanagida, Yasuhiko Management   For   For    
  3.6   Appoint a Director Hyodo, Hitoshi Management   For   For    
  3.7   Appoint a Director Nozaki, Akihiro Management   For   For    
  3.8   Appoint a Director Yoneda, Takatomo Management   For   For    
  3.9   Appoint a Director Tominaga, Yukari Management   For   For    
  3.10  Appoint a Director Nakamura, Hiroshi Management   For   For    
  3.11  Appoint a Director Ikeda, Takayuki Management   For   For    
  4     Appoint a Corporate Auditor Hirota, Keiki Management   Against   Against    
  5     Appoint a Substitute Corporate Auditor Suzuki, Michio Management   For   For    
  MEIJI HOLDINGS CO.,LTD.    
  Security J41729104       Meeting Type Annual General Meeting
  Ticker Symbol         Meeting Date 29-Jun-2022  
  ISIN JP3918000005       Agenda 715745773 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
    Please reference meeting materials. Non-Voting            
  1     Amend Articles to: Approve Minor Revisions Related to Change of Laws and Regulations Management   For   For    
  2.1   Appoint a Director Kawamura, Kazuo Management   For   For    
  2.2   Appoint a Director Kobayashi, Daikichiro Management   For   For    
  2.3   Appoint a Director Matsuda, Katsunari Management   For   For    
  2.4   Appoint a Director Shiozaki, Koichiro Management   For   For    
  2.5   Appoint a Director Furuta, Jun Management   For   For    
  2.6   Appoint a Director Matsumura, Mariko Management   For   For    
  2.7   Appoint a Director Kawata, Masaya Management   For   For    
  2.8   Appoint a Director Kuboyama, Michiko Management   For   For    
  2.9   Appoint a Director Peter D. Pedersen Management   For   For    
  3     Appoint a Substitute Corporate Auditor Imamura, Makoto Management   For   For    
  ODONATE THERAPEUTICS, INC.    
  Security 676079106       Meeting Type Annual  
  Ticker Symbol ODTC                  Meeting Date 30-Jun-2022  
  ISIN US6760791060       Agenda 935674639 - Management
                             
  Item Proposal Proposed
by		     Vote For/Against
Management		    
  1.1   Election of Director: Kevin Tang Management   Abstain   Against    
  1.2   Election of Director: Aaron Davis Management   Abstain   Against    
  1.3   Election of Director: Craig Johnson Management   Abstain   Against    
 

 

SIGNATURES

Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Registrant The Gabelli Healthcare & WellnessRx Trust

 

By (Signature and Title)*  /s/ John C. Ball
  John C. Ball, President and Principal Executive Officer

 

Date August 24, 2022

 

*Print the name and title of each signing officer under his or her signature.